
<html lang="en"     class="pb-page"  data-request-id="3c83e193-c424-4e25-942f-0bc49c3a5ef0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2010.53.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm100925m;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, Radiolabeling, and in Vivo Evaluation of Carbon-11 Labeled N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a Potential Positron Emission Tomography Tracer for the Dopamine D4 Receptors" /></meta><meta name="dc.Creator" content="Enza  Lacivita" /></meta><meta name="dc.Creator" content="Paola  De Giorgio" /></meta><meta name="dc.Creator" content="Irene T.  Lee" /></meta><meta name="dc.Creator" content="Sean I.  Rodeheaver" /></meta><meta name="dc.Creator" content="Bryan A.  Weiss" /></meta><meta name="dc.Creator" content="Claudia  Fracasso" /></meta><meta name="dc.Creator" content="Silvio  Caccia" /></meta><meta name="dc.Creator" content="Francesco  Berardi" /></meta><meta name="dc.Creator" content="Roberto  Perrone" /></meta><meta name="dc.Creator" content="Ming-Rong  Zhang" /></meta><meta name="dc.Creator" content="Jun  Maeda" /></meta><meta name="dc.Creator" content="Makoto  Higuchi" /></meta><meta name="dc.Creator" content="Tetsuya  Suhara" /></meta><meta name="dc.Creator" content="John A.  Schetz" /></meta><meta name="dc.Creator" content="Marcello  Leopoldo" /></meta><meta name="dc.Description" content="Here we describe the design, synthesis, and evaluation of physicochemical and pharmacological properties of D4 dopamine receptor ligands related to N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-m..." /></meta><meta name="Description" content="Here we describe the design, synthesis, and evaluation of physicochemical and pharmacological properties of D4 dopamine receptor ligands related to N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-m..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 27, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100925m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100925m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100925m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100925m" /></link>
        
    
    

<title>Design, Synthesis, Radiolabeling, and in Vivo Evaluation of Carbon-11 Labeled N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a Potential Positron Emission Tomography Tracer for the Dopamine D4 Receptors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100925m" /></meta><meta property="og:title" content="Design, Synthesis, Radiolabeling, and in Vivo Evaluation of Carbon-11 Labeled N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a Potential Positron Emission Tomography Tracer for the Dopamine D4 Receptors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0007.jpeg" /></meta><meta property="og:description" content="Here we describe the design, synthesis, and evaluation of physicochemical and pharmacological properties of D4 dopamine receptor ligands related to N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (2). Structural features were incorporated to increase affinity for the target receptor, to improve selectivity over D2 and σ1 receptors, to enable labeling with carbon-11 or fluorine-18, and to adjust lipophilicity within the range considered optimal for brain penetration and low nonspecific binding. Compounds 7 and 13 showed the overall best characteristics: nanomolar affinity for the D4 receptor, &gt;100-fold selectivity over D2 and D3 dopamine receptors, 5-HT1A, 5-HT2A, and 5-HT2C serotonin receptors and σ1 receptors, and log P = 2.37−2.55. Following intraperitoneal administration in mice, both compounds rapidly entered the central nervous system. The methoxy of N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide (7) was radiolabeled with carbon-11 and subjected to PET analysis in non-human primate. [11C]7 time-dependently accumulated to saturation in the posterior eye in the region of the retina, a tissue containing a high density of D4 receptors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100925m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100925m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100925m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100925m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100925m&amp;href=/doi/10.1021/jm100925m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 7344-7355</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100585j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100953c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, Radiolabeling, and in Vivo Evaluation of Carbon-11 Labeled <i>N</i>-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a Potential Positron Emission Tomography Tracer for the Dopamine D<sub>4</sub> Receptors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Enza++Lacivita">Enza Lacivita</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paola++De+Giorgio">Paola De Giorgio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irene+T.++Lee">Irene T. Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean+I.++Rodeheaver">Sean I. Rodeheaver</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+A.++Weiss">Bryan A. Weiss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Fracasso">Claudia Fracasso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvio++Caccia">Silvio Caccia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Berardi">Francesco Berardi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Perrone">Roberto Perrone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Rong++Zhang">Ming-Rong Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Maeda">Jun Maeda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Makoto++Higuchi">Makoto Higuchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tetsuya++Suhara">Tetsuya Suhara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Schetz">John A. Schetz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span><span class="author-xref-symbol "><sup>×</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcello++Leopoldo">Marcello Leopoldo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>×</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dipartimento Farmaco-Chimico, Università degli Studi di Bari “A. Moro”, Via Orabona, 4, 70125, Bari, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107-2699, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Istituto di Ricerche Farmacologiche “Mario Negri”, Via La Masa 19, 20156 Milan, Italy</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Molecular Imaging Center, National Institute of Radiological Sciences, 9-1, 4-Chome, Anagawa, Inage-ku, 263-8555, Chiba, Japan</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Psychiatry, Texas College of Osteopathic Medicine, Fort Worth, Texas 76107, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Department of Health Management and Policy, School of Public Health, Fort Worth, Texas 76107, United States</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∞</span> <span class="aff-text">Department of Biology, University of Texas at Arlington, Arlington, Texas 76109, United States</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39 080 5442798. Fax: +39 080 5442231. E-mail: <a href="/cdn-cgi/l/email-protection#caa6afa5baa5a6aea58aacabb8a7a9a2a3a7e4bfa4a3a8abe4a3be"><span class="__cf_email__" data-cfemail="670b020817080b0308270106150a040f0e0a4912090e0506490e13">[email protected]</span></a></div><div class="corresp-fn" id="fn1">×J.A.S. and M.L. contributed equally to this study.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100925m&amp;href=/doi/10.1021%2Fjm100925m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 7344–7355</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 27, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 July 2010</li><li><span class="item_label"><b>Published</b> online</span>27 September 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 October 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100925m" title="DOI URL">https://doi.org/10.1021/jm100925m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7344%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEnza%2BLacivita%252C%2BPaola%2BDe%2BGiorgio%252C%2BIrene%2BT.%2BLee%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D20%26contentID%3Djm100925m%26title%3DDesign%252C%2BSynthesis%252C%2BRadiolabeling%252C%2Band%2Bin%2BVivo%2BEvaluation%2Bof%2BCarbon-11%2BLabeled%2BN-%255B2-%255B4-%25283-Cyanopyridin-2-yl%2529piperazin-1-yl%255Dethyl%255D-3-methoxybenzamide%252C%2Ba%2BPotential%2BPositron%2BEmission%2BTomography%2BTracer%2Bfor%2Bthe%2BDopamine%2BD4%2BReceptors%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7355%26publicationDate%3DOctober%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100925m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1210</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100925m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, Radiolabeling, and in Vivo Evaluation of Carbon-11 Labeled N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a Potential Positron Emission Tomography Tracer for the Dopamine D4 Receptors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Enza&quot;,&quot;last_name&quot;:&quot;Lacivita&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;De Giorgio&quot;},{&quot;first_name&quot;:&quot;Irene&quot;,&quot;last_name&quot;:&quot;T. Lee&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;I. Rodeheaver&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;A. Weiss&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Fracasso&quot;},{&quot;first_name&quot;:&quot;Silvio&quot;,&quot;last_name&quot;:&quot;Caccia&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Berardi&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Perrone&quot;},{&quot;first_name&quot;:&quot;Ming-Rong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Maeda&quot;},{&quot;first_name&quot;:&quot;Makoto&quot;,&quot;last_name&quot;:&quot;Higuchi&quot;},{&quot;first_name&quot;:&quot;Tetsuya&quot;,&quot;last_name&quot;:&quot;Suhara&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Schetz&quot;},{&quot;first_name&quot;:&quot;Marcello&quot;,&quot;last_name&quot;:&quot;Leopoldo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7344-7355&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100925m&quot;},&quot;abstract&quot;:&quot;Here we describe the design, synthesis, and evaluation of physicochemical and pharmacological properties of D4 dopamine receptor ligands related to N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (2). Structural features were incorporated to increase affinity for the target receptor, to improve selectivity over D2 and σ1 receptors, to enable labeling with carbon-11 or fluorine-18, and to adjust lipophilicity within the range considered optimal for brain penetration and low nonspecific binding. Compounds 7 and 13 showed the overall best characteristics: nanomolar affinity for the D4 receptor, &gt;100-fold selectivity over D2 and D3 dopamine receptors, 5-HT1A, 5-HT2A, and 5-HT2C serotonin receptors and σ1 receptors, and log P = 2.37−2.55. Following intraperitoneal administration in mice, both compounds rapidly entered the central nervous system. The methoxy of N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide (7) was radiolabeled with carbon-11 and subjected to PET analysis in &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100925m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100925m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100925m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100925m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100925m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100925m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100925m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100925m&amp;href=/doi/10.1021/jm100925m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100925m" /></input><a href="/doi/pdf/10.1021/jm100925m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100925m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100925m%26sid%3Dliteratum%253Aachs%26pmid%3D20873719%26genre%3Darticle%26aulast%3DLacivita%26date%3D2010%26atitle%3DDesign%252C%2BSynthesis%252C%2BRadiolabeling%252C%2Band%2Bin%2BVivo%2BEvaluation%2Bof%2BCarbon-11%2BLabeled%2BN-%255B2-%255B4-%25283-Cyanopyridin-2-yl%2529piperazin-1-yl%255Dethyl%255D-3-methoxybenzamide%252C%2Ba%2BPotential%2BPositron%2BEmission%2BTomography%2BTracer%2Bfor%2Bthe%2BDopamine%2BD4%2BReceptors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D20%26spage%3D7344%26epage%3D7355%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jmcmar.2010.53.issue-20/production/jmcmar.2010.53.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Here we describe the design, synthesis, and evaluation of physicochemical and pharmacological properties of D<sub>4</sub> dopamine receptor ligands related to <i>N</i>-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (<b>2</b>). Structural features were incorporated to increase affinity for the target receptor, to improve selectivity over D<sub>2</sub> and σ<sub>1</sub> receptors, to enable labeling with carbon-11 or fluorine-18, and to adjust lipophilicity within the range considered optimal for brain penetration and low nonspecific binding. Compounds <b>7</b> and <b>13</b> showed the overall best characteristics: nanomolar affinity for the D<sub>4</sub> receptor, >100-fold selectivity over D<sub>2</sub> and D<sub>3</sub> dopamine receptors, 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>2C</sub> serotonin receptors and σ<sub>1</sub> receptors, and log <i>P</i> = 2.37−2.55. Following intraperitoneal administration in mice, both compounds rapidly entered the central nervous system. The methoxy of <i>N</i>-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide (<b>7</b>) was radiolabeled with carbon-11 and subjected to PET analysis in non-human primate. [<sup>11</sup>C]<b>7</b> time-dependently accumulated to saturation in the posterior eye in the region of the retina, a tissue containing a high density of D<sub>4</sub> receptors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The dopamine D<sub>4</sub> receptor belongs to the D<sub>2</sub>-like receptor family which is characterized by its ability to interact with G<sub>i/o</sub> proteins resulting in inhibition of adenylyl cyclase. Early interest in the D<sub>4</sub> receptor originated from the finding that the D<sub>2</sub>-like receptor antagonist clozapine, an atypical antipsychotic drug with high antipsychotic efficacy and reduced extrapyramidal and neuroendocrine side effects, had 10 times higher affinity for this receptor than for other D<sub>2</sub>-like receptor subtypes.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> This resulted in an intense search for dopamine D<sub>4</sub> antagonists.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, L-745,870 (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), one of the first highly D<sub>4</sub>-selective antagonists to be reported, failed to show antipsychotic potential in animal models.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In placebo-controlled clinical trials, the more bioavailable congener of <b>1</b> (L-745,870) named L-750,667 (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) did not alleviate any of the symptoms of schizophrenia.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Instead, there was a trend toward a worsening of psychotic symptoms. Although these findings seemed to exclude the D<sub>4</sub> receptor as an antipsychotic drug target, later in vitro studies with <b>1</b> provided evidence for its weak partial agonist activity.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Subsequently, the selective D<sub>4</sub> ligand FAUC 213 (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), structurally related to <b>1</b>, was characterized as a “neutral antagonist” using a different measure of functional activity (thymidine incorporation instead of cAMP accumulation).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Years later, a dose of this same ligand, which reduced amphetamine-induced increased locomotor activity, was demonstrated to have atypical antipsychotic potential in animal models predictive of antipsychotic efficacy in humans.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This is in contrast to the structurally distinct D<sub>4</sub>-selective neutral antagonist PNU-101,387G (sonepiprazole) (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), which has no demonstrable antipsychotic activity in humans.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Representative Selective Dopamine D<sub>4</sub> Receptor Ligands</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The D<sub>4</sub> receptor has been suggested as a candidate gene for novelty seeking behavior<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> and attention deficit hyperactivity disorder (ADHD<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>),<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ADHD, attention deficit hyperactivity disorder; PET, positron emission tomography; GPCR, G-protein-coupled receptor; BBB, blood−brain barrier.</p></div> although the latter association or its basis has been questioned.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> While certain antagonists of the D<sub>4</sub> receptor reduced hyperactivity in a neonatal 6-hydroxydopamine lesioned rat model of ADHD,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> the hyperactivity due to neonatal lesioning appears to be mediated by compensatory changes in serotonin transporters.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> More recently, the D<sub>4</sub> agonist A-412997 (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) was shown to improve cognitive function in both a five-trial inhibitory avoidance paradigm and the social recognition model, which are two animal models thought to be predictive of anti-ADHD efficacy.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">The D<sub>4</sub> receptor has been implicated in the control of penile tumescence. For instance, D<sub>4</sub> selective agonists like ABT-724 (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) produce erectogenesis in animal models without nausea.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> However, studies in rats support a role for the D<sub>3</sub> receptor, but not the D<sub>4</sub> receptor, in the induction of penile erection by D<sub>2</sub>-like agonists in rodents.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Although the D<sub>4</sub> receptor is expressed at low levels in the brain, much higher densities of this receptor are expressed in the retina.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Dopamine, via D<sub>4</sub> receptors, normally modulates the cascade that couples light responses to adenylyl cyclase activity in photoreceptor cells in the retina.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a></div><div class="NLM_p">To better understand dopamine D<sub>4</sub> receptor biology in vivo, a suitable D<sub>4</sub> receptor positron emission tomography (PET) tracer would be a powerful tool allowing noninvasive D<sub>4</sub> receptor imaging. A number of attempts have been made to identify a D<sub>4</sub>-selective PET radioligand.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35 ref36">(30-36)</a> In 2000, Langer and co-workers reported an attempt to visualize the dopamine D<sub>4</sub> receptor in primate brain with [<sup>11</sup>C]PB-12 (compound <b>2</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The radioligand was of little use in visualizing D<sub>4</sub> receptors because it exhibited a very high background due to nonspecific binding. Similar results were obtained 2 years later by Zhang and co-workers who prepared and tested [<sup>11</sup>C]<b>2</b> and [<sup>11</sup>C]YM-50001 (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) with both radioligands being unsuitable for D<sub>4</sub> receptor imaging with PET.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In each case, it was suggested that the high nonspecific binding of [<sup>11</sup>C]<b>2</b> could be due to its relatively high lipophilicity (ClogP = 3.72).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> More recently, Prante and co-workers reported on the rational design of a series of pyrazolo[1,5-<i>a</i>]pyridine-based dopamine D<sub>4</sub> receptor ligands for potential use as PET ligands. However, the most promising radioligand of the series, [<sup>18</sup>F]<b>3</b> (ClogP = 2.9) (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), was only tested in rat brain slices by in vitro autoradiography.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Thus, to date, there are no verified examples of a D<sub>4</sub>-selective PET tracer.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Lipophilicity Values and Binding Affinities at Dopamine D<sub>4</sub> Receptors of the Target Benzamides</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0008.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0009.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div></div><div class="NLM_p">An adequate PET tracer for neuroreceptor visualization must fulfill many criteria:<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> high affinity for the target receptor (usually in the nanomolar range); selectivity for its target (>100-fold); ease of labeling with <sup>11</sup>C or <sup>18</sup>F at high specific radioactivity; safe administration at low tracer dose; high blood−brain barrier (BBB) penetrance; inability to serve as a substrate for efflux transporters; low nonspecific binding; suitable brain pharmacokinetics in relation to radiolabel half-life (observable brain uptake and washout kinetics); lack of troublesome radiometabolites. Of particular importance with respect to BBB penetration and low nonspecific binding is tracer lipophilicity. In general, brain penetration by passive diffusion of molecules across the BBB becomes poor when the log <i>P</i> is greater than 4.0, molecular weight is larger than 450 Da, and the number of hydrogen bond donors is greater than 5. However, if molecules are too hydrophilic, their BBB passage is prevented as well. It has been reported for many drug classes that the optimum log <i>P</i> value for central nervous system (CNS) targeted drugs lies between 2.0 and 3.5. Moreover, high lipophilicity attributed to adhesion to proteins and lipids tends to increase nonspecific binding, an essentially nonsaturable component of the total tissue uptake of a radioligand. Therefore, it appears that there is an optimal range of lipophilicity for brain radioligands, wherein brain uptake is high and nonspecific binding comparatively weak. From data in the literature, log <i>P</i> = 3.5 appears to be the acceptable upper limit of lipophilicity for a PET radioligand.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p last">Here we describe the synthesis and in vitro characterization of an improved series of D<sub>4</sub> receptor agents derived from our lead compound <b>2</b>,<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41-43)</a> which we rationally designed specifically for use as a PET radiotracer. By use of our newly developed selection criteria and assay cascade, one of a dozen compounds was selected for radiolabeling with carbon-11 and PET studies in monkey brain.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the final compounds is depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The preparation of the target compounds required the key amines <b>18a</b>−<b>f</b>. Among these, 4-(4-chlorophenyl)-1-piperazineethanamine (<b>18a</b>) and 4-(4-methylphenyl)-1-piperazineethanamine (<b>18b</b>) were prepared according to the literature.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Amines <b>18c</b>−<b>e</b> were prepared as follows: the appropriate 1-arylpiperazine was alkylated with 2-haloethanol to the corresponding alcohol <b>15c</b>−<b>e</b>. These latter were subsequently condensed, under Mitsunobu conditions, with phthalimide to give <b>16c</b>−<b>e</b>, which were hydrolyzed with hydrazine hydrate to afford primary amines <b>18c</b>−<b>e</b>. An alternative synthetic route was followed to prepare amine <b>18f</b>: 1-(5-chloro-2-pyridinyl)piperazine<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> was first alkylated with chloroacetonitrile and then treated with borane dimethyl sulfide complex to afford the desired amine <b>18f</b>. The final compounds were prepared by condensing 3-methoxy- or 4-fluorobenzoic acid with amines <b>18a</b>−<b>f</b> in the presence of 1,1′-carbonyldiimidazole.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (A) 2-chloroethanol or 2-bromoethanol, K<sub>2</sub>CO<sub>3</sub>; (B) phthalimide, Ph<sub>3</sub>P, DEAD; (C) (i) hydrazine hydrate, (ii) conc HCl; (D) chloroacetonitrile, K<sub>2</sub>CO<sub>3</sub>; (E) borane−methyl sufide complex; (F) 3-methoxy- or 4-fluorobenzoic acid, CDI.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Lipophilicity Evaluation</h3><div class="NLM_p last">The pivotal role of PET tracer lipophilicity is well recognized, and it has been reviewed in depth by Waterhouse.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Lipophilicity can be evaluated in various theoretical and experimental ways. The most common experimental lipophilicity measurement involves partitioning of a compound between octanol and aqueous solution (log <i>P</i>). The log <i>P</i> refers to partitioning of the neutral molecule species and log <i>D</i><sub>7.4</sub> the partitioning of all species present in solution at a given pH, which accounts for solubility effects associated with ionization. When lipophilicity is expressed as log <i>P</i> or log <i>D</i><sub>7.4</sub>, compounds that seem most effective for imaging have log <i>P</i> or log <i>D</i><sub>7.4</sub> of <3.5. On such a basis, we have modified our reference compound <b>2</b> and designed compounds <b>4</b>−<b>14</b> which showed computer estimated values of lipophilicity below the guideline value (3.5). Then, the experimental log <i>P</i>, log <i>D</i><sub>7.4</sub>, and p<i>K</i><sub>a</sub> values of <b>4</b>−<b>14</b> were determined by potentiometric titrations (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Considering the p<i>K</i><sub>a</sub> values of target compounds, it can be deduced that the percentage of protonated species at physiological pH is not very high, and this accounts for the similarities between log <i>P</i> and log <i>D</i><sub>7.4</sub> values. Experimental log <i>P</i> values were, however, different from the calculated values. The largest difference (1.05 log units) was shown in the case of compound <b>7</b> (ClogP = 1.50 vs log <i>P</i> = 2.55), whereas the smallest (0.26 log units) was for <b>12</b> (ClogP = 2.81 vs log <i>P</i> = 2.37). While the explanation of such differences is beyond the scope of this study, these data confirm that the lipophilicity of a molecule is the result of all intermolecular solute−solvent interactions in both aqueous and organic solvents and not only the sum of the contribution of isolated fragments. In fact, the difference between log <i>P</i> values and ClogP can, and in our case does, vary among structurally related compounds. For example, compounds <b>5</b> and <b>11</b> have a difference between the calculated and experimental log <i>P</i> of 0.37 and 0.93, respectively; for <b>7</b> and <b>13</b>, the difference was 1.05 and 0.43, respectively. In spite of these discrepancies, all the experimental log <i>P</i> values were below the guideline value with the exception of those for <b>9</b> and <b>11</b>, which had log <i>P</i> values of 3.75 and 3.79, respectively. Therefore, in those cases when lipophilicity must fall within a narrow range and ClogP values are borderline, an experimental determination is prudent.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Rational Design and Structure−Affinity Relationships</h3><div class="NLM_p">All the target compounds were designed taking into account the structural requirements for an adequate PET tracer as detailed in the <a class="ref internalNav" href="#sec1" aria-label="Introduction">Introduction</a>. Compounds <b>4</b>−<b>8</b> have a methoxy group that can be easily accessed in the [<sup>11</sup>C] radiolabeled form via the corresponding phenol derivative. Compounds <b>9</b>−<b>14</b> possess the 4-fluorobenzamide group which can be obtained in the [<sup>18</sup>F] radiolabeled form via the corresponding 4-nitrobenzamide or 4-tributyltinphenyl analogue. The structural modifications of <b>2</b> were also guided by the previous structure−affinity relationship studies. Thus, in the first group of compounds the <i>N</i>-[2-(4-arylpiperazin-1-yl)ethyl]-3-methoxybenzamide structure was left unchanged (compounds <b>4</b>−<b>8</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The modification was limited to the aryl group linked to the piperazine ring. In particular, replacement of −Cl in <b>2</b> with −CH<sub>3</sub> led to <b>4</b> which has only 2-fold lower affinity for the D<sub>4</sub> receptor than <b>2</b>. On the other hand, replacement of −Cl in <b>2</b> with −CN gave <b>6</b> which had considerably less affinity than <b>2</b> (<i>K</i><sub>i</sub> = 63.95 nM). Replacement of the phenyl ring in <b>2</b> with a 2-pyridyl gave <b>8</b> which demonstrated only 2-fold less affinity than <b>2</b>. In a previous study we found that <i>N</i>-[4-[4-(1,2-benzisoxazol-3-yl)piperazin-1-yl]butyl]-3-methoxybenzamide displayed high affinity (<i>K</i><sub>i</sub> = 7.58 nM) for the D<sub>4</sub> receptor.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Thus, we wanted to evaluate if a shorter alkyl chain (ethyl vs butyl) increased affinity for the D<sub>4</sub> receptor. Compound <b>5</b> displayed higher affinity (<i>K</i><sub>i</sub> = 1.93 nM) than either the butyl homologue cited above and <b>2</b>. The replacement of 4-chlorophenyl group in <b>2</b> by the 3-cyano-2-pyridinyl one (<b>7</b>) was undertaken because a number of D<sub>4</sub> ligands reported in the literature were characterized by such a group.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> This replacement was particularly beneficial because <b>7</b> had improved affinity for the D<sub>4</sub> receptor (<i>K</i><sub>i</sub> = 1.52 nM). A second set of derivatives were designed by replacing the 3-methoxybenzamide of <b>2</b>, <b>4</b>−<b>8</b> with a 4-fluorobenzamide (compounds <b>9</b>−<b>14</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The 4-fluorobenzamides <b>9</b>−<b>14</b> possessed higher D<sub>4</sub> affinities than their 3-methoxy counterparts. The most notable increase in affinity was observed in the case of 1,2-benzisoxazol-3-yl derivative <b>11</b> which has approximately 6-fold higher affinity than the 3-methoxy analogue <b>5</b>. Also, the rank order of binding affinity among the derivatives was practically unchanged with the sole exception of 3-cyano-2-pyridinyl <b>13</b>, which had slightly less affinity than the 1,2-benzisoxazol-3-yl <b>11</b>. All in all, the proposed structural modifications led to a range of D<sub>4</sub> ligands possessing affinities higher than the lead compound <b>2</b>. Among them, <b>11</b> and <b>13</b> demonstrated subnanomolar <i>K</i><sub>i</sub> values. Subsequently, all compounds were evaluated at 1 μM for their ability to displace [<sup>3</sup>H]methylspiperone from the rat cloned D<sub>2L</sub> dopamine receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Strong displacement was observed for compounds <b>5</b> and <b>11</b>, indicating that they have significant affinity for the D<sub>2L</sub> receptor. Moderate displacement (40−50%) was observed for <b>9</b>, <b>10</b>, <b>13</b>, and <b>14</b>, whereas <b>2</b>, <b>4</b>, <b>6</b>−<b>8</b>, and <b>12</b>, had practically no effect on the specific binding of the radioligand to the D<sub>2L</sub> receptor. Because some compounds touted as being D<sub>4</sub>-selective actually have high affinity for the σ<sub>1</sub> receptor,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> all compounds were evaluated at 1 μM for their ability to displace specifically bound [<sup>3</sup>H]-(+)-pentazocine from the human cloned σ<sub>1</sub> receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Little or no displacement (<40%) was observed for all the tested compounds, indicating that they have little or no affinity for the σ<sub>1</sub> receptor. Taken together, these data indicate that compounds <b>7</b> and <b>13</b> have high selectivity for the D<sub>4</sub> receptor over D<sub>2L</sub> and σ<sub>1</sub> receptors. Therefore, both compounds were evaluated further for potential interactions with selected other G-protein-coupled receptors (GPCRs) and for their functional properties at the D<sub>4</sub> receptor. While <b>7</b> and <b>13</b> had a similar binding profile for D<sub>3</sub>, CB<sub>1</sub>, and 5-HT<sub>2C</sub> receptors, <b>7</b> had significantly less radioligand displacing activity at 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors than <b>13</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Both <b>7</b> and <b>13</b> were able to stimulate D<sub>4</sub> receptors measured as a decrease in forskolin-stimulated levels of cAMP accumulation (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), indicating that they have agonist properties.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compounds <b>7</b> and <b>13</b> are agonists of the cloned D<sub>4</sub> dopamine receptor as determined by G<sub>i/o</sub>-mediated changes in intracellular cAMP. The D<sub>4</sub>-selective antagonist spiperone, the D<sub>4</sub>-selective agonist PD168,077, the D<sub>2</sub>-like agonist (−)-quinpirole, and dopamine are shown for comparison.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Displacement of Specifically Bound Radioligand from Cloned Dopamine D<sub>2L</sub> and σ<sub>1</sub> Receptors by a Single High Concentration of Compound (1 μM)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">% displacement ± SEM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">D<sub>2L</sub></th><th class="colsep0 rowsep0" align="center">σ<sub>1</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">7.8 ± 4.2</td><td class="colsep0 rowsep0" align="left">22 ± 7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">7.6 ± 3.7</td><td class="colsep0 rowsep0" align="left">7.2 ± 8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">84 ± 3.0</td><td class="colsep0 rowsep0" align="left">13 ± 4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">0 ± 2.8</td><td class="colsep0 rowsep0" align="left">27 ± 15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">4.4 ± 1.3</td><td class="colsep0 rowsep0" align="left">8.3 ± 6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">5.8 ± 0.95</td><td class="colsep0 rowsep0" align="left">15 ± 8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">48 ± 10</td><td class="colsep0 rowsep0" align="left">29 ± 3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">29 ± 4.6</td><td class="colsep0 rowsep0" align="left">21 ± 4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">89 ± 5.2</td><td class="colsep0 rowsep0" align="left">21 ± 2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0 ± 0.58</td><td class="colsep0 rowsep0" align="left">4.6 ± 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">32 ± 8.4</td><td class="colsep0 rowsep0" align="left">1.0 ± 3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">43 ± 2.1</td><td class="colsep0 rowsep0" align="left">33 ± 1.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Nonspecific binding is defined by the following: 5 μM (+)-butaclamol displaced 100% of [<sup>3</sup>H]MSP from D<sub>2L</sub> receptors, and 5 μM BD1063 displaced 100% of [<sup>3</sup>H]-(+)-pentazocine from σ<sub>1</sub> receptors.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Displacement of Specifically Bound Radioligand by <b>7</b> and <b>13</b> from Cloned Human Dopamine D<sub>3</sub> Receptor, Cloned Serotonin Receptor Subtypes, and the CB<sub>1</sub> Cannabinoid Receptor by a Single High Concentration of Compound (1 μM)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">% displacement ± SEM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor</th><th class="colsep0 rowsep0" align="center"><b>7</b></th><th class="colsep0 rowsep0" align="center"><b>13</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub><b>3</b></sub></td><td class="colsep0 rowsep0" align="left">5.1 ± 1.1</td><td class="colsep0 rowsep0" align="left">7.2 ± 3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">9.3 ± 5.9</td><td class="colsep0 rowsep0" align="left">29 ± 4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">24 ± 4.7</td><td class="colsep0 rowsep0" align="left">53 ± 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">3.2 ± 3.8</td><td class="colsep0 rowsep0" align="left">0 ± 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CB<sub>1</sub></td><td class="colsep0 rowsep0" align="left">6.5 ± 16</td><td class="colsep0 rowsep0" align="left">9.9 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Nonspecific binding is defined by the following: 5 μM 7-OH-DPAT displaced 100% of [<sup>3</sup>H]MSP from D<sub>3</sub> receptors; 5 μM NAN-190 displaced 100% of [<sup>3</sup>H]-MPPF from 5-HT<sub>1A</sub> receptors; 5 μM mianserin displaced 100% of [<sup>3</sup>H]MSP from 5-HT<sub>2A</sub> receptors; 5 μM mianserin displaced 100% of [<sup>3</sup>H]mesulergine from 5-HT<sub>2C</sub> receptors; 10 μM O-2050 displaced 100% of [<sup>3</sup>H]CP55,940 from rat brain CB<sub>1</sub> receptors.</p></div></div></div><div class="NLM_p last">Considering that a PET tracer needs to have high affinity for the target receptor and, in particular, it is preferable that the <i>B</i><sub>max</sub> clearly exceeds the <i>K</i><sub>d</sub> of the ligand (ideally <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> >10),<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> one could ask if compounds <b>7</b> and <b>13</b> meet this requirement. D<sub>4</sub> receptor binding sites have previously been determined indirectly by the use of [<sup>3</sup>H]NGD-94-1,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> [<sup>3</sup>H]PNU-101958,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and [<sup>3</sup>H]nemonapride.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> However, these studies have delivered controversial data on the distribution and concentration of D<sub>4</sub> receptor in the human and rat brain. For example, using [<sup>3</sup>H]nemonapride in combination with <b>1</b>, raclopride, sulpiride, and a σ receptor antagonist, a low density of D<sub>4</sub> receptors was observed (<i>B</i><sub>max</sub> = 8.9 fmol·(mg of protein)<sup>−1</sup>) only in the hippocampus.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In contrast, Primus and co-workers used [<sup>3</sup>H]NGD-94-1 and reported <i>B</i><sub>max</sub> values ranging from 8.9 to 28.9 fmol·(mg of protein)<sup>−1</sup> in hippocampal, cortical, and limbic regions.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Importantly, these values originate from homogenized tissue and do not necessarily reflect the tissue heterogeneity to be encountered in the intact brain in vivo.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Therefore, the concentration of D<sub>4</sub> receptor sites determined by indirect methods should be viewed with some caution, making the lack of precise <i>B</i><sub>max</sub> values for the D<sub>4</sub> receptor in the brain difficult to estimate the affinity value to be targeted when developing a D<sub>4</sub> PET tracer. Since compounds <b>7</b> and <b>13</b> had the best combination of lipophilicity, high affinity (<i>K</i><sub>i</sub> in the low nanomolar range), and selectivity for the D<sub>4</sub> receptor of the ligands listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, they were selected for further testing in order to assess their potential of use in vivo as PET tracers.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Disposition Studies in Mice with Compounds <b>7</b> and <b>13</b></h3><div class="NLM_p">Mice were given an intraperitoneal dose of the 4-fluorobenzamide <b>13</b> and the 3-methoxybenzamide <b>7</b> and were sacrificed at various times thereafter to obtain basic information on the concentrations of unchanged compound achieved in brain and their relationship with plasma concentrations. The presence of 1-(6-cyano-2-pyridyl)piperazine was also monitored in parallel because many N-substituted 1-arylpiperazines are reported to undergo metabolic N-dealkylation.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, compound <b>13</b> rapidly reached the systemic circulation with maximal plasma concentrations (<i>C</i><sub>max</sub>) 15 min after dosing (i.e., the first sampling time). However, these plasma concentrations were low and variable (0.13 ± 0.10 μg/mL) and rapidly fell below the limit of quantitation after 30 min (i.e., less than 0.1 μg/mL, using 0.2 mL of mouse plasma). Compound <b>7</b> peaked slightly later, yielding a higher mean <i>C</i><sub>max</sub> (0.37 ± 0.21 μg/mL at 30 min), and these concentrations were consistently detected only up to 60 min after dosing. Thus, in both cases the data did not permit adequate determination of a terminal elimination phase and the calculation of conventional pharmacokinetic parameters. This behavior may be partly due to a large presystemic biotransformation after intraperitoneal dosing because 1-arylpiperazine derivatives are generally extensively biotransformed before reaching the systemic circulation, and their clearance is almost entirely due to hepatic metabolism.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Concentrations of 1-(6-cyano-2-pyridyl)piperazine, however, were low for <b>7</b> (0.10−0.2 μg/mL) or not detectable for <b>13</b> (<0.1 μg/mL) within 30−60 min of intraperitoneal dosing (10 mg/kg). This suggests that N-dealkylation of the aliphatic side chain may have contributed to but did not account for the first-pass effect and clearance of <b>7</b> and <b>13</b> in mice. Brain uptake was rapid for both derivatives: quantifiable levels were consistently evident up to 30 min for <b>7</b> and 60 min in the case of <b>13</b>. Mean brain <i>C</i><sub>max</sub> averaged 0.47 ± 0.20 μg/g for the 4-fluorobenzamide <b>13</b> (at 15 min post dose) and 0.14 ± 0.02 μg/g for the 3-methoxybenzamide <b>7</b> (at 30 min post dose), giving rise, at these times, to a mean brain-to-plasma concentration ratio higher for the more lipophilic fluorobenzamide derivative. While an accurate determination of whole brain exposure and brain-to-plasma distribution ratios was not possible, rough estimates based on the limits of quantification further suggested that the fluorobenzamide is concentrated in brain tissue of mice more than its methoxybenzamide analogue. In both cases the brain concentrations of the dealkylated metabolite 1-(6-cyano-2-pyridyl)piperazine were below the limit of detection within 180 min of dosing (about 0.1 μg/g, using approximately 200 mg of brain tissue).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Mean ± SD (<i>n</i> = 3) Maximum Plasma and Brain Concentrations after ip Dosing of 10 mg/kg of Compounds <b>7</b> (after 30 min) and <b>13</b> (after 15 min) in Mice<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">concentration</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">plasma (μg/mL)</th><th class="colsep0 rowsep0" align="center">brain (μg/g)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">0.37 ± 0.21 (0.22 ± 0.12)</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.02 (<0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.13 ± 0.10 (<0.1)</td><td class="colsep0 rowsep0" align="left">0.47 ± 0.20 (<0.1)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Shown in parentheses is the N-dealkylated metabolite 1-(6-cyano-2-pyridyl)piperazine.</p></div></div></div><div class="NLM_p last">These data indicated that both <b>7</b> and <b>13</b> can reach the brain and have fast uptake kinetics ideal for a PET tracer. Because of the relative ease of radiolabeling, compound <b>7</b> was selected as a PET D<sub>4</sub> tracer candidate.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Radiosynthesis of [<sup>11</sup>C]<b>7</b></h3><div class="NLM_p">Derivative <b>19</b>, the desmethyl precursor for <sup>11</sup>C-radiolabeling, was prepared as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. 3-Hydroxybenzoic acid was condensed with 4-(3-cyanopyridin-2-yl)-1-piperazinoethanamine (<b>18e</b>) to give benzamide <b>19</b> in 40% yield. For the radiolabeling <b>19</b> was reacted with [<sup>11</sup>C]CH<sub>3</sub>I in DMF and 0.5 N NaOH to afford [<sup>11</sup>C]<b>7</b> in an incorporation yield of 40.5 ± 10.8% (<i>n</i> = 4, determined by HPLC). Purification by semipreparative reverse-phase HPLC afforded [<sup>11</sup>C]<b>7</b> (>99%). No significant peak of unreacted <b>19</b> was seen on the HPLC chromatogram of the final radioactive product. The retention time of [<sup>11</sup>C]<b>7</b> on the analytical reverse-phase HPLC system was 6.2 min. The total synthesis time was about 28 min from the end of bombardment. The specific radioactivity at time of injection of [<sup>11</sup>C]<b>7</b> was 2885 GBq/μmol, corresponding to a total injected dose of 150.3 MBq (52 pmol, 18 ng) in the monkey experiments.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (A) 3-hydroxybenzoic acid, CDI; (B) [<sup>11</sup>C]CH<sub>3</sub>I, NaOH.</p></p></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> PET Studies in Rhesus Monkey</h3><div class="NLM_p">After intravenous injection of [<sup>11</sup>C]<b>7</b> in a male rhesus monkey, the uptake of [<sup>11</sup>C]<b>7</b> in all brain regions peaked at 45 s and then the radioactivity rapidly declined, suggestive of no specific binding in these regions (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). About 3.1% of the injected radioactivity reached the brain at peak time. In contrast, radioactivity was markedly higher in the retina compared to the brain regions examined (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The ratio of retinal radioactivity to the cerebral radioactivity was more than 6-fold at the end of the scanning period.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time−activity curves of [<sup>11</sup>C]<b>7</b> in seven CNS regions for 90 min in rhesus monkey.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PET imaging in rhesus monkey with [<sup>11</sup>C]<b>7</b> reveals time dependent and saturable binding that is most intense in the posterior regions of the eye. Importantly, there is an intense signal in the region of the retina with little or no background signal in other parts of the CNS. Note different scales used to capture data for retina and brain. Mean images of [<sup>11</sup>C]<b>7</b> from 30 to 90 min after ligand injection are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">While [<sup>11</sup>C]<b>7</b> did not accumulate in any region of the brain that has been reported to express dopamine D<sub>4</sub> receptors, it accumulated to saturable levels in the posterior eye in the region of retina. This is consistent with the reported high density of dopamine D<sub>4</sub> receptors (<i>B</i><sub>max</sub> = 134 fmol·(mg of protein)<sup>−1</sup>) determined by in situ autoradiography with the D<sub>4</sub>-selective ligand [<sup>125</sup>I]L-750,667.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The presence of the radioligand in the region of the retina suggests that the compound was able to cross the blood−retina barrier, and therefore, it also has the potential to cross the BBB because it has been reported that both barriers display very similar properties.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Moreover, the lack of a persistent signal in other CNS structures indicates that [<sup>11</sup>C]<b>7</b> undergoes a rapid wash-out from the tissues in which it is not significantly bound to the D<sub>4</sub> receptor. It also demonstrates that [<sup>11</sup>C]<b>7</b> has very low nonspecific binding or off-target binding characteristics. This behavior suggests that labeling of lower density brain regions would require a D<sub>4</sub> ligand having an in vitro affinity higher than that of <b>7</b> (<i>K</i><sub>i</sub> = 1.52 nM).</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We report here on a systematic strategy for discovering ligands suitable as PET radiotracers for imaging of dopamine D<sub>4</sub> the receptor in the CNS. Starting from our high-affinity ligand <b>2</b> and guided in part by previous structure−activity relationship studies from our laboratories and other laboratories, we developed an assay cascade leading to the design of a set of compounds possessing chemical features amenable to carbon-11 or fluorine-18 labeling and calculated log <i>P</i> values within the range that is considered optimal for a radiotracer. The log <i>P</i> values of the target compounds were determined experimentally confirming that almost all the compounds possessed the desired lipophilicity. Affinity screening of compounds at the dopamine D<sub>4</sub> receptor as well as at selected other off-target receptors (dopamine D<sub>2</sub>, dopamine D<sub>3</sub>, serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub>, σ<sub>1</sub>, and cannabinoid CB<sub>1</sub>) guided our selection of two potent and selective ligands, namely, <i>N</i>-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide (<b>7</b>) and <i>N</i>-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-4-fluorobenzamide (<b>13</b>). Compounds <b>7</b> and <b>13</b> showed <i>K</i><sub>i</sub> values of 1.52 and 0.93 nM, respectively, and >100-fold selectivity over the off-target receptors. When tested in disposition studies in mice to evaluate their BBB penetrance and first-pass metabolism characteristics, both <b>7</b> and <b>13</b> rapidly entered the brain and, importantly in this context, were also rapidly cleared from the brain. Carbon-11 radiolabeling of the phenol precursor <b>19</b> resulted in the 3-methoxybenzamide derivative [<sup>11</sup>C]<b>7</b>. [<sup>11</sup>C]<b>7</b> was injected into rhesus monkey, and brain penetrance as well as its fast washout was confirmed in this non-human primate. Despite there being no labeling of dopamine D<sub>4</sub> receptor in the brain regions examined, [<sup>11</sup>C]<b>7</b> did accumulate in a time-dependent and saturable fashion in the posterior eye in the region of the retina, a CNS tissue rich in dopamine D<sub>4</sub> receptors. While more questions may need to be answered and further improvements could be made, we believe that <b>7</b> represents a significant step forward in the development of a CNS PET tracer selective for the dopamine D<sub>4</sub> receptor, having allowed for the first time CNS imaging of D<sub>4</sub> receptor in a structure with the highest known density of this receptor subtype. Importantly, the strategy we worked out appears to serve as a suitable paradigm for developing additional D<sub>4</sub>-selective PET tracers which would have higher affinity presumably making them suitable for imaging in brain regions having a very low density of the D<sub>4</sub> receptor. Finally, because of its high affinity and specificity, compound <b>7</b> in the tritiated form may have utility as a radioligand for studying the distribution and density of the dopamine D<sub>4</sub> receptor protein in ex vivo or in vitro studies.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p last">The purity of the tested compounds <b>2</b>, <b>4</b>−<b>14</b> has been assessed by RP-HPLC and combustion analysis. All compounds showed ≥95% purity. Column chromatography was performed with 1:30 Merck silica gel 60A (63−200 μm) as the stationary phase. Melting points were determined in open capillaries on a Gallenkamp electrothermal apparatus. Elemental analyses (C, H, N) were performed on Eurovector Euro EA 3000 analyzer; the analytical results were within ±0.4% of the theoretical values for the formula given. <sup>1</sup>H NMR spectra were recorded at 300 MHz on a Varian Mercury-VX spectrometer. All spectra were recorded on free bases. All chemical shift values are reported in ppm (δ). Recording of mass spectra was done on an HP6890-5973 MSD gas chromatograph/mass spectrometer; only significant <i>m</i>/<i>z</i> peaks, with their percentage of relative intensity in parentheses, are reported. ESI<sup>+</sup>-MS/MS analysis were performed with an Agilent 1100 series LC-MSD trap system VL workstation. All spectra were in accordance with the assigned structures. RP-HPLC analysis was performed on a Perkin-Elmer series 200 LC instrument using a Phenomenex Gemini RP-18 column, (250 mm × 4.6 mm, 5 μm particle size) and equipped with a Perkin-Elmer 785A UV/vis detector setting of λ = 254 nm. Compounds <b>2</b> and <b>4</b>−<b>14</b> were eluted with CH<sub>3</sub>OH/H<sub>2</sub>O/Et<sub>3</sub>N, 4:1:0.01, v/v at a flow rate of 1 mL/min. When necessary, a standard procedure was used to transform final compounds into their hydrochloride salts. The following compounds were synthesized according to published procedures: 1-(4-chloro-2-pyridinyl)piperazine,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> 1-(3-cyano-2-pyridinyl)piperazine,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> 4-(4-chlorophenyl)-1-piperazinoethanamine (<b>18a</b>),<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> 4-(4-methylphenyl)-1-piperazinoethanamine (<b>18b</b>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The NMR and MS spectra of compounds <b>2</b>, <b>4</b>, and <b>8</b> have been reported earlier.<a onclick="showRef(event, 'ref42 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref46">(42, 46)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 3-[4-(2-Hydroxyethyl)-1-piperazinyl]-1,2-benzisoxazole (<b>15c</b>)</h3><div class="NLM_p last">A solution of 3-(1-piperazinyl)-1,2-benzisoxazole (0.6 g, 2.96 mmol) in dioxane (15 mL) was treated with anhydrous K<sub>2</sub>CO<sub>3</sub> (1.43 g, 10.3 mmol) and KI (0.04 g, 0.2 mmol). After addition of 2-bromoethanol (1.2 mL, 17.3 mmol) the mixture was refluxed overnight. The solvent was distilled off, and the residue was partitioned between H<sub>2</sub>O (20 mL) and CHCl<sub>3</sub> (20 mL). The organic phase was separated, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude residue was chromatographed (CHCl<sub>3</sub>/MeOH 19:1, as eluent) to afford the pure alcohol as a white solid (0.56 g, 77% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.10 (br s, 1H, D<sub>2</sub>O exchanged), 2.64 (t, 2H, <i>J</i> = 5.5 Hz), 2.73 (app t, 4H), 3.60 (app t, 4H), 3.68 (t, 2H, <i>J</i> = 5.5 Hz), 7.20−7.24 (m, 1H), 7.44−7.49 (m, 2H), 7.69 (d, 1H, <i>J</i> = 8.0 Hz). ESI<sup>+</sup>-MS <i>m</i>/<i>z</i> 248.2 (MH<sup>+</sup>). ESI<sup>+</sup>-MS/MS <i>m</i>/<i>z</i> 161.2 (100), 114.4 (22).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-[4-(2-Hydroxyethyl)-1-piperazinyl]benzonitrile (<b>15d</b>)</h3><div class="NLM_p last">A stirred mixture of 4-piperazinobenzonitrile (0.37 g, 2.0 mmol), 2-chloroethanol (0.17 mL, 2.4 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.35 g, 2.5 mmol) in acetonitrile was refluxed overnight. After cooling, the mixture was evaporated to dryness and H<sub>2</sub>O (20 mL) was added to the residue. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL). The collected organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated under reduced pressure. The crude residue was chromatographed (CHCl<sub>3</sub>/CH<sub>3</sub>OH, 19:1 as eluent) to yield pure <b>15d</b> as a white solid (0.30 g, 64% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.71 (br s, 1H, D<sub>2</sub>O exchanged), 2.61 (t, 2H, <i>J</i> = 5.5 Hz), 2.65 (app t, 4H), 3.34 (app t, 4H), 3.67 (t, 2H, <i>J</i> = 5.5 Hz), 6.83−6.88 (m, 2H), 7.47−7.52 (m, 2H). GC−MS <i>m</i>/<i>z</i> 232 (M<sup>+</sup> + 1, 5), 231 (M<sup>+</sup>, 17), 200 (100), 157 (24), 129 (24).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-Cyano-2-[4-(2-hydroxyethyl)-1-piperazinyl]pyridine (<b>15e</b>)</h3><div class="NLM_p last">Title compound was prepared from 1-(3-cyano-2-pyridyl)piperazine and 2-chloroethanol following the same procedure described above for <b>15d</b>. Pure <b>15e</b> was obtained by column chromatography (CHCl<sub>3</sub>/CH<sub>3</sub>OH, 19:1, as eluent) as a yellow oil in 83% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.51 (br s, 1H, D<sub>2</sub>O exchanged), 2.75 (t, 2H, <i>J</i> = 5.3 Hz), 2.83 (app t, 4H), 3.76 (t, 2H, <i>J</i> = 5.3 Hz), 3.83 (app t, 4H), 6.80 (q, 1H, <i>J</i> = 7.4, 7.7 Hz), 7.79 (dd, 1H, <i>J</i> = 1.9, 7.7 Hz), 8.34−8.37 (m, 1H). GC−MS <i>m</i>/<i>z</i> 233 (M<sup>+</sup> + 1, 1), 232 (M<sup>+</sup>, 5), 201 (100), 172 (47), 146 (46), 100 (40).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for Preparation of Compounds <b>16c</b>−<b>e</b></h3><div class="NLM_p">Diethyl azodicarboxylate (2.25 mmol) was added to a stirred solution containing the appropriate alcohol <b>15c</b>−<b>e</b> (1.5 mmol), triphenylphosphine (1.5 mmol), and phthalimide (2.25 mmol) in anhydrous THF (20 mL). The resulting mixture was stirred at room temperature under anhydrous condition until the alcohol disappeared (TLC). Then the mixture was partitioned between AcOEt (20 mL) and H<sub>2</sub>O (20 mL). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. The crude residue was chromatographed as detailed below to afford pure compounds as pale yellow solids in quantitative yield.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-[2-[4-(1,2-Benzisoxazol-3-yl)-1-piperazinyl]ethyl]-1<i>H</i>-isoindole-1,3(2<i>H</i>)-dione (<b>16c</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/AcOEt, 1:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.69−2.74 (m, 6H), 3.50 (app t, 4H), 3.86 (t, 2H, <i>J</i> = 6.4 Hz), 7.20 (dtd, 1H, <i>J</i> = 1.6, 6.3, 8.1 Hz), 7.43−7.49 (m, 2H), 7.66−7.74 (m, 3H), 7.83−7.85 (m, 2H). ESI<sup>+</sup>-MS <i>m</i>/<i>z</i> 377.1 (MH<sup>+</sup>). ESI<sup>+</sup>-MS/MS <i>m</i>/<i>z</i> 174.2 (100), 147.3 (24).</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-[2-[4-(4-Cyanophenyl)-1-piperazinyl]ethyl]-1<i>H</i>-isoindole-1,3(2<i>H</i>)-dione (<b>16d</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/AcOEt, 9:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.64 (app t, 4H), 2.69 (t, 2H, <i>J</i> = 6.3 Hz), 3.24 (app t, 4H), 3.85 (t, 2H, <i>J</i> = 6.3 Hz), 6.80−6.84 (m, 2H), 7.45−7.48 (m, 2H), 7.71−7.73 (m, 2H), 7.83−7.85 (m, 2H). GC−MS <i>m</i>/<i>z</i> 361 (M<sup>+</sup> + 1, 1), 360 (M<sup>+</sup>, 1), 200 (100), 157 (17).</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-[2-[4-(3-Cyanopyridin-2-yl)-1-piperazinyl]ethyl]-1<i>H</i>-isoindole-1,3(2<i>H</i>)-dione (<b>16e</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/AcOEt, 1:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.66 (app t, 4H), 2.69 (t, 2H, <i>J</i> = 6.3 Hz), 3.66 (app t, 4H), 3.85 (t, 2H, <i>J</i> = 6.3 Hz), 6.71 (q, 1H, <i>J</i> = 7.7 Hz), 7.70−7.75 (m, 3H), 7.82−7.86 (m, 2H), 8.31 (dd, 2H, <i>J</i> = 1.9, 5.0 Hz). GC−MS <i>m</i>/<i>z</i> 362 (M<sup>+</sup> + 1, 1), 361 (M<sup>+</sup>, 4), 242 (19), 201 (100), 172 (19).</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-(5-Chloropyridin-2-yl)piperazinoacetonitrile (<b>17</b>)</h3><div class="NLM_p last">A stirred mixture of 1-(5-chloropyridin-2-yl)piperazine (2.25 g, 11.4 mmol), chloroacetonitrile (0.60 mL, 9.5 mmol), and an excess of K<sub>2</sub>CO<sub>3</sub> in acetonitrile (50 mL) was refluxed overnight. After cooling, the mixture was evaporated to dryness. Then H<sub>2</sub>O was added to the residue. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 30 mL), and the collected organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated under reduced pressure. The crude residue was chromatographed (CHCl<sub>3</sub>/AcOEt, 9:1, as eluent) to give pure <b>17</b> as a pale yellow semisolid (2.0 g, 90% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.69 (app t, 4H), 3.55−3.59 (m, 6H), 6.59 (dd, 1H, <i>J</i> = 0.5, 9.1 Hz), 7.43 (dd, 1H, <i>J</i> = 2.5, 9.1 Hz), 8.11 (dd, 1H, <i>J</i> = 0.5, 2.5 Hz). GC−MS <i>m</i>/<i>z</i> 238 (M<sup>+</sup> + 2, 9), 236 (M<sup>+</sup>, 27), 143 (33), 141 (100), 113 (21).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for Preparation of Amines <b>18c</b>−<b>e</b></h3><div class="NLM_p">Phthalimide derivative <b>16c</b>−<b>e</b> (1.5 mmol) was mixed with an excess of hydrazine hydrate in EtOH (20 mL) and refluxed for 8 h. Then the mixture was cooled on ice bath and acidified with concentrated HCl. The mixture was refluxed for 1 h. Then the mixture was cooled and filtered. The filtrate was concentrated under reduced pressure, and the residue was partitioned between 10% aqueous NaOH and CHCl<sub>3</sub>. The separated organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give the pure amine in 70−80% yield.</div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(1,2-Benzisoxazol-3-yl)-1-piperazinoethanamine (<b>18c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.72 (br s, 2H, D<sub>2</sub>O exchanged), 2.50 (t, 2H, <i>J</i> = 6.0 Hz), 2.65 (app t, 4H), 2.83 (t, 2H, <i>J</i> = 6.0 Hz), 3.58 (app t, 4H), 7.20 (dtd, 1H, <i>J</i> = 1.6, 6.2, 8.0 Hz), 7.42−7.50 (m, 2H), 7.68 (d, 1H, <i>J</i> = 8.3 Hz). ESI<sup>+</sup>-MS <i>m</i>/<i>z</i> 247.2 (MH<sup>+</sup>). ESI<sup>+</sup>-MS/MS <i>m</i>/<i>z</i> 230.2 (100).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(4-Cyanophenyl)-1-piperazinoethanamine (<b>18d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.83 (br s, 2H, D<sub>2</sub>O exchanged), 2.47 (t, 2H, <i>J</i> = 6.0 Hz), 2.58 (app t, 4H), 2.82 (t, 2H, <i>J</i> = 6.3 Hz), 3.32 (app t, 4H), 6.82−6.88 (m, 2H), 7.45−7.50 (m, 2H). GC−MS <i>m</i>/<i>z</i> 231 (M<sup>+</sup> + 1, 1), 230 (M<sup>+</sup>, 3), 200 (100), 157 (33), 70 (34).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-(3-Cyanopyridin-2-yl)-1-piperazinoethanamine (<b>18e</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.75 (br s, 2H, D<sub>2</sub>O exchanged), 2.48 (t, 2H, <i>J</i> = 6.1 Hz), 2.59 (app t, 4H), 2.82 (t, 2H, <i>J</i> = 6.3 Hz), 3.73 (app t, 4H), 6.73 (q, 1H, <i>J</i> = 7.4, 7.7 Hz), 7.75 (dd, 1H, <i>J</i> = 1.9, 7.6 Hz), 8.32 (dd, 1H, <i>J</i> = 1.9, 4.7 Hz). GC−MS <i>m</i>/<i>z</i> 232 (M<sup>+</sup> + 1, 1), 231 (M<sup>+</sup>, 1), 201 (100), 172 (37), 146 (36).</div></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-(5-Chloropyridin-2-yl)piperazineethanamine (<b>18f</b>)</h3><div class="NLM_p last">Borane−methyl sulfide complex as 10.0 M BH<sub>3</sub> in excess methyl sulfide (1.6 mL, 16 mmol) was dropped into an ice cooled solution of nitrile <b>17</b> (5.1 mmol) in anhydrous THF (10 mL), under stirring. After being refluxed for 4 h, the reaction mixture was cooled at −10 °C and MeOH was added dropwise very carefully until gas evolution ceased. The mixture was treated with 3 N HCl (20 mL) and was refluxed for 1 h. After cooling, the mixture was alkalized with 3 N NaOH and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 30 mL). The collected organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent was evaporated under reduced pressure to give the pure amine as a white semisolid (64% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.73 (br s, 2H, D<sub>2</sub>O exchanged), 2.46 (t, 2H, <i>J</i> = 6.1 Hz), 2.54 (app t, 4H), 2.82 (app t, 2H), 3.50 (app t, 4H), 6.57 (d, 1H, <i>J</i> = 9.1 Hz), 7.40 (dd, 1H, <i>J</i> = 2.5, 9.1 Hz), 8.09 (d, 1H, <i>J</i> = 2.5 Hz). GC−MS <i>m</i>/<i>z</i> 242 (M<sup>+</sup> + 2, 1), 240 (M<sup>+</sup>, 4), 212 (33), 210 (100), 181 (57), 155 (62), 112 (33).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for Preparation of Compounds <b>5</b>−<b>7</b>, <b>9</b>−<b>14</b>, <b>19</b></h3><div class="NLM_p">A mixture of the appropriate benzoic acid (0.48 mmol) and 1,1′-carbonyldiimidazole (0.50 mmol) in 10 mL of anhydrous THF was stirred for 8 h. A solution of amine <b>18a</b>−<b>f</b> (0.48 mmol) in anhydrous THF (10 mL) was added, and then the mixture was stirred until the benzoic acid disappeared (TLC). The reaction mixture was partitioned between AcOEt (20 mL) and H<sub>2</sub>O (20 mL). The separated organic layer was washed with a saturated aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. The crude residue was chromatographed as detailed below to afford the pure arylcarboxamide in 40−50% yield.</div><div id="sec5_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-[2-[4-(1,2-Benzisoxazol-3-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide (<b>5</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/MeOH, 98:2. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.73 (t, 2H, <i>J</i> = 5.5 Hz), 2.77 (app t, 4H), 3.60−3.65 (m, 6H), 3.84 (s, 3H), 6.95 (br s, 1H, D<sub>2</sub>O exchanged), 7.03 (dt, 1H, <i>J</i> = 2.5, 6.9 Hz), 7.20−7.22 (m, 2H), 7.23−7.26 (m, 1H), 7.29−7.34 (m, 1H), 7.37−7.52 (m, 2H), 7.66−7.69 (m, 1H). ESI<sup>+</sup>-MS <i>m</i>/<i>z</i> 381.0 (MH<sup>+</sup>). ESI<sup>+</sup>-MS/MS <i>m</i>/<i>z</i> 178.2 (100). The hydrochloride salt melted at 202−204 °C (from MeOH/Et<sub>2</sub>O). Anal. (C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>·HCl·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-[2-[4-(4-Cyanophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (<b>6</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/MeOH, 19:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.66−2.70 (m, 6H), 3.36 (app t, 4H), 3.60 (q, 2H, <i>J</i> = 5.5 Hz), 3.84 (s, 3H), 6.79 (br s, 1H, D<sub>2</sub>O exchanged), 6.84−6.89 (m, 2H), 7.03 (dq, 1H, <i>J</i> = 1.1, 1.4, 8.0 Hz), 7.26−7.38 (m, 3H), 7.47−7.52 (m, 2H). GC−MS <i>m</i>/<i>z</i> 364 (M<sup>+</sup>, 2), 213 (16), 200 (100), 157 (21). Mp 174−175 °C (from CHCl<sub>3</sub>/<i>n</i>-hexane). Anal. (C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide (<b>7</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/AcOEt, 1:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.67−2.71 (m, 6H), 3.60 (q, 2H, <i>J</i> = 5.3 Hz), 3.76 (app t, 4H), 3.85 (s, 3H), 6.77 (dd, 1H, <i>J</i> = 4.7, 7.7 Hz), 6.85 (br s, 1H, D<sub>2</sub>O exchanged), 7.02−7.05 (m, 1H), 7.26−7.38 (m, 3H), 7.77 (dd, 1H, <i>J</i> = 1.1, 8.7 Hz), 8.35 (dd, 1H, <i>J</i> = 1.1, 3.7 Hz). GC−MS <i>m</i>/<i>z</i> 366 (M<sup>+</sup> + 1, 1), 365 (M<sup>+</sup>, 2), 201 (100), 146 (18). The hydrochloride salt melted at 180 °C dec (from MeOH/Et<sub>2</sub>O). Anal. (C<sub>20</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>·2HCl) C, H, N.</div></div><div id="sec5_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-4-fluorobenzamide (<b>9</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/MeOH, 19:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.72−2.76 (m, 6H), 3.23 (app t, 4H), 3.62 (q, 2H, <i>J</i> = 5.3 Hz), 6.81−6.87 (m, 2H), 6.99 (br s, 1H, D<sub>2</sub>O exchanged), 7.07−7.15 (m, 2H), 7.18−7.24 (m, 2H), 7.79−7.85 (m, 2H). GC−MS <i>m</i>/<i>z</i> 363 (M<sup>+</sup> + 2, 3), 361 (M<sup>+</sup>, 8), 211 (32), 209 (100), 166 (23). Mp 180−181 °C (from CHCl<sub>3</sub>/<i>n</i>-hexane). Anal. (C<sub>19</sub>H<sub>21</sub>FClN<sub>3</sub>O) C, H, N.</div></div><div id="sec5_12_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-[2-[4-(4-Methylphenyl)piperazin-1-yl]ethyl]-4-fluorobenzamide (<b>10</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/MeOH, 19:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.27 (s, 3H), 2.71−2.76 (m, 6H), 3.22 (app t, 4H), 3.62 (q, 2H, <i>J</i> = 5.5 Hz), 6.83−6.87 (m, 2H), 7.00 (br s, 1H, D<sub>2</sub>O exchanged), 7.01−7.14 (m, 4H), 7.79−7.85 (m, 2H). GC−MS <i>m</i>/<i>z</i> 342 (M<sup>+</sup> + 1, 3), 341 (M<sup>+</sup>, 13), 189 (100), 123 (22). Mp 156−158 °C (from CHCl<sub>3</sub>/<i>n</i>-hexane). Anal. (C<sub>20</sub>H<sub>24</sub>FN<sub>3</sub>O) C, H, N.</div></div><div id="sec5_12_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-[2-[4-(1,2-Benzisoxazol-3-yl)piperazin-1-yl]ethyl]-4-fluorobenzamide (<b>11</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/MeOH, 98:2. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.74−2.82 (m, 6H), 3.61−3.68 (m, 6H), 6.93 (br s, 1H, D<sub>2</sub>O exchanged), 7.03−7.15 (m, 2H), 7.19−7.24 (m, 1H), 7.44−7.53 (m, 2H), 7.67 (d, 1H, <i>J</i> = 8.0 Hz) 7.80−7.87 (m, 2H). ESI<sup>+</sup>-MS <i>m</i>/<i>z</i> 369.1 (MH<sup>+</sup>). ESI<sup>+</sup>-MS/MS <i>m</i>/<i>z</i> 166.2 (100). Mp 138−140 °C (from CHCl<sub>3</sub>/<i>n</i>-hexane). Anal. (C<sub>20</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_12_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-[2-[4-(4-Cyanophenyl)piperazin-1-yl]ethyl]-4-fluorobenzamide (<b>12</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/MeOH, 19:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.70−2.72 (m, 6H), 3.39 (app t, 4H), 3.59−3.65 (m, 2H), 6.84−6.89 (m, 2H), 6.93 (br s, 1H, D<sub>2</sub>O exchanged), 7.07−7.15 (m, 2H), 7.48−7.52 (m, 2H), 7.78−7.83 (m, 2H). GC−MS <i>m</i>/<i>z</i> 353 (M<sup>+</sup> + 1, 1), 351 (M<sup>+</sup>, 2), 200 (100), 157 (20). Mp 193−194 °C (from CHCl<sub>3</sub>/<i>n</i>-hexane). Anal. (C<sub>20</sub>H<sub>21</sub>FN<sub>4</sub>O) C, H, N.</div></div><div id="sec5_12_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-4-fluorobenzamide (<b>13</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/MeOH, 19:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.78 (br s, 6H), 3.62−3.67 (m, 2H), 3.82 (app t, 4H), 6.80 (q, 1H, <i>J</i> = 7.4, 7.7 Hz), 6.93 (br s, 1H, D<sub>2</sub>O exchanged), 7.08−7.16 (m, 2H), 7.79 (dd, 1H, <i>J</i> = 1.9, 7.4 Hz), 7.82−7.87 (m, 2H), 8.36 (dd, 1H, <i>J</i> = 1.9, 5.0 Hz). GC−MS <i>m</i>/<i>z</i> 354 (M<sup>+</sup> + 1, 1), 353 (M<sup>+</sup>, 1), 201 (100), 123 (22). Mp 155−156 °C (from CHCl<sub>3</sub>/<i>n</i>-hexane). Anal. (C<sub>19</sub>H<sub>20</sub>FN<sub>5</sub>O) C, H, N.</div></div><div id="sec5_12_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-[2-[4-(5-Chloropyridin-2-yl)piperazin-1-yl]ethyl]-4-fluorobenzamide (<b>14</b>)</h4><div class="NLM_p last">Eluted with CHCl<sub>3</sub>/MeOH, 19:1. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.65−2.72 (m, 6H), 3.56−3.64 (m, 6H), 6.59 (d, 1H, <i>J</i> = 9.1 Hz), 6.93 (br s, 1H, D<sub>2</sub>O exchanged), 7.07−7.15 (m, 2H), 7.43 (dd, 1H, <i>J</i> = 2.8, 9.1 Hz), 7.78−7.84 (m, 2H), 8.11 (d, 1H, <i>J</i> = 2.5 Hz). GC−MS <i>m</i>/<i>z</i> 364 (M<sup>+</sup> + 2, 1), 362 (M<sup>+</sup>, 3), 210 (100), 181 (34), 155 (40), 123 (52). Mp 173−175 °C (from CHCl<sub>3</sub>/<i>n</i>-hexane). Anal. (C<sub>18</sub>H<sub>20</sub>FClN<sub>4</sub>O) C, H, N.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-hydroxybenzamide (<b>19</b>)</h4><div class="NLM_p last">Eluted with AcOEt. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.67−2.71 (m, 6H), 3.56−3.62 (m, 2H), 3.76 (app t, 4H), 6.75−6.79 (m, 1H), 6.96 (br s, 1H, D<sub>2</sub>O exchanged), 6.97−6.99 (m, 1H), 7.18−7.24 (m, 2H), 7.48 (m, 1H), 7.78 (dd, 1H, <i>J</i> = 1.9, 7.4 Hz), 8.35 (dd, 1H, <i>J</i> = 1.9, 4.7 Hz). ESI<sup>+</sup>-MS <i>m</i>/<i>z</i> 352.1 (MH<sup>+</sup>). ESI<sup>+</sup>-MS/MS <i>m</i>/<i>z</i> 164.2 (100), 121.2 (15).</div></div></div><div id="sec5_13_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Lipophilicity Data</h3><div class="NLM_p last">Lipophilicity data of compounds <b>2</b> and <b>4</b>−<b>13</b> were obtained by the pH metric technique using a Glp<i>K</i><sub>a</sub> apparatus (Sirius Analytical Instruments Ltd., Forrest Row, East Sussex, United Kingdom) as described elsewhere.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The low aqueous solubility of the investigated compounds required p<i>K</i><sub>a</sub> measurements to be performed in the presence of methanol as cosolvent. Three separate 20 mL semiaqueous solutions of approximately 5 × 10<sup>−5</sup> M, in 20−50% w/w of MeOH, were initially acidified with 0.5 M HCl to pH 3.5. The solutions were then titrated with 0.5 M KOH to pH 11. The initial estimates of the p<sub>s</sub><i>K</i><sub>a</sub> values, which are the apparent ionization constants in the mixed solvent, were obtained by Bjerrum plots. These values were then refined by a weighted nonlinear least-squares procedure (Refinement Pro 1.0 software) to create a multiset, where the refined values were extrapolated to zero cosolvent concentration using the Yasuda−Shedlovsky equation.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> To obtained log <i>P</i> data, at least three separate titrations were performed on each compound, of approximately 5 × 10<sup>−5</sup> M, using various <i>n</i>-octanol/water ratios (from 0.005 to 1). The biphasic solutions were initially acidified to pH 3.5 with 0.5 M HCl and then titrated with 0.5 M KOH to pH 11. The obtained data were refined as described above. The log <i>P</i> values were obtained by the multiset approach, as described elsewhere.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> All titrations were carried out at 25 ± 0.1 °C under an inert nitrogen gas atmosphere to exclude CO<sub>2</sub>.</div></div><div id="sec5_13_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Radiosynthesis of [<sup>11</sup>C]<b>7</b></h3><div class="NLM_p last">Carbon-11 was produced by <sup>14</sup>N(p, α)<sup>11</sup>C nuclear reaction using CYPRIS HM-18 cyclotron (Sumitomo Heavy Industry Co. Ltd., Tokyo, Japan). [<sup>11</sup>C]CH<sub>3</sub>I with high specific activity was produced by the single-pass I<sub>2</sub> method as described previously.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> By the nuclear reaction and a successive hot atom process, [<sup>11</sup>C]CH<sub>4</sub> (total radioactivity: 44 GBq) was produced in the target chamber at an initial pressure of 15 bar with 18 MeV protons (14.2 Mev on target). [<sup>11</sup>C]CH<sub>4</sub> was passed through a heated I<sub>2</sub> column once and converted to [<sup>11</sup>C]CH<sub>3</sub>I, which was collected in a reaction vessel containing a 300 μL of anhydrous DMF solution of desmethyl precursor <b>19</b> (1 mg) and NaOH (10 μL, 0.5 N) at −15 to −20 °C. After radioactivity reached a plateau, the reaction mixture was heated at 70 °C for 3 min. The HPLC solvent was added to the reaction vessel to terminate the reaction. The radioactive mixture was applied to an HPLC purification system (SHISEIDO CAPCELL PAK C18 UG80 column, 10 mm × 250 mm; mobile phase CH<sub>3</sub>OH/H<sub>2</sub>O/triethylamine, 6/4/0.1%; flow rate, 5 mL/min; λ = 254 nm). The fraction corresponding to [<sup>11</sup>C]<b>7</b> was collected in a flask containing 100 μL of ascorbic acid (25%) and evaporated to dryness under a vacuum. The residue was dissolved in 3 mL of saline (pH 7.4) for animal experiments. At the end of synthesis, 210−440 MBq (<i>n</i> = 4) of [<sup>11</sup>C]<b>7</b> was obtained as an intravenous injectable solution. The radiochemical purity and specific activity of [<sup>11</sup>C]<b>7</b> were assayed by analytical HPLC (SHISEIDO CAPCELL PAK C18 UG80 column, 10 mm × 250 mm; mobile phase CH<sub>3</sub>OH/H<sub>2</sub>O/triethylamine, 6/4/0.1%; flow rate, 5 mL/min; λ = 254 nm). The identity of [<sup>11</sup>C]<b>7</b> was confirmed by co-injection with an authentic nonradioactive sample. The amount of carrier in the final product solution was measured by the same analytical HPLC. The radiochemical purity and specific activity was >99% and 2770−3890 GBq/μmol (<i>n</i> = 4), respectively.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Biological Methods</h3><div id="sec6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">1 Preparation of Crude Membranes for Binding Assays</h4><div class="NLM_p">A human embryonic kidney cell line (HEK293) was employed as the host cell for expressing individually the cloned rat dopamine D<sub>2</sub> and D<sub>4</sub> receptors and human serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>2C</sub> receptors because all these receptor subtypes are absent in HEK293 cells; i.e., HEK293 cells lack specific binding for the radioligands used to characterize each of the receptor subtypes (data not shown). HEK293 cell lines stably expressing high levels of D<sub>2</sub>, D<sub>4</sub>, 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, or 5-HT<sub>2C</sub> receptors were created as described by us previously.<a onclick="showRef(event, 'ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62">(60-62)</a> The expression levels of the different receptor subtypes in individual clonal lines were determined by radioligand saturation isotherm binding utilizing standard rapid filtration techniques and cell membrane preparations as described by us previously.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Cloned human σ<sub>1</sub> receptors were stably expressed in human MCF-7 cells as described by us previously, because MCF-7 cells lack specific binding for [<sup>3</sup>H]-(+)-pentazocine, the radioligand used to characterize σ<sub>1</sub> receptor binding potential.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The membranes from these σ<sub>1</sub>-expressing MCF-7 cells were prepared as described previously.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> With the exception of membranes containing D<sub>3</sub> receptors, all membranes isolated from clonal cell lines were placed in their respective binding buffers (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) and kept on ice until use that same day. Frozen membranes from CHO-K1 cells containing the human dopamine D<sub>3</sub> receptor were purchased from Perkin-Elmer Life Science.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Radioligand and Drugs Used to Define Nonspecific Binding for Each of the Receptor Subtypes Tested<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col width="19.760479041916167%" align="left" /></col><col width="20.159680638722556%" align="left" /></col><col width="19.960079840319363%" align="left" /></col><col width="20.159680638722556%" align="left" /></col><col width="19.960079840319363%" align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor</th><th class="colsep0 rowsep0" align="center">radioligand</th><th class="colsep0 rowsep0" align="center">drug for defining nonspecific binding</th><th class="colsep0 rowsep0" align="center">binding buffer</th><th class="colsep0 rowsep0" align="center">binding conditions</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]MPPF</td><td class="colsep0 rowsep0" align="left">NAN-190</td><td class="colsep0 rowsep0" align="left">50 mM Tris, pH 7.4 at 25 °C</td><td class="colsep0 rowsep0" align="left">90 min at 25 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]MSP</td><td class="colsep0 rowsep0" align="left">mianserin</td><td class="colsep0 rowsep0" align="left">50 mM Tris, pH 7.4 at 25 °C</td><td class="colsep0 rowsep0" align="left">90 min at 25 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]mesulergine</td><td class="colsep0 rowsep0" align="left">mianserin</td><td class="colsep0 rowsep0" align="left">50 mM Tris, pH 7.4 at 25 °C</td><td class="colsep0 rowsep0" align="left">90 min at 25 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>2</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]MSP</td><td class="colsep0 rowsep0" align="left">(+)-butaclamol</td><td class="colsep0 rowsep0" align="left">50 mM Tris, pH 7.4 at 25 °C</td><td class="colsep0 rowsep0" align="left">90 min at 25 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>3</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]MSP</td><td class="colsep0 rowsep0" align="left">7-OH-DPAT</td><td class="colsep0 rowsep0" align="left">50 mM Tris, pH 7.4 at 25 °C</td><td class="colsep0 rowsep0" align="left">90 min at 25 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>4</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]MSP</td><td class="colsep0 rowsep0" align="left">(+)-butaclamol</td><td class="colsep0 rowsep0" align="left">50 mM Tris, pH 7.4 at 25 °C</td><td class="colsep0 rowsep0" align="left">90 min at 25 °C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">σ<sub>1</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-(+)-pentazocine</td><td class="colsep0 rowsep0" align="left">BD1063</td><td class="colsep0 rowsep0" align="left">50 mM Tris, pH 8.0 at 37 °C</td><td class="colsep0 rowsep0" align="left">180 min at 37 °C with shaking</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CB<sub>1</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]CP55,940</td><td class="colsep0 rowsep0" align="left">O-2050</td><td class="colsep0 rowsep0" align="left">50 mM Tris, pH 7.4 at 30 °C, 2.5 mM EDTA, 5 mM MgCl<sub>2</sub>, 5 mg/mL fatty acid free BSA</td><td class="colsep0 rowsep0" align="left">180 min at 30 °C with shaking</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">[<sup>3</sup>H]MPPF is 4-(2′′-methoxy)phenyl-1-[2′′-(<i>N</i>-2-pyridinyl)-<i>p</i>-fluorobenzamido]ethylpiperazine (Perkin Elmer, St. Louis, MO, NET-1109, 80 Ci/mmol). [<sup>3</sup>H]MSP is [<sup>3</sup>H]methylspiperone (Perkin Elmer, St. Louis, MO, NET-856, 84 Ci/mmol). [<sup>3</sup>H]mesulergine (GE Healthcare Life Sciences, Piscataway, NJ, TRK845, 80 Ci/mmol). [<sup>3</sup>H]-(+)-pentazocine (Perkin Elmer, St. Louis, MO, NET1056, 29 Ci/mmol). [<sup>3</sup>H]CP55,940 (Perkin Elmer, St. Louis, MO, NET1051, 180 Ci/mmol). Note that all radioligands were tested at approximately 0.5 pM, except for [<sup>3</sup>H]-(+)-pentazocine and [<sup>3</sup>H]CP55,940, which were tested at 1 and 2 nM, respectively. A concentration of 5 μM was used to define nonspecific binding for all receptors.</p></div></div></div><div class="NLM_p last">Whole rat brains with the cerebellum and brain stem removed were used as the tissue source for rat cannabinoid CB<sub>1</sub> receptors. Briefly, two to three stripped and frozen Sprague−Dawley rat brains (Pel Freeze Bio, 56005-2) were allowed to slow-thaw by incubating on ice in 30 mL of cold 20 mM Tris, pH 7.4, at 2 °C and 1:1000 v/v diluted protease inhibitor cocktail (Sigma-Aldrich, P8340). Thawed brains were homogenized with 10 strokes in a Dounce glass−glass homogenizer and the suspension was centrifuged for 10 min at 1000<i>g</i> (Sorvall Legend RT). The resulting supernatant was transferred to a new tube and centrifuged for 1 h at 4 °C at 25000<i>g</i> (Sorvall RC-5). The supernatant was discarded and the pellet resuspended in 5 mL of cold 20 mM Tris, pH 7.4, at 2 °C and rehomogenized with four strokes. The homogenate was separated into 1 mL aliquots in cryotubes and stored in liquid nitrogen until use at a 1:5 v/v dilution in binding buffer (see Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">2 Radioligand Binding Assays</h4><div class="NLM_p last">Compounds were tested for their ability to compete with radioligands specifically bound to membranes from cells or tissues expressing the dopamine D<sub>2</sub> or D<sub>3</sub> or D<sub>4</sub> receptors, serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, or 5-HT<sub>2C</sub> receptors, σ<sub>1</sub> receptors, and cannabinoid CB<sub>1</sub> receptors. The radioligands and drugs used to define nonspecific binding to each receptor system are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. All binding reactions were allowed to reach equilibrium prior to rapid filtration. Glass tubes were used in all binding reactions except those for cannabinoid receptors which utilized silanized glass tubes. Binding reactions were rapidly terminated by filtration through GF/C filters pretreated with 0.5% polyethyleneimine, or GF/B filter pretreated with 1% polyethyleneimine in the case of cannabinoid receptors, and washing with 3 × 3 mL of ice-cold (0−2 °C) binding buffer at the pH at that temperature. Radioactivity bound to filters was quantified in a scintillation counter. Membrane protein concentrations were determined using the bicinchonic acid protein reagent (BCA) and a bovine serum albumin standard curve. Membranes protein concentrations varied from 0.01 to 0.05 mg/mL. Binding affinities (<i>K</i><sub>i</sub>) were determined by competition binding with fixed concentrations of the radioligands described in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. With the exception of <b>6</b>, <b>7</b>, and <b>12</b>, which were dissolved in DMF, all compounds were solubilized in DMSO at concentrations ranging from 1 to 10 mM. These nonaqueous solution stocks were then diluted at least 1:1000 v/v in the final assay solution.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">3 Calculations and Data Analysis</h4><div class="NLM_p last">All points were run in triplicate. Each experiment was repeated three to four times, and averaged values were reported with their standard deviation or standard error. The inhibition constant (<i>K</i><sub>i</sub>) values were calculated from IC<sub>50</sub> values using the Cheng−Prusoff equation: <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [ligand]/<i>K</i><sub>D</sub>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In cases where the displacement was >20% but less than 100% at the highest concentration of inhibitor, the bottom of the curve fit was set to zero so that accurate IC<sub>50</sub> values could be calculated. A 95% confidence interval was employed for all curve-fitting procedures using Graphpad’s Prism software, version 4.0.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">4 Preliminary Disposition Studies</h4><div class="NLM_p">Male CD1 mice weighing 25−30 g (Charles River, Italy) were administered compounds <b>7</b> or <b>13</b> (10 mg/kg ip, dissolved in ethanol/PEG 40/saline (10:40:50, v/v) and were sacrificed by decapitation at 15, 30, 60, 120, and 240 min after dosing to determine the plasma and brain concentrations of the parent compounds and their potential metabolite 1-(6-cyano-2-pyridyl)piperazine. Procedures involving animals and their care were conducted in conformity with the institutional guidelines that are in complicance with national (D.L. n. 116, G.U., Suppl. 40, 18 Febbraio 1992, Circolare No. 8, G.U., 14 Luglio 1994) and international laws and policies (EEC Council Directive 86/609, OJ L 358, 1, Dec 12, 1987; Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 1996). Concentrations of the selected compounds were determined by HPLC with UV detection (λ = 264 nm). Briefly, to 0.2 mL of plasma, 0.01 mL of 1 M NaOH, 0.03 mL of the internal standard 1-(2-thiazolyl)piperazine (10 μg/mL), and 5 mL of dicloromethane were added. After being shaken, samples were centrifuged, and to the organic extract 0.15 mL of mobile phase was added. After further shaking and centrifugation, 0.1 mL of the mobile phase was injected onto the HPLC system. Brains were homogenized in distilled water (1 g/10 mL), and an amount of 2 mL of the homogenate was processed as above. Chromatography was performed on a reversed-phase column XTerra RP 18 (4.6 mm × 150 mm, 5 μm particle size). The mobile phase was CH<sub>3</sub>CN/ 0.005 M KH<sub>2</sub>PO<sub>4</sub> (pH 3.5) (5:95, v/v) (solvent A) and CH<sub>3</sub>CN/ 0.005 M KH<sub>2</sub>PO<sub>4</sub> (pH 3.5) (70:30, v/v) (solvent B). The HPLC system was set up to operate at a flow rate of 1 mL/min, following a simple gradient: step 1, from the initial condition (100% solvent A) to 20% solvent A (80% B) in 12 min; step 2, from 20% to 100% solvent A (from 80% to 0% of solvent B) in 2 min. The total run time was 18 min.</div><div class="NLM_p last">The retention times were 8.7 min for <b>7</b>, 8.8 for <b>13</b>, 4.5 min for 1-(6-cyano-2-pyridyl)piperazine, and 7.7 min for internal standard. The limit of quantification was about 100 ng/mL or ng/g, using 0.2 mL of plasma or about 200 mg of tissue. At these concentrations, the coefficients of variation (CV) were generally between 10% and 15%, and all higher concentrations gave CV between 5% and 10% for all compounds in both tissues.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">5 Monkey PET Scan</h4><div class="NLM_p last">PET scans were performed on a male rhesus monkey (<i>Macaca mulatta</i>) weighing 4.4 kg. The animal was maintained and handled in accordance with recommendations by the U.S. National Institutes of Health and our institutional guidelines (National Institute of Radiological Sciences). The studies were approved by the Animal Ethics Committee of the National Institute of Radiological Sciences, Chiba, Japan. PET scan was performed using a high-resolution SHR-7700 PET camera (Hamamatsu Photonics K.K., Japan) designed for laboratory animals, which provides 31 transaxial slices 3.6 mm (center-to-center) apart, a 33.1 cm field of view, and spatial resolution of 2.6 mm full width at half-maximum.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The monkey was anesthetized with ketamine at 10 mg/kg im (Ketalar, Sankyo Co. Ltd., Japan) with a head fixation device to ensure accuracy of repositioning.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Following transmission scans for attenuation correction using a <sup>68</sup>Ge−<sup>68</sup>Ga source for 20 min, a dynamic emission scan in 3D acquisition mode was immediately performed after intravenous injection of [<sup>11</sup>C]<b>7</b> (38.5 ± MBq; specific radioactivity, 2.9 TBq/μmol at injection) for 90 min (0.5 min × 6 frames, 1 min × 7 frames, 2 min × 20 frames, 5 min × 8 frames). Dynamic emission scan images were reconstructed with filtered back-projection using a 4.0 mm Colsher filter. Volumes of interest (VOIs) were placed on the hippocampus, entorhinal cortex, and striatum using PMOD image analysis software (PMOD Group, Zurich, Switzerland) with reference to the magnetic resonance (MR) image of the monkey brain. The MR image was acquired with a 1.5 T gyroscan S15/ACS2 (Philips Electronic, Eindhoven, The Netherlands) by means of a three-dimensional <i>T</i><sub>1</sub>-weighted spin−echo sequence. The tracer uptake in each VOI was estimated as percent of injected dose per unit volume (% ID/mL).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/jm100925m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08445" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08445" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data of target compounds and time−activity data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100925m/suppl_file/jm100925m_si_001.pdf">jm100925m_si_001.pdf (47.66 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100925m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcello Leopoldo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco-Chimico, Università degli Studi di Bari “A. Moro”, Via Orabona, 4, 70125, Bari, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d8b4bdb7a8b7b4bcb798beb9aab5bbb0b1b5f6adb6b1bab9f6b1ac"><span class="__cf_email__" data-cfemail="d3bfb6bca3bcbfb7bc93b5b2a1beb0bbbabefda6bdbab1b2fdbaa7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enza Lacivita</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco-Chimico, Università degli Studi di Bari “A. Moro”, Via Orabona, 4, 70125, Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola De Giorgio</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco-Chimico, Università degli Studi di Bari “A. Moro”, Via Orabona, 4, 70125, Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irene T. Lee</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107-2699, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean I. Rodeheaver</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107-2699, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan A. Weiss</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107-2699, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Fracasso</span> - <span class="hlFld-Affiliation affiliation">Istituto di Ricerche Farmacologiche “Mario Negri”, Via La Masa 19, 20156 Milan, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvio Caccia</span> - <span class="hlFld-Affiliation affiliation">Istituto di Ricerche Farmacologiche “Mario Negri”, Via La Masa 19, 20156 Milan, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Berardi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco-Chimico, Università degli Studi di Bari “A. Moro”, Via Orabona, 4, 70125, Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Perrone</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco-Chimico, Università degli Studi di Bari “A. Moro”, Via Orabona, 4, 70125, Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Rong Zhang</span> - <span class="hlFld-Affiliation affiliation">Molecular Imaging Center, National Institute of Radiological Sciences, 9-1, 4-Chome, Anagawa, Inage-ku, 263-8555, Chiba, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Maeda</span> - <span class="hlFld-Affiliation affiliation">Molecular Imaging Center, National Institute of Radiological Sciences, 9-1, 4-Chome, Anagawa, Inage-ku, 263-8555, Chiba, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Makoto Higuchi</span> - <span class="hlFld-Affiliation affiliation">Molecular Imaging Center, National Institute of Radiological Sciences, 9-1, 4-Chome, Anagawa, Inage-ku, 263-8555, Chiba, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tetsuya Suhara</span> - <span class="hlFld-Affiliation affiliation">Molecular Imaging Center, National Institute of Radiological Sciences, 9-1, 4-Chome, Anagawa, Inage-ku, 263-8555, Chiba, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Schetz</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107-2699, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Psychiatry, Texas College of Osteopathic Medicine, Fort Worth, Texas 76107, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Health Management and Policy, School of Public Health, Fort Worth, Texas 76107, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Biology, University of Texas at Arlington, Arlington, Texas 76109, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by the National Institutes of Health [Grants R01-MH063162 and R01-MH063162-06S1 (J.A.S.)] and the National Science Foundation [DBI-0649889 (J.A.S.)].</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 66 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Van Tol, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunahara, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Cloning of the gene for a human dopamine D<sub>4</sub> receptor with high affinity for the antipsychotic clozapine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2F350610a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=1840645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK38XhsV2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1991&pages=610-614&author=H.+H.+Van+Tolauthor=J.+R.+Bunzowauthor=H.+C.+Guanauthor=R.+K.+Sunaharaauthor=P.+Seemanauthor=H.+B.+Niznikauthor=O.+Civelli&title=Cloning+of+the+gene+for+a+human+dopamine+D4+receptor+with+high+affinity+for+the+antipsychotic+clozapine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</span></div><div class="casAuthors">Van Tol, Hubert H. M.; Bunzow, James R.; Guan, Hong Chang; Sunahara, Roger K.; Seeman, Philip; Niznik, Hyman B.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6319</span>),
    <span class="NLM_cas:pages">610-14</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The cloning of a gene that encodes a clozapine-sensitive dopamine receptor, D4 is reported.  The D4 receptor gene has high homol. to the human dopamine D2 and D3 receptor genes.  The pharmacol. characteristics of this receptor resemble those of the D2 and D3 receptors, but its affinity for clozapine is one order of magnitude higher.  Recognition and characterization of this clozapine neuroleptic site may prove useful in the design of new types of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpneU9aH4jnoLVg90H21EOLACvtfcHk0lhXpMsvRVZzEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsV2n&md5=de5f7ade54d85f54181c53d15d6af169</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F350610a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F350610a0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGuan%26aufirst%3DH.%2BC.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DCloning%2520of%2520the%2520gene%2520for%2520a%2520human%2520dopamine%2520D4%2520receptor%2520with%2520high%2520affinity%2520for%2520the%2520antipsychotic%2520clozapine%26jtitle%3DNature%26date%3D1991%26volume%3D350%26spage%3D610%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lahti, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figur, L. M.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> versus D<sub>2</sub> receptor selectivity of dopamine receptor antagonists: possible therapeutic implications</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2F0014-2999%2893%2990488-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=8102973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK3sXltVyrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1993&pages=483-486&author=R.+A.+Lahtiauthor=D.+L.+Evansauthor=N.+C.+Stratmanauthor=L.+M.+Figur&title=Dopamine+D4+versus+D2+receptor+selectivity+of+dopamine+receptor+antagonists%3A+possible+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: Possible therapeutic implications</span></div><div class="casAuthors">Lahti, Robert A.; Evans, Dawna L.; Stratman, Nancy C.; Figur, Lana M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">483-6</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The dopamine D4 receptor, which is considered a close variant of the dopamine D2 receptor, has recently been cloned.  Receptor binding studies demonstrated that clozapine, which is an effective antipsychotic agent but atypical in that it lacks the usual side effects of other antipsychotic agents, has high selectivity for the dopamine D4 receptor vs. the dopamine D2 receptor.  Comparative binding affinity studies have been carried out for a no. of interesting dopaminergic agents using membranes prepd. from cloned dopamine D2 and D4 receptor contg. cells.  It was found that clozapine is selective for the dopamine D4 vs. the D2 receptor by a factor of 2.8.  Other compds. with dopamine D4 receptor selectivity were (+)-apomorphine (8.7), (+)-N-propylnorapomorphine (NPA) (2.4) and melperone (1.3).  Compds. with considerable selectivity for the dopamine D2 receptor were haloperidol (0.31), chlorpromazine (0.084), trifluoperazine (0.034) and raclopride (0.001).  Overall, the results with the antipsychotic agents tested, support the concept that dopamine D4 receptor selectivity may confer clozapine-like antipsychotic efficacy and furthermore that dopamine D2 receptor selectivity may confer side effect liability (extrapyramidal side effects and tardive dyskinesia).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSanftB8vEaLVg90H21EOLACvtfcHk0lhXpMsvRVZzEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltVyrtb4%253D&md5=4a44bcdae05b03355ef71a8f6278f7fb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990488-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990488-4%26sid%3Dliteratum%253Aachs%26aulast%3DLahti%26aufirst%3DR.%2BA.%26aulast%3DEvans%26aufirst%3DD.%2BL.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DFigur%26aufirst%3DL.%2BM.%26atitle%3DDopamine%2520D4%2520versus%2520D2%2520receptor%2520selectivity%2520of%2520dopamine%2520receptor%2520antagonists%253A%2520possible%2520therapeutic%2520implications%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D236%26spage%3D483%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardessarini, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarazi, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumeyer, J. L.</span><span> </span><span class="NLM_article-title">Selective dopamine D<sub>4</sub> receptor antagonists: review of structure−activity relationships</span> <span class="citation_source-journal">Curr. Med. Chem.: Cent. Nerv. Syst. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.2174%2F1568015023357914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslKlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=259-274&author=K.+Zhangauthor=R.+J.+Bardessariniauthor=F.+I.+Taraziauthor=J.+L.+Neumeyer&title=Selective+dopamine+D4+receptor+antagonists%3A+review+of+structure%E2%88%92activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Selective dopamine D4 receptor antagonists: Review of structure-activity relationships</span></div><div class="casAuthors">Zhang, Kehong; Baldessarini, Ross J.; Tarazi, Frank I.; Neumeyer, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Central Nervous System Agents</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-274</span>CODEN:
                <span class="NLM_cas:coden">CMCCCO</span>;
        ISSN:<span class="NLM_cas:issn">1568-0150</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cloned in 1991, the human dopamine D4 receptor is found mainly in cortical and limbic areas of brain.  Many chem. dissimilar D4 receptor-selective antagonists have been developed, initially stimulated by partial D4 receptor-selectivity of the clin. superior antipsychotic agent clozapine.  Implication of D4 receptor in the pathophysiol. or treatment of idiopathic psychotic disorders, however, remains elusive.  Moreover, L-745,870, a selective D4 antagonist, and fananserin, a mixed antagonist of D4 and 5-HT2 receptors, failed to show antipsychotic efficacy.  Interest in D4 receptor pharmacol. was re-kindled by the 1996 discovery that D4 receptor gene polymorphism is assocd. with attention deficit-hyperactivity disorder (ADHD) and related personality traits.  D4 receptors are also implicated in mood disorders and the actions of psychostimulants.  Development of many chem. dissimilar D4-selective antagonists has contributed to improved understanding of D4 receptor neurobiol.  This review summarizes recent advances in the synthetic chem. of D4 receptor antagonists, and considers selected neuropharmacol. studies suggestive of their potential clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps76M1Nwm1w7Vg90H21EOLACvtfcHk0lgeZcbkKGZ3HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslKlsL0%253D&md5=24b4ad9f0f6bcf4072582943cc7758ba</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568015023357914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568015023357914%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DBardessarini%26aufirst%3DR.%2BJ.%26aulast%3DTarazi%26aufirst%3DF.%2BI.%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26atitle%3DSelective%2520dopamine%2520D4%2520receptor%2520antagonists%253A%2520review%2520of%2520structure%25E2%2588%2592activity%2520relationships%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Cent.%2520Nerv.%2520Syst.%2520Agents%26date%3D2002%26volume%3D2%26spage%3D259%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bristow, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragan, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saywell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M.</span><span> </span><span class="NLM_article-title">L-745,870, a subtype selective dopamine D<sub>4</sub> receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9400001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1cXis1Cqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=1256-1263&author=L.+J.+Bristowauthor=N.+Collinsonauthor=G.+P.+Cookauthor=N.+Curtisauthor=S.+B.+Freedmanauthor=J.+J.+Kulagowskiauthor=P.+D.+Leesonauthor=S.+Patelauthor=C.+I.+Raganauthor=M.+Ridgillauthor=K.+L.+Saywellauthor=M.+Tricklebank&title=L-745%2C870%2C+a+subtype+selective+dopamine+D4+receptor+antagonist%2C+does+not+exhibit+a+neuroleptic-like+profile+in+rodent+behavioral+tests"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">L-745870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests</span></div><div class="casAuthors">Bristow, Linda J.; Collinson, Neil; Cook, Gina P.; Curtis, Neil; Freedman, Stephen B.; Kulagowski, Janusz J.; Leeson, Paul D.; Patel, Smita; Ragan, C. Ian; Ridgill, Mark; Saywell, Kay L.; Tricklebank, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1256-1263</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">This study examd. the high-affinity, selective dopamine D4 receptor antagonist, L-745870 (3-{[4-(4-chlorophenyl)piperazin-1-yl]methyl}-1H-pyrrolo[2,3-b]pyridine) in rodent behavioral models used to predict antipsychotic potential and side-effect liabilities in humans.  In contrast to the classical neuroleptic, haloperidol, and the atypical neuroleptic, clozapine, L-745870 failed to antagonize amphetamine-induced hyperactivity in mice or impair conditioned avoidance responding in the rat at doses selectively blocking D4 receptors.  Furthermore, L-745870 failed to reverse the deficit in prepulse inhibition of acoustic startle responding induced by the nonselective dopamine D2/3/4 receptor agonist apomorphine, an effect which was abolished in rats pretreated with the D2/3 receptor antagonist, raclopride (0.2 mg/kg s.c.).  L-745870 had no effect on apomorphine-induced stereotypy in the rat but did induce catalepsy in the mouse, albeit at a high dose of 100 mg/kg, which is likely to occupy dopamine D2 receptors in vivo.  High doses also impaired motor performance; in rats L-745870 significantly reduced spontaneous locomotor activity (min. ED = 30 mg/kg) and in mice, L-745870 reduced the time spent on a rotarod revolving at 15 rpm (min. ED = 100 mg/kg).  Altogether these results suggest that dopamine D4 receptor antagonism is not responsible for the ability of clozapine to attenuate amphetamine-induced hyperactivity and conditioned avoidance responding in rodents.  Furthermore, the lack of effect of L-745870 in these behavioral tests is consistent with the inability of the compd. to alleviate psychotic symptoms in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-i7KBCKHpxrVg90H21EOLACvtfcHk0lgeZcbkKGZ3HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1Cqtg%253D%253D&md5=6fa87b67fd755980d2c41851e444de1b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DCollinson%26aufirst%3DN.%26aulast%3DCook%26aufirst%3DG.%2BP.%26aulast%3DCurtis%26aufirst%3DN.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26aulast%3DRidgill%26aufirst%3DM.%26aulast%3DSaywell%26aufirst%3DK.%2BL.%26aulast%3DTricklebank%26aufirst%3DM.%26atitle%3DL-745%252C870%252C%2520a%2520subtype%2520selective%2520dopamine%2520D4%2520receptor%2520antagonist%252C%2520does%2520not%2520exhibit%2520a%2520neuroleptic-like%2520profile%2520in%2520rodent%2520behavioral%2520tests%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D1256%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kramer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Last, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reines, S. A.</span><span> </span><span class="NLM_article-title">The effects of a selective D<sub>4</sub> dopamine receptor antagonist (L-745,870) in acutely psychotic in patients with schizophrenia. D<sub>4</sub> dopamine antagonist group</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1001%2Farchpsyc.1997.01830180085011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9193198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK2sXksFWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=567-572&author=M.+S.+Kramerauthor=B.+Lastauthor=A.+Getsonauthor=S.+A.+Reines&title=The+effects+of+a+selective+D4+dopamine+receptor+antagonist+%28L-745%2C870%29+in+acutely+psychotic+in+patients+with+schizophrenia.+D4+dopamine+antagonist+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">the effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia</span></div><div class="casAuthors">Kramer, Mark S.; Last, Barbara; Getson, Albert; Reines, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-572</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Based mainly on the selective antagonism of clozapine at D4 compared with D2 dopamine receptors, hopes have run high that a selective D4 dopamine receptor antagonist might improve the pharmacol. treatment of patients with schizophrenia.  We report, to our knowledge, the first multicenter study of the antipsychotic potential of a highly specific D4 dopamine receptor antagonist (ie, L-745,870) in patients with acute schizophrenia.  Thirty-eight acutely psychotic and neuroleptic responsive (by history) newly admitted inpatients with schizophrenia were randomized to 4 wk of double-blind treatment (2:1) with either L-745,870 (n = 26), 15 mg/d, or placebo (n = 12) after 3- to 5-day placebo run-in period.  Overall, a greater percentage of patients receiving L-745,870 compared with patients receiving placebo discontinued the study for insufficient therapeutic response (32% vs 16%).  At the end of 4 wk by last observation carried forward anal., the mean change from baseline to week 4 on the total Brief Psychiatric Rating Scale favored placebo (ie, -8 points [-15% change from baseline] vs -1 point [-2% change from baseline] from placebo vs L-745,870, P = 0.09).  Similar differences in favor of placebo in changes from baseline mean scores were obsd. for the not carried forward anal. on the total Brief Psychiatric Rating Scale (P < 0.03), for not carried forward and last observation carried forward analyses on the sum of selected pos. symptom items of the Brief Psychiatric Rating Scale, and for the Clin. Global Impression anal. (P = 0.03, last observation carried forward).  A greater percentage of patients receiving L-745,870 had scores indicative of some level of worsening (compared with baseline) on the total Brief Psychiatric Rating Scale and the Clin. Global Impressions' Severity of Illness Scale as well as pos. symptoms compared with those receiving placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOzPyP-d8vUrVg90H21EOLACvtfcHk0lgBP6Bo4xBtiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFWhsLk%253D&md5=1491ce3ea914e3cf85cf4025dd2bd2ba</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1997.01830180085011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1997.01830180085011%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DM.%2BS.%26aulast%3DLast%26aufirst%3DB.%26aulast%3DGetson%26aufirst%3DA.%26aulast%3DReines%26aufirst%3DS.%2BA.%26atitle%3DThe%2520effects%2520of%2520a%2520selective%2520D4%2520dopamine%2520receptor%2520antagonist%2520%2528L-745%252C870%2529%2520in%2520acutely%2520psychotic%2520in%2520patients%2520with%2520schizophrenia.%2520D4%2520dopamine%2520antagonist%2520group%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1997%26volume%3D54%26spage%3D567%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Gazi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobirnac, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danzeisen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schupbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruinvels, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeffter, P.</span><span> </span><span class="NLM_article-title">The agonist activities of the putative antipsychotic agents, L745,870 and U-101958 in HEK293 cells expressing the human dopamine D<sub>4.4</sub> receptor</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2Fsj.bjp.0701921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9692773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1cXksFSntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1998&pages=889-896&author=L.+Gaziauthor=I.+Bobirnacauthor=M.+Danzeisenauthor=E.+Schupbachauthor=A.+T.+Bruinvelsauthor=S.+Geisseauthor=B.+Sommerauthor=D.+Hoyerauthor=M.+Tricklebankauthor=P.+Schoeffter&title=The+agonist+activities+of+the+putative+antipsychotic+agents%2C+L745%2C870+and+U-101958+in+HEK293+cells+expressing+the+human+dopamine+D4.4+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor</span></div><div class="casAuthors">Gazi, L.; Bobirnac, I.; Danzeisen, M.; Schupbach, E.; Bruinvels, A. T.; Geisse, S.; Sommer, B.; Hoyer, D.; Tricklebank, M.; Schoeffter, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">889-896</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Dopamine D4 receptor antagonists are being developed by several pharmaceutical companies as putative novel antipsychotics, possibly with low propensity to side-effects.  Two such compds., L-745,870 and U-101958 have been recently introduced.  The radioligand binding and functional activities of L-745,870 and U-101958 were investigated in human embryonic kidney (HEK)293 cells expressing the human recombinant dopamine D4.4 receptor (HEK293/D4 cells).  [3H]-spiperone binding expts. were performed and inhibition of forskolin-stimulated cAMP accumulation was used as the functional response.  [3H]-spiperone was found to label a homogeneous and saturable population of specific binding sites in HEK293/D4 cell homogenates (Bmax 505±90 fmol mg-1 protein, pKD 9.5±0.1, n=3).  Inhibition of specific [3H]-spiperone binding was obsd. with spiperone (pKi 9.6±0.1, n=3), clozapine (pKi 7.4±0.1, n=4), L-745,870 (pKi 8.5±0.1, n=3) and U-101958 (pKi 8.9±0.1, n=3).  By contrast, raclopride was very weak (pKi<5, n=3).  Dopamine inhibited forskolin-stimulated cAMP accumulation in HEK293/D4 cells in a concn.-dependent fashion (Emax 71±2% inhibition of forskolin-stimulated levels, pEC50 8.7±0.1, n=10).  This effect was mimicked by the dopamine D2-like receptor agonists, quinpirole and 7-hydroxy-2-dipropylaminotetralin (7-OH-DPAT).  L-745,870 and U-101958 also inhibited forskolin-stimulated cAMP accumulation in HEK293/D4 cells in a concn.-dependent way.  L-745,870 was less efficacious than dopamine (71% the efficacy of dopamine), whereas U-101958 behaved as a full agonist compared to dopamine.  Potencies (pEC50) values of L-745,870 and U-101958 were 9.0±0.2 (n=4) and 8.7±0.3 (n=3), consistent with pKi values detd. in radioligand binding studies.  Dopamine, L-745,870 and U-101958 (up to 1 μM) were devoid of effect on forskolin-stimulated cAMP accumulation in control, non-transfected HEK293 cells.  The agonist effects of dopamine, L-745,870 and U-101958 in HEK293/D4 cells could be antagonized by spiperone (pKB 8.2-8.8) and clozapine (pKB 7.1), but not by raclopride (pKB<5).  None of these antagonists had any significant agonist activity at concns. up to 10 μM.  These results show that the putative dopamine D4 receptor antagonists, L-745,870 and U-101958 are not devoid of intrinsic activity at human recombinant dopamine D4.4 receptors.  Therefore, they may not represent the most appropriate drugs for testing the benefit of D4 receptor antagonism in schizophrenic patients, if agonism should translate in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7I9SZhh3SKLVg90H21EOLACvtfcHk0lgBP6Bo4xBtiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksFSntrw%253D&md5=0912e6b596be02fad5c2bc5038cf8727</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701921%26sid%3Dliteratum%253Aachs%26aulast%3DGazi%26aufirst%3DL.%26aulast%3DBobirnac%26aufirst%3DI.%26aulast%3DDanzeisen%26aufirst%3DM.%26aulast%3DSchupbach%26aufirst%3DE.%26aulast%3DBruinvels%26aufirst%3DA.%2BT.%26aulast%3DGeisse%26aufirst%3DS.%26aulast%3DSommer%26aufirst%3DB.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DTricklebank%26aufirst%3DM.%26aulast%3DSchoeffter%26aufirst%3DP.%26atitle%3DThe%2520agonist%2520activities%2520of%2520the%2520putative%2520antipsychotic%2520agents%252C%2520L745%252C870%2520and%2520U-101958%2520in%2520HEK293%2520cells%2520expressing%2520the%2520human%2520dopamine%2520D4.4%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D124%26spage%3D889%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gazi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozulak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeffter, P.</span><span> </span><span class="NLM_article-title">NGD 94-1 as an agonist at human recombinant dopamine D<sub>4.4</sub> receptors expressed in HEK293 cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">R9</span><span class="NLM_x">–</span> <span class="NLM_lpage">R10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1999&pages=R9-R10&author=L.+Gaziauthor=B.+Sommerauthor=J.+Nozulakauthor=P.+Schoeffter&title=NGD+94-1+as+an+agonist+at+human+recombinant+dopamine+D4.4+receptors+expressed+in+HEK293+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGazi%26aufirst%3DL.%26aulast%3DSommer%26aufirst%3DB.%26aulast%3DNozulak%26aufirst%3DJ.%26aulast%3DSchoeffter%26aufirst%3DP.%26atitle%3DNGD%252094-1%2520as%2520an%2520agonist%2520at%2520human%2520recombinant%2520dopamine%2520D4.4%2520receptors%2520expressed%2520in%2520HEK293%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D372%26spage%3DR9%26epage%3DR10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lober, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Rationally based efficacy tuning of selective dopamine D4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-<i>a</i>]pyridine (FAUC 213)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2691</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm015522j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2691-2694&author=S.+Loberauthor=H.+Hubnerauthor=W.+Utzauthor=P.+Gmeiner&title=Rationally+based+efficacy+tuning+of+selective+dopamine+D4+receptor+ligands+leading+to+the+complete+antagonist+2-%5B4-%284-chlorophenyl%29piperazin-1-ylmethyl%5Dpyrazolo%5B1%2C5-a%5Dpyridine+%28FAUC+213%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm015522j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm015522j%26sid%3Dliteratum%253Aachs%26aulast%3DLober%26aufirst%3DS.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRationally%2520based%2520efficacy%2520tuning%2520of%2520selective%2520dopamine%2520D4%2520receptor%2520ligands%2520leading%2520to%2520the%2520complete%2520antagonist%25202-%255B4-%25284-chlorophenyl%2529piperazin-1-ylmethyl%255Dpyrazolo%255B1%252C5-a%255Dpyridine%2520%2528FAUC%2520213%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2691%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Boeckler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldon, J.</span><span> </span><span class="NLM_article-title">FAUC 213, a highly selective dopamine D<sub>4</sub> receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2004&pages=7-17&author=F.+Boecklerauthor=H.+Russigauthor=W.+Zhangauthor=S.+L%C3%B6berauthor=J.+Schetzauthor=H.+H%C3%BCbnerauthor=B.+Fergerauthor=P.+Gmeinerauthor=J.+Feldon&title=FAUC+213%2C+a+highly+selective+dopamine+D4+receptor+full+antagonist%2C+exhibits+atypical+antipsychotic+properties+in+behavioural+and+neurochemical+models+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckler%26aufirst%3DF.%26aulast%3DRussig%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DSchetz%26aufirst%3DJ.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DFeldon%26aufirst%3DJ.%26atitle%3DFAUC%2520213%252C%2520a%2520highly%2520selective%2520dopamine%2520D4%2520receptor%2520full%2520antagonist%252C%2520exhibits%2520atypical%2520antipsychotic%2520properties%2520in%2520behavioural%2520and%2520neurochemical%2520models%2520of%2520schizophrenia%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D175%26spage%3D7%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Corrigan, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonura, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, K. M.</span><span> </span><span class="NLM_article-title">Effectiveness of the selective D<sub>4</sub> antagonist sonepiprazole in schizophrenia: a placebo-controlled trial. Sonepiprazole study group</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.biopsych.2003.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=15023570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=445-451&author=M.+H.+Corriganauthor=C.+C.+Gallenauthor=M.+L.+Bonuraauthor=K.+M.+Merchant&title=Effectiveness+of+the+selective+D4+antagonist+sonepiprazole+in+schizophrenia%3A+a+placebo-controlled+trial.+Sonepiprazole+study+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial</span></div><div class="casAuthors">Corrigan, Mark H.; Gallen, Christopher C.; Bonura, M. Luisa; Merchant, Kalpana M.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-451</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Selective localization of dopamine D4 receptors in the prefrontal cortex and preferential affinity of clozapine for the dopamine D4 receptor over the D2 receptor led to the hypothesis that the superior efficacy of clozapine may be mediated via blockade of the D4 receptor.  This hypothesis was tested by evaluating sonepiprazole, a selective D4 dopamine antagonist, in schizophrenia patients.  Methods: We treated 467 hospitalized schizophrenia patients with scores of ≥ 60 on the Pos. and Neg. Syndrome Scale (PANSS) with sonepiprazole (U-101387G/ PNU-101387G), olanzapine, or placebo once daily for 6 wk.  The primary efficacy end point was the mean change from baseline in the PANSS total score at 6 wk.  Secondary efficacy end points were the mean change from baseline in the PANSS factor scores, the Brief Psychiatric Rating Scale score, the Clin. Global Impressions Severity of Illness score, and the Calgary Depression Scale score.  Results: No statistically significant differences were obsd. between placebo and any sonepiprazole dose on the primary or any secondary end point after 6 wk of treatment.  Statistically significant differences, favoring olanzapine over placebo, were obsd. on all efficacy end points but the Calgary Depression Scale.  Conclusions: Sonepiprazole was ineffective for the treatment of patients with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltnMZ4pnVarVg90H21EOLACvtfcHk0lh-q9dRfKVMcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFCiurw%253D&md5=63a033c1ea77434e18f158a0fa8dd85f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2003.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2003.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCorrigan%26aufirst%3DM.%2BH.%26aulast%3DGallen%26aufirst%3DC.%2BC.%26aulast%3DBonura%26aufirst%3DM.%2BL.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26atitle%3DEffectiveness%2520of%2520the%2520selective%2520D4%2520antagonist%2520sonepiprazole%2520in%2520schizophrenia%253A%2520a%2520placebo-controlled%2520trial.%2520Sonepiprazole%2520study%2520group%26jtitle%3DBiol.%2520Psychiatry%26date%3D2004%26volume%3D55%26spage%3D445%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ebstein, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novick, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umansky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osher, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belmaker, R. H.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor (D<sub>4</sub>DR) exon III polymorphism associated with the human personality trait of novelty seeking</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2Fng0196-78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=8528256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK28XhsV2htw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1996&pages=78-80&author=R.+P.+Ebsteinauthor=O.+Novickauthor=R.+Umanskyauthor=B.+Prielauthor=Y.+Osherauthor=D.+Blaineauthor=E.+R.+Bennettauthor=L.+Nemanovauthor=M.+Katzauthor=R.+H.+Belmaker&title=Dopamine+D4+receptor+%28D4DR%29+exon+III+polymorphism+associated+with+the+human+personality+trait+of+novelty+seeking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking</span></div><div class="casAuthors">Ebstein, Richard P.; Novick, Olga; Umansky, Roberto; Priel, Beatrice; Osher, Yamima; Blaine, Darren; Bennet, , Estelle R.; Nemanov, Lubov; Katz, Miri; Belmaker, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-80</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Higher than av. Novelty Seeking test scores on the tridimensional personality questionnaire in a group of 124 unrelated Israeli subjects were significantly assocd. with a particular exonic polymorphism, the 7-repeat allele in the D4 dopamine receptor gene (D4DR).  The assocn. of high Novelty Seeking and the 7-repeat allele was independent of ethnicity, sex or age of the subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-BzcPKeJjZLVg90H21EOLACvtfcHk0lh-q9dRfKVMcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsV2htw%253D%253D&md5=fd30717fb970ae4474a29aa6b9b840ad</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fng0196-78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0196-78%26sid%3Dliteratum%253Aachs%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26aulast%3DNovick%26aufirst%3DO.%26aulast%3DUmansky%26aufirst%3DR.%26aulast%3DPriel%26aufirst%3DB.%26aulast%3DOsher%26aufirst%3DY.%26aulast%3DBlaine%26aufirst%3DD.%26aulast%3DBennett%26aufirst%3DE.%2BR.%26aulast%3DNemanov%26aufirst%3DL.%26aulast%3DKatz%26aufirst%3DM.%26aulast%3DBelmaker%26aufirst%3DR.%2BH.%26atitle%3DDopamine%2520D4%2520receptor%2520%2528D4DR%2529%2520exon%2520III%2520polymorphism%2520associated%2520with%2520the%2520human%2520personality%2520trait%2520of%2520novelty%2520seeking%26jtitle%3DNat.%2520Genet.%26date%3D1996%26volume%3D12%26spage%3D78%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ebstein, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjamin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belmaker, R. H.</span><span> </span><span class="NLM_article-title">Personality and polymorphisms of genes involved in aminergic neurotransmission</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0014-2999%2800%2900852-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11134670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFKjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2000&pages=205-214&author=R.+P.+Ebsteinauthor=J.+Benjaminauthor=R.+H.+Belmaker&title=Personality+and+polymorphisms+of+genes+involved+in+aminergic+neurotransmission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Personality and polymorphisms of genes involved in aminergic neurotransmission</span></div><div class="casAuthors">Ebstein, R. P.; Benjamin, J.; Belmaker, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with ∼120 refs.  Genetic factors significantly contribute to the detn. of human personality traits assessed by self-report questionnaires.  However, only in the past few years have common genetic polymorphisms esp. the dopamine D4 receptor and the serotonin transporter promoter region been assocd. with specific personality traits such as novelty seeking and harm avoidance, resp.  The effects of these genes are modest and several genes are likely accounting for individual differences in personality dimensions that can be attributed to genetic factors.  Mol. genetic studies of adult personality have also been extended to investigations of early human temperament and some of the genes assocd. with adult personality traits are also contributing to the earliest developmental expressions of human behavior.  Addnl., some of these same genes have also been implicated in various types of abnormal behavior including addiction, obsessive-compulsive disorder, attention deficit, depression, aggression and psychosis.  Future research directions will no doubt take advantage of the bioinformatics revolution coinciding with the completion of the first phase of the human genome project.  It should soon be possible to identify many of the genes contributing to specific personality traits and to better define their role in detg. normal and abnormal behavior from early development through adulthood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp604dZVgrZDbVg90H21EOLACvtfcHk0lg-fsCRCUk9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFKjuro%253D&md5=574c38e41802105d7c62c60f75b7e009</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900852-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900852-9%26sid%3Dliteratum%253Aachs%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26aulast%3DBenjamin%26aufirst%3DJ.%26aulast%3DBelmaker%26aufirst%3DR.%2BH.%26atitle%3DPersonality%2520and%2520polymorphisms%2520of%2520genes%2520involved%2520in%2520aminergic%2520neurotransmission%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D410%26spage%3D205%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Dulawa, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulus, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M. A.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor-knock-out mice exhibit reduced exploration of novel stimuli</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">9550</span><span class="NLM_x">–</span> <span class="NLM_lpage">9556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1523%2FJNEUROSCI.19-21-09550.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=10531457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=9550-9556&author=S.+C.+Dulawaauthor=D.+K.+Grandyauthor=M.+J.+Lowauthor=M.+P.+Paulusauthor=M.+A.+Geyer&title=Dopamine+D4+receptor-knock-out+mice+exhibit+reduced+exploration+of+novel+stimuli"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli</span></div><div class="casAuthors">Dulawa, Stephanie C.; Grandy, David K.; Low, Malcolm J.; Paulus, Martin P.; Geyer, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9550-9556</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The involvement of dopamine neurotransmission in behavioral responses to novelty is suggested by reports that reward is related to increased dopamine activity, that dopamine modulates exploratory behavior in animals, and that Parkinson's disease patients report diminished responses to novelty.  Some studies have reported that polymorphisms of the human dopamine D4 receptor (D4R) gene are assocd. with personality inventory measures of the trait called "novelty-seeking".  To explore a potential role for the D4R in behavioral responses to novelty, the authors evaluated D4R-knock-out (D4R-/-) and wild-type (D4R+/+) mice in three approach-avoidance paradigms: the open field, emergence, and novel object tests.  These three paradigms differ in the degree to which they elicit approach, or exploratory behavior, and avoidance, or anxiety-related behavior.  Thus, the authors used these three tests to det. whether the D4R primarily influences the exploratory or the anxious component of responses to approach-avoidance conflicts.  D4R-/- mice were significantly less behaviorally responsive to novelty than D4R+/+ mice in all three tests.  The largest phenotypic differences were obsd. in the novel object test, which maximizes approach behavior, and the smallest phenotypic differences were found in the open field test, which maximizes avoidance behavior.  Hence, D4R-/- mice exhibit redns. in behavioral responses to novelty, reflecting a decrease in novelty-related exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2jXdkLWYVlLVg90H21EOLACvtfcHk0lg-fsCRCUk9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyhsrs%253D&md5=e1add51d912b10438d34b921cfa2cbf9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-21-09550.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-21-09550.1999%26sid%3Dliteratum%253Aachs%26aulast%3DDulawa%26aufirst%3DS.%2BC.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DLow%26aufirst%3DM.%2BJ.%26aulast%3DPaulus%26aufirst%3DM.%2BP.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26atitle%3DDopamine%2520D4%2520receptor-knock-out%2520mice%2520exhibit%2520reduced%2520exploration%2520of%2520novel%2520stimuli%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D9550%26epage%3D9556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Powell, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulus, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M. A.</span><span> </span><span class="NLM_article-title">RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=473-481&author=S.+B.+Powellauthor=M.+P.+Paulusauthor=D.+S.+Hartmanauthor=T.+Godelauthor=M.+A.+Geyer&title=RO-10-5824+is+a+selective+dopamine+D4+receptor+agonist+that+increases+novel+object+exploration+in+C57+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DS.%2BB.%26aulast%3DPaulus%26aufirst%3DM.%2BP.%26aulast%3DHartman%26aufirst%3DD.%2BS.%26aulast%3DGodel%26aufirst%3DT.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26atitle%3DRO-10-5824%2520is%2520a%2520selective%2520dopamine%2520D4%2520receptor%2520agonist%2520that%2520increases%2520novel%2520object%2520exploration%2520in%2520C57%2520mice%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D44%26spage%3D473%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Faraone, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biederman, J.</span><span> </span><span class="NLM_article-title">Meta-analysis of the association between the 7-repeat allele of the dopamine D<sub>4</sub> receptor gene and attention deficit hyperactivity disorder</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1176%2Fappi.ajp.158.7.1052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11431226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD3MznsVegtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=1052-1057&author=S.+V.+Faraoneauthor=A.+E.+Doyleauthor=E.+Mickauthor=J.+Biederman&title=Meta-analysis+of+the+association+between+the+7-repeat+allele+of+the+dopamine+D4+receptor+gene+and+attention+deficit+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder</span></div><div class="casAuthors">Faraone S V; Doyle A E; Mick E; Biederman J</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1052-7</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Family, twin, and adoption studies show attention deficit hyperactivity disorder (ADHD) to have a substantial genetic component.  Although several studies have shown an association between ADHD and the 7-repeat allele of the dopamine D(4) receptor gene (DRD4), several studies have not.  Thus, the status of the ADHD-DRD4 association is uncertain.  METHOD:  Meta-analysis was applied to case-control and family-based studies of the association between ADHD and DRD4 to assess the joint evidence for the association, the influence of individual studies, and evidence for publication bias.  RESULTS:  For both the case-control and family-based studies, the authors found 1) support for the association between ADHD and DRD4, 2) no evidence that this association was accounted for by any one study, and 3) no evidence for publication bias.  CONCLUSIONS:  Although the association between ADHD and DRD4 is small, these results suggest that it is real.  Further studies are needed to clarify what variant of DRD4 (or some nearby gene) accounts for this association.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcx_1FDHwS4RLDWw4HIq2sfW6udTcc2eZ8ViW18gNcFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MznsVegtw%253D%253D&md5=1b494e0b3597559b6fe0ca3e905d0be3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.158.7.1052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.158.7.1052%26sid%3Dliteratum%253Aachs%26aulast%3DFaraone%26aufirst%3DS.%2BV.%26aulast%3DDoyle%26aufirst%3DA.%2BE.%26aulast%3DMick%26aufirst%3DE.%26aulast%3DBiederman%26aufirst%3DJ.%26atitle%3DMeta-analysis%2520of%2520the%2520association%2520between%2520the%25207-repeat%2520allele%2520of%2520the%2520dopamine%2520D4%2520receptor%2520gene%2520and%2520attention%2520deficit%2520hyperactivity%2520disorder%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2001%26volume%3D158%26spage%3D1052%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Grady, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flodman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyzis, R. K.</span><span> </span><span class="NLM_article-title">High prevalence of rare dopamine receptor D<sub>4</sub> alleles in children diagnosed with attention-deficit hyperactivity disorder</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2Fsj.mp.4001350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=12808433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFKmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=536-545&author=D.+L.+Gradyauthor=H.+C.+Chiauthor=Y.+C.+Dingauthor=M.+Smithauthor=E.+Wangauthor=S.+Schuckauthor=P.+Flodmanauthor=M.+A.+Spenceauthor=J.+M.+Swansonauthor=R.+K.+Moyzis&title=High+prevalence+of+rare+dopamine+receptor+D4+alleles+in+children+diagnosed+with+attention-deficit+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder</span></div><div class="casAuthors">Grady, D. L.; Chi, H.-C.; Ding, Y-C.; Smith, M.; Wang, E.; Schuck, S.; Flodman, P.; Spence, M. A.; Swanson, J. M.; Moyzis, R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">536-545</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Assocns. have been reported of the 7-repeat (7R) allele of the human dopamine receptor D4 (DRD4) gene with both the personality trait of novelty seeking and attention-deficit/hyperactivity disorder (ADHD).  The increased prevalence of the 7R allele in ADHD probands is consistent with the common variant-common disorder hypothesis, which proposes that the high frequency of many complex genetic disorders is related to common DNA variants.  Recently, based on the unusual DNA sequence organization and strong linkage disequil. surrounding the DRD4 7R allele, we proposed that this allele originated as a rare mutational event, which nevertheless increased to high prevalence in human populations by pos. selection.  We have now detd., by DNA resequencing of 250 DRD4 alleles obtained from 132 ADHD probands, that most ADHD 7R alleles are of the conserved haplotype found in our previous 600 allele worldwide DNA sample.  Interestingly, however, half of the 24 haplotypes uncovered in ADHD probands were novel (not one of the 56 haplotypes found in our prior population studies).  Over 10 percent of the ADHD probands had these novel haplotypes, most of which were 7R allele derived.  The probability that this high incidence of novel alleles occurred by chance in our ADHD sample is much less than 0.0001.  These results suggest that allelic heterogeneity at the DRD4 locus may also contribute to the obsd. assocn. with ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnIXh9LNwhFrVg90H21EOLACvtfcHk0lizKs0bK4U2xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFKmu74%253D&md5=146c5543c239583d2d1c25b7ad1791ae</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001350%26sid%3Dliteratum%253Aachs%26aulast%3DGrady%26aufirst%3DD.%2BL.%26aulast%3DChi%26aufirst%3DH.%2BC.%26aulast%3DDing%26aufirst%3DY.%2BC.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DSchuck%26aufirst%3DS.%26aulast%3DFlodman%26aufirst%3DP.%26aulast%3DSpence%26aufirst%3DM.%2BA.%26aulast%3DSwanson%26aufirst%3DJ.%2BM.%26aulast%3DMoyzis%26aufirst%3DR.%2BK.%26atitle%3DHigh%2520prevalence%2520of%2520rare%2520dopamine%2520receptor%2520D4%2520alleles%2520in%2520children%2520diagnosed%2520with%2520attention-deficit%2520hyperactivity%2520disorder%26jtitle%3DMol.%2520Psychiatry%26date%3D2003%26volume%3D8%26spage%3D536%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">LaHoste, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigal, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. L.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor gene polymorphism is associated with attention deficit hyperactivity disorder</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9118321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADyaK2s3jtlartg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=121-124&author=G.+J.+LaHosteauthor=J.+M.+Swansonauthor=S.+B.+Wigalauthor=C.+Glabeauthor=T.+Wigalauthor=N.+Kingauthor=J.+L.+Kennedy&title=Dopamine+D4+receptor+gene+polymorphism+is+associated+with+attention+deficit+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder</span></div><div class="casAuthors">LaHoste G J; Swanson J M; Wigal S B; Glabe C; Wigal T; King N; Kennedy J L</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-4</span>
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    </div><div class="casAbstract">Dopamine is believed to play a major role in the manifestation of attention deficit hyperactivity disorder (ADHD), which affects 3-6% of school-age children and shows evidence of familiarity.  The dopamine D4 receptor, which is preferentially distributed in cortical and limbic regions of the brain, is currently of major interest because of the high degree of functionally relevant variability in its gene (DRD4), and the association of this gene with Novelty Seeking behavior.  We examined the variability in the length of a region of DRD4 that contains a 48-bp repeat sequence in children with ADHD and controls matched for ethnicity.  ADHD children differed from controls in that the 7-fold repeat form of DRD4 occurred significantly more frequently than in the control sample.  This form of the receptor has previously been shown to mediate a blunted intracellular response to dopamine.  Although ADHD is likely to be multifactorial in its etiology and its heritability is likely to be polygenetic, the present findings suggest that polymorphic variation in the gene encoding the D4 dopamine receptor may be a contributing factor in the expression of symptoms associated with ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN_l8s_261K2lSCSgBhwJFfW6udTcc2eaVCrGP8PmXybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3jtlartg%253D%253D&md5=ce39ec8adf6503bb18524d566f891988</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaHoste%26aufirst%3DG.%2BJ.%26aulast%3DSwanson%26aufirst%3DJ.%2BM.%26aulast%3DWigal%26aufirst%3DS.%2BB.%26aulast%3DGlabe%26aufirst%3DC.%26aulast%3DWigal%26aufirst%3DT.%26aulast%3DKing%26aufirst%3DN.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26atitle%3DDopamine%2520D4%2520receptor%2520gene%2520polymorphism%2520is%2520associated%2520with%2520attention%2520deficit%2520hyperactivity%2520disorder%26jtitle%3DMol.%2520Psychiatry%26date%3D1996%26volume%3D1%26spage%3D121%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Swanson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunohara, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fineberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaHoste, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigal, S.</span><span> </span><span class="NLM_article-title">Association of the dopamine receptor D<sub>4</sub> (DRD<sub>4</sub>) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2Fsj.mp.4000354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9491811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls1Gls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=38-41&author=J.+M.+Swansonauthor=G.+A.+Sunoharaauthor=J.+L.+Kennedyauthor=R.+Reginoauthor=E.+Finebergauthor=T.+Wigalauthor=M.+Lernerauthor=L.+Williamsauthor=G.+J.+LaHosteauthor=S.+Wigal&title=Association+of+the+dopamine+receptor+D4+%28DRD4%29+gene+with+a+refined+phenotype+of+attention+deficit+hyperactivity+disorder+%28ADHD%29%3A+a+family-based+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach</span></div><div class="casAuthors">Swanson, J. M.; Sunohara, G. A.; Kennedy, J. L.; Regino, R.; Fineberg, E.; Wigal, T.; Lerner, M.; Williams, L.; LaHoste, G. J.; Wigal, S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-41</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Previously in this journal, we reported an assocn. of the dopamine D4 receptor gene (DRD4) and attention deficit hyperactivity disorder (ADHD).  In a population-assocn. (case-control) study of 39 children with a refined phenotype of ADHD and 39 ethnically matched controls, we obsd. an increased percentage of the 7 repeat allele (29% vs 12%) and the 7+ genotype (49% vs 21%) in the ADHD group compared to the control group.  In a replication and an extension of our initial study, we recruited another sample of ADHD subjects and found percentages of the 7 repeat allele (28%) and the 7+ genotype (48%) consistent with our previous findings.  We used a family-based approach to evaluate a predicted assocn. of DRD4 and ADHD based on a test of allele transmission focused on the 7 repeat allele.  We identified 52 families based on the diagnosis of the refined phenotype of ADHD in the proband and the availability of DNA from both biol. parents as well as the proband.  Haplotype relative risk (HRR) anal. was performed to test our a priori hypothesis and produced significant results (chi-square = 4.65, P < 0.035).  This provides addnl. evidence that the DRD4 gene is assocd. with a refined phenotype of ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXa1p8iCTavLVg90H21EOLACvtfcHk0lizKs0bK4U2xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls1Gls7w%253D&md5=265f8eb286348a4ec43f2df66b4fc1ed</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4000354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4000354%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DJ.%2BM.%26aulast%3DSunohara%26aufirst%3DG.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26aulast%3DRegino%26aufirst%3DR.%26aulast%3DFineberg%26aufirst%3DE.%26aulast%3DWigal%26aufirst%3DT.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DLaHoste%26aufirst%3DG.%2BJ.%26aulast%3DWigal%26aufirst%3DS.%26atitle%3DAssociation%2520of%2520the%2520dopamine%2520receptor%2520D4%2520%2528DRD4%2529%2520gene%2520with%2520a%2520refined%2520phenotype%2520of%2520attention%2520deficit%2520hyperactivity%2520disorder%2520%2528ADHD%2529%253A%2520a%2520family-based%2520approach%26jtitle%3DMol.%2520Psychiatry%26date%3D1998%26volume%3D3%26spage%3D38%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Johansson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halleland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmøy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landaas, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dramsdahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasmer, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsholm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundervold, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugdahl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knappskog, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haavik, J.</span><span> </span><span class="NLM_article-title">Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD<sub>4</sub> or SLC6A3 VNTRs</span> <span class="citation_source-journal">Am. J. Med. Genet., Part B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">1470</span><span class="NLM_x">–</span> <span class="NLM_lpage">1475</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1002%2Fajmg.b.30662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2008&pages=1470-1475&author=S.+Johanssonauthor=H.+Hallelandauthor=A.+Halm%C3%B8yauthor=K.+K.+Jacobsenauthor=E.+T.+Landaasauthor=M.+Dramsdahlauthor=O.+B.+Fasmerauthor=P.+Bergsholmauthor=A.+J.+Lundervoldauthor=C.+Gillbergauthor=K.+Hugdahlauthor=P.+M.+Knappskogauthor=J.+Haavik&title=Genetic+analyses+of+dopamine+related+genes+in+adult+ADHD+patients+suggest+an+association+with+the+DRD5-microsatellite+repeat%2C+but+not+with+DRD4+or+SLC6A3+VNTRs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs</span></div><div class="casAuthors">Johansson, S.; Halleland, H.; Halmoey, A.; Jacobsen, K. K.; Landaas, E. T.; Dramsdahl, M.; Fasmer, O. B.; Bergsholm, P.; Lundervold, A. J.; Gillberg, C.; Hugdahl, K.; Knappskog, P. M.; Haavik, J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">147B</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1470-1475</span>CODEN:
                <span class="NLM_cas:coden">AJMGC9</span>;
        ISSN:<span class="NLM_cas:issn">1552-4841</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Attention deficit hyperactivity disorder (ADHD) is a common and highly heritable psychiatric disorder in children and adults.  Recent meta-analyses have indicated an assocn. between genes involved in dopaminergic signaling and childhood ADHD, but little is known about their possible role in adult ADHD.  In this study of adults with ADHD, we evaluated the three most commonly studied ADHD candidate genetic polymorphisms; the dopamine receptor D4 (DRD4) exon 3 VNTR repeat, a microsatellite repeat 18.5 kb upstream of the DRD5 locus and the 3'UTR dopamine transporter SLC6A3 (DAT 1) VNTR.  We examd. 358 clin. diagnosed adult Norwegian ADHD patients (51% males) and 340 ethnically matched controls.  We found a nominally significant overall assocn. with adult ADHD for the DRD5 microsatellite marker (P = 0.04), and a trend toward increased risk assocd. with the 148-bp allele consistent with recent meta-analyses.  The strongest overall assocn. (P = 0.02) and increased risk for the 148-bp allele [odds ratio (OR) = 1.27 (95% CI: 1.00-1.61)] were seen in the inattentive and combined inattentive/hyperactive group as previously reported for childhood ADHD.  No assocn. was found for the DRD4 or SLC6A3 polymorphisms in this patient sample.  In conclusion, our results among adults with a clin. diagnosis of ADHD support an assocn. between ADHD and the DRD5 locus, but not the DRD4 or SLC6A3 loci.  It is possible that the latter polymorphisms are assocd. with a transient form of ADHD with better long-term clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwK-rBIMt2GrVg90H21EOLACvtfcHk0liR4z0r4IC1Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktLjO&md5=c3fe8f5d952121cc2ae0d377de1502ea</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fajmg.b.30662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.b.30662%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DS.%26aulast%3DHalleland%26aufirst%3DH.%26aulast%3DHalm%25C3%25B8y%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DK.%2BK.%26aulast%3DLandaas%26aufirst%3DE.%2BT.%26aulast%3DDramsdahl%26aufirst%3DM.%26aulast%3DFasmer%26aufirst%3DO.%2BB.%26aulast%3DBergsholm%26aufirst%3DP.%26aulast%3DLundervold%26aufirst%3DA.%2BJ.%26aulast%3DGillberg%26aufirst%3DC.%26aulast%3DHugdahl%26aufirst%3DK.%26aulast%3DKnappskog%26aufirst%3DP.%2BM.%26aulast%3DHaavik%26aufirst%3DJ.%26atitle%3DGenetic%2520analyses%2520of%2520dopamine%2520related%2520genes%2520in%2520adult%2520ADHD%2520patients%2520suggest%2520an%2520association%2520with%2520the%2520DRD5-microsatellite%2520repeat%252C%2520but%2520not%2520with%2520DRD4%2520or%2520SLC6A3%2520VNTRs%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520B%26date%3D2008%26volume%3D147%26spage%3D1470%26epage%3D1475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Shaw, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gornick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addington, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giedd, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellanos, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapoport, J. L.</span><span> </span><span class="NLM_article-title">Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1001%2Farchpsyc.64.8.921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=17679637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD2svmt1Sitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=921-931&author=P.+Shawauthor=M.+Gornickauthor=J.+Lerchauthor=A.+Addingtonauthor=J.+Sealauthor=D.+Greensteinauthor=W.+Sharpauthor=A.+Evansauthor=J.+N.+Gieddauthor=F.+X.+Castellanosauthor=J.+L.+Rapoport&title=Polymorphisms+of+the+dopamine+D4+receptor%2C+clinical+outcome%2C+and+cortical+structure+in+attention-deficit%2Fhyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder</span></div><div class="casAuthors">Shaw Philip; Gornick Michele; Lerch Jason; Addington Anjene; Seal Jeffrey; Greenstein Deanna; Sharp Wendy; Evans Alan; Giedd Jay N; Castellanos F Xavier; Rapoport Judith L</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-31</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">CONTEXT:  Attention-deficit/hyperactivity disorder (ADHD) is one of the most heritable neuropsychiatric disorders, and a polymorphism within the dopamine D4 receptor (DRD4) gene has been frequently implicated in its pathogenesis.  OBJECTIVE:  To examine the effects of the 7-repeat microsatellite in the DRD4 gene on clinical outcome and cortical development in ADHD.  We drew comparisons with a single nucleotide polymorphism in the dopamine D1 receptor (DRD1) gene, which was associated with ADHD within our cohort, and a polymorphism within the dopamine transporter (DAT1) gene, reported to have additive effects with the DRD4 7-repeat allele.  DESIGN:  Longitudinal cohort study.  SETTING:  National Institutes of Health, Bethesda, Maryland.  PARTICIPANTS:  One hundred five children (with 222 neuroanatomical magnetic resonance images) with ADHD (mean age at entry, 10.1 years) and 103 healthy controls (total of 220 magnetic resonance images).  Sixty-seven subjects with ADHD (64%) had follow-up clinical evaluations (mean follow-up, 6 years).  MAIN OUTCOME MEASURES:  Cortical thickness across the cerebrum and presence of DSM-IV-defined ADHD at follow-up.  RESULTS:  Possession of the DRD4 7-repeat allele was associated with a thinner right orbitofrontal/inferior prefrontal and posterior parietal cortex.  This overlapped with regions that were generally thinner in subjects with ADHD compared with controls.  Participants with ADHD carrying the DRD4 7-repeat allele had a better clinical outcome and a distinct trajectory of cortical development.  This group showed normalization of the right parietal cortical region, a pattern that we have previously linked with better clinical outcome.  By contrast, there were no significant effects of the DRD1 or DAT1 polymorphisms on clinical outcome or cortical development.  CONCLUSIONS:  The DRD4 7-repeat allele, which is widely associated with a diagnosis of ADHD, and in our cohort with better clinical outcome, is associated with cortical thinning in regions important in attentional control.  This regional thinning is most apparent in childhood and largely resolves during adolescence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUXFWCGa_7WxLDWw4HIq2sfW6udTcc2ebMGqn1sva0H7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svmt1Sitw%253D%253D&md5=591d5aafd957c4f5a440904e2706e367</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.64.8.921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.64.8.921%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DP.%26aulast%3DGornick%26aufirst%3DM.%26aulast%3DLerch%26aufirst%3DJ.%26aulast%3DAddington%26aufirst%3DA.%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DGreenstein%26aufirst%3DD.%26aulast%3DSharp%26aufirst%3DW.%26aulast%3DEvans%26aufirst%3DA.%26aulast%3DGiedd%26aufirst%3DJ.%2BN.%26aulast%3DCastellanos%26aufirst%3DF.%2BX.%26aulast%3DRapoport%26aufirst%3DJ.%2BL.%26atitle%3DPolymorphisms%2520of%2520the%2520dopamine%2520D4%2520receptor%252C%2520clinical%2520outcome%252C%2520and%2520cortical%2520structure%2520in%2520attention-deficit%252Fhyperactivity%2520disorder%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2007%26volume%3D64%26spage%3D921%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Schetz, J. A.; Sibley, D. R.</span><span> </span><span class="NLM_article-title">Dopaminergic Neurotransmission</span>. In  <span class="citation_source-book">Handbook of Contemporary Neuropharmacology</span>; <span class="NLM_contrib-group">Sibley, D.; Hanin, I.; Kuhar, M.; Skolnick, P.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">221</span>− <span class="NLM_lpage">256</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=221-256&author=J.+A.+Schetz&author=D.+R.+Sibleyauthor=D.+Sibley&author=I.+Hanin&author=M.+Kuhar&author=P.+Skolnick&title=Handbook+of+Contemporary+Neuropharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DDopaminergic%2520Neurotransmission%26btitle%3DHandbook%2520of%2520Contemporary%2520Neuropharmacology%26aulast%3DSibley%26aufirst%3DD.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2007%26spage%3D221%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarazi, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldessarini, R. J.</span><span> </span><span class="NLM_article-title">Role of dopamine D<sub>4</sub> receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0893-133X%2801%2900262-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11682245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnslCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=624-632&author=K.+Zhangauthor=F.+I.+Taraziauthor=R.+J.+Baldessarini&title=Role+of+dopamine+D4+receptors+in+motor+hyperactivity+induced+by+neonatal+6-hydroxydopamine+lesions+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats</span></div><div class="casAuthors">Zhang, Kehong; Tarazi, Frank I.; Baldessarini, Ross J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">624-632</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The role of dopamine D4 receptors in behavioral hyperactivity was investigated by assessing D4 receptor expression in brain regions and behavioral effects of D4 receptor-selective ligands in juvenile rats with neonatal 6-hydroxydopamine lesions, a lab. model for attention deficit-hyperactivity disorder (ADHD).  Autoradiog. anal. indicated that motor hyperactivity in lesioned rats was closely correlated with increases in D4 but not D2 receptor levels in caudate-putamen.  D4-selective antagonist CP-293,019 dose-dependently reversed lesion-induced hyperactivity, and D4-agonist CP-226,269 increased it.  These results indicate a physiol. role of dopamine D4 receptors in motor behavior, and may suggest much-needed innovative treatments for ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLwJLfQQgg3bVg90H21EOLACvtfcHk0lgNSu5XHcRJaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnslCjsLY%253D&md5=22ce93f3b654bee58d47552e6057bd1c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0893-133X%2801%2900262-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0893-133X%252801%252900262-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DTarazi%26aufirst%3DF.%2BI.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26atitle%3DRole%2520of%2520dopamine%2520D4%2520receptors%2520in%2520motor%2520hyperactivity%2520induced%2520by%2520neonatal%25206-hydroxydopamine%2520lesions%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2001%26volume%3D25%26spage%3D624%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davids, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarazi, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldessarini, R. J.</span><span> </span><span class="NLM_article-title">Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity</span> <span class="citation_source-journal">Dev. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0165-3806%2802%2900436-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=135-138&author=K.+Zhangauthor=E.+Davidsauthor=F.+I.+Taraziauthor=R.+J.+Baldessarini&title=Serotonin+transporter+binding+increases+in+caudate-putamen+and+nucleus+accumbens+after+neonatal+6-hydroxydopamine+lesions+in+rats%3A+implications+for+motor+hyperactivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0165-3806%2802%2900436-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-3806%252802%252900436-4%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DDavids%26aufirst%3DE.%26aulast%3DTarazi%26aufirst%3DF.%2BI.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26atitle%3DSerotonin%2520transporter%2520binding%2520increases%2520in%2520caudate-putamen%2520and%2520nucleus%2520accumbens%2520after%2520neonatal%25206-hydroxydopamine%2520lesions%2520in%2520rats%253A%2520implications%2520for%2520motor%2520hyperactivity%26jtitle%3DDev.%2520Brain%2520Res.%26date%3D2002%26volume%3D30%26spage%3D135%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molesky, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komater, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span> </span><span class="NLM_article-title">A-412997, a selective dopamine D<sub>4</sub> agonist, improves cognitive performance in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2005&pages=148-155&author=K.+E.+Browmanauthor=P.+Curzonauthor=J.+B.+Panauthor=A.+L.+Moleskyauthor=V.+A.+Komaterauthor=M.+W.+Deckerauthor=J.+D.+Brioniauthor=R.+B.+Morelandauthor=G.+B.+Fox&title=A-412997%2C+a+selective+dopamine+D4+agonist%2C+improves+cognitive+performance+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DMolesky%26aufirst%3DA.%2BL.%26aulast%3DKomater%26aufirst%3DV.%2BA.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DMoreland%26aufirst%3DR.%2BB.%26aulast%3DFox%26aufirst%3DG.%2BB.%26atitle%3DA-412997%252C%2520a%2520selective%2520dopamine%2520D4%2520agonist%252C%2520improves%2520cognitive%2520performance%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2005%26volume%3D82%26spage%3D148%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly- Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakowski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, K.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span> </span><span class="NLM_article-title">Activation of dopamine D<sub>4</sub> receptors by ABT-724 induces penile erection in rats</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">6758</span><span class="NLM_x">–</span> <span class="NLM_lpage">6763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1073%2Fpnas.0308292101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=15087502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVyhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=6758-6763&author=J.+D.+Brioniauthor=R.+B.+Morelandauthor=M.+Cowartauthor=G.+C.+Hsiehauthor=A.+O.+Stewartauthor=P.+Hedlundauthor=D.+L.+Donnelly-+Robertsauthor=M.+Nakaneauthor=J.+J.+Lynchauthor=T.+Kolasaauthor=J.+S.+Polakowskiauthor=M.+A.+Osinskiauthor=K.+Marshauthor=K.-E.+Anderssonauthor=J.+P.+Sullivan&title=Activation+of+dopamine+D4+receptors+by+ABT-724+induces+penile+erection+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats</span></div><div class="casAuthors">Brioni, Jorge D.; Moreland, Robert B.; Cowart, Marlon; Hsieh, Gin C.; Stewart, Andrew O.; Hedlund, Petter; Donnelly-Roberts, Diana L.; Nakane, Masaki; Lynch, James J., III; Kolasa, Teodozyi; Polakowski, James S.; Osinski, Mark A.; Marsh, Kennan; Andersson, Karl-Erik; Sullivan, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6758-6763</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apomorphine, a nonselective dopamine receptor agonist, facilitates penile erection and is effective in patients suffering from erectile dysfunction.  The specific dopamine receptor subtype(s) responsible for its erectogenic effect is not known.  Here we report that the dopamine D4 receptor plays a role in the regulation of penile function.  ABT-724 is a selective dopamine D4 receptor agonist that activates human dopamine D4 receptors with an EC50 of 12.4 nM and 61% efficacy, with no effect on dopamine D1, D2, D3, or D5 receptors.  ABT-724 dose-dependently facilitates penile erection when given s.c. to conscious rats, an effect that is blocked by haloperidol and clozapine but not by domperidone.  A proerectile effect is obsd. after intracerebroventricular but not intrathecal administration, suggesting a supraspinal site of action.  S.c. injections of ABT-724 increase intracavernosal pressure in awake freely moving rats.  In the presence of sildenafil, a potentiation of the proerectile effect of ABT-724 is obsd. in conscious rats.  The ability of ABT-724 to facilitate penile erection together with the favorable side-effect profile indicates that ABT-724 could be useful for the treatment of erectile dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_CPLyHqtzJ7Vg90H21EOLACvtfcHk0lgNSu5XHcRJaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVyhs7g%253D&md5=b37690221970ae889a6589e9177cf321</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308292101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308292101%26sid%3Dliteratum%253Aachs%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DMoreland%26aufirst%3DR.%2BB.%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DHedlund%26aufirst%3DP.%26aulast%3DDonnelly-%2BRoberts%26aufirst%3DD.%2BL.%26aulast%3DNakane%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DPolakowski%26aufirst%3DJ.%2BS.%26aulast%3DOsinski%26aufirst%3DM.%2BA.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DAndersson%26aufirst%3DK.-E.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26atitle%3DActivation%2520of%2520dopamine%2520D4%2520receptors%2520by%2520ABT-724%2520induces%2520penile%2520erection%2520in%2520rats%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D6758%26epage%3D6763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truccone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haji-Abdi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greedy, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enguehard-Gueiffier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueiffier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunahara, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">Proerectile effects of dopamine D<sub>2</sub>-like agonists are mediated by the D<sub>3</sub> receptor in rats and mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1124%2Fjpet.108.144048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=19136638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=210-217&author=G.+T.+Collinsauthor=A.+Trucconeauthor=F.+Haji-Abdiauthor=A.+H.+Newmanauthor=P.+Grundtauthor=K.+C.+Riceauthor=S.+M.+Husbandsauthor=B.+M.+Greedyauthor=C.+Enguehard-Gueiffierauthor=A.+Gueiffierauthor=J.+Chenauthor=S.+Wangauthor=J.+L.+Katzauthor=D.+K.+Grandyauthor=R.+K.+Sunaharaauthor=J.+H.+Woods&title=Proerectile+effects+of+dopamine+D2-like+agonists+are+mediated+by+the+D3+receptor+in+rats+and+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice</span></div><div class="casAuthors">Collins, Gregory T.; Truccone, Andrew; Haji-Abdi, Faiza; Newman, Amy Hauck; Grundt, Peter; Rice, Kenner C.; Husbands, Stephen M.; Greedy, Benjamin M.; Enguehard-Gueiffier, Cecile; Gueiffier, Alain; Chen, Jianyong; Wang, Shaomeng; Katz, Jonathan L.; Grandy, David K.; Sunahara, Roger K.; Woods, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210-217</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine D2-like agonists induce penile erection (PE) and yawning in a variety of species, effects that have been suggested recently to be specifically mediated by the D4 and D3 receptors, resp.  The current studies were aimed at characterizing a series of D2, D3, and D4 agonists with respect to their capacity to induce PE and yawning in the rat and the proerectile effects of apomorphine [(R)-(-)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride] in wild-type and D4 receptor (R) knockout (KO) mice.  All D3 agonists induced dose-dependent increases in PE and yawning over a similar range of doses, whereas significant increases in PE or yawning were not obsd. with any of the D4 agonists.  Likewise, D2, D3, and D4 antagonists were assessed for their capacity to alter apomorphine- and pramipexole (N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride)-induced PE and yawning.  The D3 antagonist, PG01037 inhibited the induction of PE and yawning, whereas the D2 antagonist, L-741,626, reversed the inhibition of PE and yawning obsd. at higher doses.  The D4 antagonist, L-745,870 did not alter apomorphine- or pramipexole-induced PE or yawning.  A role for the D3 receptor was further supported because apomorphine was equipotent at inducing PE in wild-type and D4R KO mice, effects that were inhibited by the D3 antagonist, PG01037, in both wild-type and D4R KO mice.  Together, these studies provide strong support that D2-like agonist-induced PE and yawning are differentially mediated by the D3 (induction) and D2 (inhibition) receptors.  These studies fail to support a role for the D4 receptor in the regulation of PE or yawning by D2-like agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMBqypmUs6YrVg90H21EOLACvtfcHk0lh2RJzzPqpd5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKnu78%253D&md5=42514c75312cd5ac99611a9d55619fd1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.144048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.144048%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DTruccone%26aufirst%3DA.%26aulast%3DHaji-Abdi%26aufirst%3DF.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DGreedy%26aufirst%3DB.%2BM.%26aulast%3DEnguehard-Gueiffier%26aufirst%3DC.%26aulast%3DGueiffier%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DProerectile%2520effects%2520of%2520dopamine%2520D2-like%2520agonists%2520are%2520mediated%2520by%2520the%2520D3%2520receptor%2520in%2520rats%2520and%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D210%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragan, C. I.</span><span> </span><span class="NLM_article-title">Pharmacological and functional characterisation of dopamine D<sub>4</sub> receptors in the rat retina</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=1038-1046&author=S.+Patelauthor=K.+L.+Chapmanauthor=D.+Marstonauthor=P.+H.+Hutsonauthor=C.+I.+Ragan&title=Pharmacological+and+functional+characterisation+of+dopamine+D4+receptors+in+the+rat+retina"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DK.%2BL.%26aulast%3DMarston%26aufirst%3DD.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26atitle%3DPharmacological%2520and%2520functional%2520characterisation%2520of%2520dopamine%2520D4%2520receptors%2520in%2520the%2520rat%2520retina%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D44%26spage%3D1038%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Cohen, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, K. L.</span><span> </span><span class="NLM_article-title">Photoreceptors of the mouse retina possess D<sub>4</sub> receptors coupled to adenylyl cyclase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">12093</span><span class="NLM_x">–</span> <span class="NLM_lpage">12097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=12093-12097&author=A.+I.+Cohenauthor=R.+D.+Toddauthor=S.+Harmonauthor=K.+L.+O%E2%80%99Malley&title=Photoreceptors+of+the+mouse+retina+possess+D4+receptors+coupled+to+adenylyl+cyclase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DA.%2BI.%26aulast%3DTodd%26aufirst%3DR.%2BD.%26aulast%3DHarmon%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DK.%2BL.%26atitle%3DPhotoreceptors%2520of%2520the%2520mouse%2520retina%2520possess%2520D4%2520receptors%2520coupled%2520to%2520adenylyl%2520cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1992%26volume%3D89%26spage%3D12093%26epage%3D12097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Nir, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haque, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuvone, P. M.</span><span> </span><span class="NLM_article-title">Dysfunctional light-evoked regulation of cAMP in photoreceptors and abnormal retinal adaptation in mice lacking dopamine D<sub>4</sub> receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2063</span><span class="NLM_x">–</span> <span class="NLM_lpage">2073</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11896146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVegtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2063-2073&author=I.+Nirauthor=J.+M.+Harrisonauthor=R.+Haqueauthor=M.+J.+Lowauthor=D.+K.+Grandyauthor=M.+Rubinsteinauthor=P.+M.+Iuvone&title=Dysfunctional+light-evoked+regulation+of+cAMP+in+photoreceptors+and+abnormal+retinal+adaptation+in+mice+lacking+dopamine+D4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dysfunctional light-evoked regulation of cAMP in photoreceptors and abnormal retinal adaptation in mice lacking dopamine D4 receptors</span></div><div class="casAuthors">Nir, Izhak; Harrison, Joseph M.; Haque, Rashidul; Low, Malcolm J.; Grandy, David K.; Rubinstein, Marcelo; Luvone, P. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2063-2073</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Dopamine is a retinal neuromodulator that has been implicated in many aspects of retinal physiol.  Photoreceptor cells express dopamine D4 receptors that regulate cAMP metab.  To assess the effects of dopamine on photoreceptor physiol., we examd. the morphol., electrophysiol., and regulation of cAMP metab. in mice with targeted disruption of the dopamine D4 receptor gene.  Photoreceptor morphol. and outer segment disk shedding after light onset were normal in D4 knock-out (D4KO) mice.  Quinpirole, a dopamine D2/D3/D4 receptor agonist, decreased cAMP synthesis in retinas of wild-type (WT) mice but not in retinas of D4KO mice.  In WT retinas, the photoreceptors of which were functionally isolated by incubation in the presence of exogenous glutamate, light also suppressed cAMP synthesis.  Despite the similar inhibition of cAMP synthesis, the effect of light is directly on the photoreceptors and independent of dopamine modulation, because it was unaffected by application of the D4 receptor antagonist L-745870.  Nevertheless, compared with WT retinas, basal cAMP formation was reduced in the photoreceptors of D4KO retinas, and light had no addnl. inhibitory effect.  The results suggest that dopamine, via D4 receptors, normally modulates the cascade that couples light responses to adenylyl cyclase activity in photoreceptor cells, and the absence of this modulation results in dysfunction of the cascade.  Dark-adapted electroretinogram (ERG) responses were normal in D4KO mice.  However, ERG b-wave responses were greatly suppressed during both light adaptation and early stages of dark adaptation.  Thus, the absence of D4 receptors affects adaptation, altering transmission of light responses from photoreceptors to inner retinal neurons.  These findings indicate that dopamine D4 receptors normally play a major role in regulating photoreceptor cAMP metab. and adaptive retinal responses to changing environmental illumination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEmWw0jICytrVg90H21EOLACvtfcHk0lh2RJzzPqpd5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVegtro%253D&md5=177ddb2267abce9a71bd9d1a1ce0dfcf</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNir%26aufirst%3DI.%26aulast%3DHarrison%26aufirst%3DJ.%2BM.%26aulast%3DHaque%26aufirst%3DR.%26aulast%3DLow%26aufirst%3DM.%2BJ.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DRubinstein%26aufirst%3DM.%26aulast%3DIuvone%26aufirst%3DP.%2BM.%26atitle%3DDysfunctional%2520light-evoked%2520regulation%2520of%2520cAMP%2520in%2520photoreceptors%2520and%2520abnormal%2520retinal%2520adaptation%2520in%2520mice%2520lacking%2520dopamine%2520D4%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D2063%26epage%3D2073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Matarrese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soloviev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moresco, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli Kienle, M.</span><span> </span><span class="NLM_article-title">Synthesis and in vivo evaluation of 3-[<sup>11</sup>C]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D<sub>4</sub> receptors antagonist for PET</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1002%2F%28SICI%291099-1344%2820000330%2943%3A4%3C359%3A%3AAID-JLCR323%3E3.0.CO%3B2-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=359-374&author=M.+Matarreseauthor=D.+Solovievauthor=R.+M.+Morescoauthor=S.+Toddeauthor=P.+Simonelliauthor=D.+Colomboauthor=F.+Magniauthor=A.+Carpinelliauthor=F.+Fazioauthor=M.+Galli+Kienle&title=Synthesis+and+in+vivo+evaluation+of+3-%5B11C%5Dmethyl-%283-methoxy-naphthalen%29-2-yl-%281-benzyl-piperidin%29-4-yl-acetate+%28SB-235753%29%2C+as+a+putative+dopamine+D4+receptors+antagonist+for+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vivo evaluation of 1-(Phenylmethyl)-4-piperidine acetic acid 3-(methoxy-11C)-2-naphthalenyl ester (SB-235753), as a putative dopamine D4 receptors antagonist for PET</span></div><div class="casAuthors">Matarrese, M.; Soloviev, D.; Moresco, R. M.; Todde, S.; Simonelli, P.; Colombo, D.; Magni, F.; Carpinelli, A.; Fazio, F.; Kienle, M. Galli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-374</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">1-(Phenylmethyl)-4-piperidine acetic acid 3-(methoxy-11C)-2-naphthalenyl ester ester (SB-235753) (t1/2=20.4 min) was prepd. as a putative radioligand for the non-invasive assessment of Dopamine D4 receptors in vivo with positron emission tomog. (PET).  The precursor for the radiosynthesis 1-(Phenylmethyl)-4-piperidineacetic acid 3-hydroxy-2-naphthalenyl ester hydrochloride was prepd. by a four-step synthesis starting from 4-pyridineacetic acid Et ester.  The radiolabeling consisted of methylation with trifluoromethanesulfonic acid methyl-11C ester in DMF in the presence of potassium hydroxide.  [11C]SB-235753, was synthesized in 30 min with a radiochem. yield of 10 ± 5% (EOS, non-decay cor.) with 99% radiochem. purity and specific radioactivity of 10 ± 3 Ci/μmol.  Biodistribution studies in rats with [11C]SB-235753 showed the uniform distribution of the tracer within different areas of the murine brain.  At 30 min after injection 99% of the radioligand in plasma and 100% in cerebellum was metabolized.  These findings suggest that [11C]SB-235753 can not be a suitable tracer for dopamine D4 receptor studies with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg5zURP4hJkbVg90H21EOLACvtfcHk0ljpUX8kE7jI5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlajtb4%253D&md5=b731698ca1cbe347b1b4b64a58b0c898</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1344%2820000330%2943%3A4%3C359%3A%3AAID-JLCR323%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1344%252820000330%252943%253A4%253C359%253A%253AAID-JLCR323%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DMatarrese%26aufirst%3DM.%26aulast%3DSoloviev%26aufirst%3DD.%26aulast%3DMoresco%26aufirst%3DR.%2BM.%26aulast%3DTodde%26aufirst%3DS.%26aulast%3DSimonelli%26aufirst%3DP.%26aulast%3DColombo%26aufirst%3DD.%26aulast%3DMagni%26aufirst%3DF.%26aulast%3DCarpinelli%26aufirst%3DA.%26aulast%3DFazio%26aufirst%3DF.%26aulast%3DGalli%2BKienle%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520in%2520vivo%2520evaluation%2520of%25203-%255B11C%255Dmethyl-%25283-methoxy-naphthalen%2529-2-yl-%25281-benzyl-piperidin%2529-4-yl-acetate%2520%2528SB-235753%2529%252C%2520as%2520a%2520putative%2520dopamine%2520D4%2520receptors%2520antagonist%2520for%2520PET%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2000%26volume%3D43%26spage%3D359%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Eskola, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehikoinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaparanta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grönroos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsback, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solin, O.</span><span> </span><span class="NLM_article-title">Synthesis of 3-[[4-(4-[<sup>18</sup>F]fluorophenyl)piperazin-1-yl]methyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1002%2Fjlcr.597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmtlersb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=687-696&author=O.+Eskolaauthor=J.+Bergmanauthor=P.+Lehikoinenauthor=M.+Haaparantaauthor=T.+Gr%C3%B6nroosauthor=S.+Forsbackauthor=O.+Solin&title=Synthesis+of+3-%5B%5B4-%284-%5B18F%5Dfluorophenyl%29piperazin-1-yl%5Dmethyl%5D-1H-pyrrolo%5B2%2C3-b%5Dpyridine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3-[[4-(4-[18F]fluorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine</span></div><div class="casAuthors">Eskola, Olli; Bergman, Jorgen; Lehikoinen, Pertti; Haaparanta, Merja; Gronroos, Tove; Forsback, Sarita; Solin, Olof</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">687-696</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">3-[[4-(4-[18F]fluorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine, a candidate to image dopamine D4 receptors, was synthesized via electrophilic fluorination of a trimethylstannyl precursor with high specific radioactivity [18F]F2.  The precursor was obtained by a facile four-step synthetic approach; the trimethylstannyl leaving group was introduced by displacement of iodine utilizing palladium catalysis and hexamethyldistannane in an inert solvent.  The total radiosynthesis time was 50 min, including purifn. and formulation for injection.  Decay cor. radiochem. yield was <1% as calcd. from the amt. of [18F]F- produced.  Specific radioactivity at the end of synthesis was 12.8-16.4 GBq/μmol.  Radiochem. purity was 88-92%.  Ex vivo studies in rats showed homogeneous distribution of radioactivity within rat brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMWY5YQDSH9rVg90H21EOLACvtfcHk0ljpUX8kE7jI5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmtlersb4%253D&md5=ed5ebb557e09dc56cf28aac0f94708db</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.597%26sid%3Dliteratum%253Aachs%26aulast%3DEskola%26aufirst%3DO.%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DLehikoinen%26aufirst%3DP.%26aulast%3DHaaparanta%26aufirst%3DM.%26aulast%3DGr%25C3%25B6nroos%26aufirst%3DT.%26aulast%3DForsback%26aufirst%3DS.%26aulast%3DSolin%26aufirst%3DO.%26atitle%3DSynthesis%2520of%25203-%255B%255B4-%25284-%255B18F%255Dfluorophenyl%2529piperazin-1-yl%255Dmethyl%255D-1H-pyrrolo%255B2%252C3-b%255Dpyridine%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2002%26volume%3D45%26spage%3D687%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Langer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Någren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Carbon-11 PB-12: an attempt to visualize the dopamine D<sub>4</sub> receptor in the primate brain with positron emission tomography</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0969-8051%2800%2900154-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11150701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVWmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=707-714&author=O.+Langerauthor=C.+Halldinauthor=Y.+Chouauthor=J.+Sandellauthor=C.+Swahnauthor=K.+N%C3%A5grenauthor=R.+Perroneauthor=F.+Berardiauthor=M.+Leopoldoauthor=L.+Farde&title=Carbon-11+PB-12%3A+an+attempt+to+visualize+the+dopamine+D4+receptor+in+the+primate+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-11 PB-12: an attempt to visualize the dopamine D4 receptor in the primate brain with positron emission tomography</span></div><div class="casAuthors">Langer, O.; Halldin, C.; Chou, Y.-H.; Sandell, J.; Swahn, C.-G.; Nagren, K.; Perrone, R.; Berardi, F.; Leopoldo, M.; Farde, L.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">707-714</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The dopamine D4 receptor (D4R) is expressed in low d. in various extrastriatal brain regions.  This receptor subtype is discussed in relation to the pathophysiol. and treatment of schizophrenia but no selective positron emission tomog. (PET) ligand is available to date to study the distribution in vivo.  The arylpiperazine deriv. N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (PB-12) is a novel, high-affinity ( Ki=0.040 nM) and selective D4R ligand.  We radiolabeled PB-12 with carbon-11 (t1/2 20.4 min) by O-methylation of the corresponding desmethyl analog N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-hydroxybenzamide (LM-190) with [11C]methyl triflate.  Deriv. LM-190 was prepd. by condensing 3-hydroxybenzoic acid with the appropriate amine.  For the radiolabeling, the incorporation yield was >90% and the total synthesis time including high performance liq. chromatog. (HPLC) purifn. was about 35 min.  The specific radioactivity of [11C]PB-12 at time of injection was 67-118 GBq·μmol-1.  PET studies in a cynomolgus monkey showed a high uptake and widespread distribution of radioactivity in the brain, including the neocortex and thalamus.  About 40% of total radioactivity in plasma represented unchanged radioligand at 60 min after injection as detd. by HPLC.  Pretreatment with the D4R ligand 3-{[4-(4-chlorophenyl)piperazin-1-yl]methyl}-1H-pyrollo[2,3-b]pyridine (L-745,870) prior to radioligand injection failed to demonstrate receptor-specific binding in the monkey brain.  Furthermore, the brain radioactivity distribution was left unaffected by pretreating with unlabeled PB-12.  This failure to detect a D4R-specific signal may be related to a very low d. of the D4R in primate brain, insufficient binding affinity of the radioligand, and a high background of nonspecific binding.  It can be concluded from these findings that [11C]PB-12 is not suitable to visualize the D4R in the primate brain with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2LacRmVVPWrVg90H21EOLACvtfcHk0lhqhsh-lHH8rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVWmuw%253D%253D&md5=c4a3d85a356eeaa5336a29e778ccb2ea</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2800%2900154-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252800%252900154-2%26sid%3Dliteratum%253Aachs%26aulast%3DLanger%26aufirst%3DO.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DY.%26aulast%3DSandell%26aufirst%3DJ.%26aulast%3DSwahn%26aufirst%3DC.%26aulast%3DN%25C3%25A5gren%26aufirst%3DK.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DCarbon-11%2520PB-12%253A%2520an%2520attempt%2520to%2520visualize%2520the%2520dopamine%2520D4%2520receptor%2520in%2520the%2520primate%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2000%26volume%3D27%26spage%3D707%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Zhang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haradahira, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span> </span><span class="NLM_article-title">Syntheses and pharmacological evaluation of two potent antagonists for dopamine D<sub>4</sub> receptors: [<sup>11</sup>C]YM-50001 and <i>N</i>-[2-[4-(4-chlorophenyl)-piperizin-1-yl]ethyl]-3-[<sup>11</sup>C]methoxybenzamide</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0969-8051%2801%2900301-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11823129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=233-241&author=M.+R.+Zhangauthor=T.+Haradahiraauthor=J.+Maedaauthor=T.+Okauchiauthor=K.+Kawabeauthor=J.+Noguchiauthor=T.+Kidaauthor=K.+Suzukiauthor=T.+Suhara&title=Syntheses+and+pharmacological+evaluation+of+two+potent+antagonists+for+dopamine+D4+receptors%3A+%5B11C%5DYM-50001+and+N-%5B2-%5B4-%284-chlorophenyl%29-piperizin-1-yl%5Dethyl%5D-3-%5B11C%5Dmethoxybenzamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide</span></div><div class="casAuthors">Zhang, Ming-Rong; Haradahira, Terushi; Maeda, Jun; Okauchi, Takashi; Kawabe, Kouichi; Noguchi, Junko; Kida, Takayo; Suzuki, Kazutoshi; Suhara, Tetsuya</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-241</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Two benzamide derivs. as dopamine D4 receptor antagonists, YM-50001 (4) and N- [2-[4-(4-chlorophenyl)piperizin-1-yl]ethyl]-3-methoxybenzamide (9), were labeled by positron-emitter (11C), and their pharmacol. specificities to dopamine D4 receptors were examd. by quant. autoradiog. and positron emission tomog. (PET).  Radiosyntheses were accomplished by O-methylation of corresponding phenol precursors (5 and 10) with [11C]CH3I followed by HPLC purifications.  In vitro binding on rat brain slices showed different distribution patterns and pharmacol. properties between the two radioligands.  The [11C]4 showed the highest binding in the striatum, which was inhibited not only by 10 μM 4 but also by 10 μM raclopride, a selective dopamine D2 receptor antagonist.  In contrast, [11C]9 showed the highest binding in the cerebral cortex, which was inhibited by several D4 receptor antagonists (9, RBI-254, L-745,870), but not by any other receptor ligands (D1/D5, D2/D3, 5-HT1A, 5-HT2A, σ1 and α1) tested.  In vivo brain distribution of [11C]9 in rat showed the highest uptake in the frontal cortex, a region that has a high d. of D4 receptors.  These results indicate that the pharmacol. property of [11C]9 matches the rat brain D4 receptors, but that of [11C]4 rather appears to match the rat brain D2 receptors.  The results for the benzamide [11C]9 prompted us to further evaluate its potential as a PET radioligand for D4 receptors by employing PET on monkey brain.  Unfortunately, in contrast to rats, neither specific binding nor differences in regional uptake of radioactivity were obsd. in monkey brain after i.v.[11C]9 injection.  Based on that specific activities of radioligands might be crit. in mapping the neurotransmitter receptors if they are only faintly expressed in the brain, [11C]9 with an extremely high specific activity (1810 GBq/μmol) was used for PET study.  However, the effort to det. the specific binding for D4 failed.  These results indicate that both of the benzamide derivs. would not be suitable radioligands for D4 receptors with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2qkB2aMa0pLVg90H21EOLACvtfcHk0lhqhsh-lHH8rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFCmsA%253D%253D&md5=8ded703bad2950f17148b59fc9294a4a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900301-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900301-8%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DHaradahira%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DKawabe%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DJ.%26aulast%3DKida%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DSuhara%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520pharmacological%2520evaluation%2520of%2520two%2520potent%2520antagonists%2520for%2520dopamine%2520D4%2520receptors%253A%2520%255B11C%255DYM-50001%2520and%2520N-%255B2-%255B4-%25284-chlorophenyl%2529-piperizin-1-yl%255Dethyl%255D-3-%255B11C%255Dmethoxybenzamide%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2002%26volume%3D29%26spage%3D233%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zhang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haradahira, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[<sup>11</sup>C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-<i>c</i>]pyridin-5-one: a PET tracer for imaging sigma<sub>1</sub> receptors</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0969-8051%2802%2900293-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=12031882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVWjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=469-476&author=M.+R.+Zhangauthor=T.+Haradahiraauthor=J.+Maedaauthor=T.+Okauchiauthor=K.+Kawabeauthor=T.+Kidaauthor=S.+Obayashiauthor=K.+Suzukiauthor=T.+Suhara&title=Synthesis+and+evaluation+of+3-%284-chlorobenzyl%29-8-%5B11C%5Dmethoxy-1%2C2%2C3%2C4-tetrahydrochromeno%5B3%2C4-c%5Dpyridin-5-one%3A+a+PET+tracer+for+imaging+sigma1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma1 receptors</span></div><div class="casAuthors">Zhang, Ming-Rong; Haradahira, Terushi; Maeda, Jun; Okauchi, Takashi; Kawabe, Kouichi; Kida, Takayo; Suzuki, Kazutoshi; Suhara, Tetsuya</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-476</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">3-(4-Chlorobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one (1), a putative dopamine D4 receptor antagonist (ki = 8.7 nM), was labeled by positron-emitter (11C) and its pharmacol. evaluation was carried out with in vitro quant. autoradiog. and positron emission tomog. (PET).  11C-Methylation of a corresponding desmethyl precursor with [11C]CH3I gave [11C]1 with ≥98% of radiochem. purity after HPLC purifn. and 67-90 GBq/μmol of specific activity at the end of synthesis.  The in vitro autoradiog. using rat brain sections demonstrated that [11C]1 shows no specific binding to the D4 receptors, but a high specific binding to sigma1 receptors (IC50 = 105 nM).  In the PET study with monkey brain, [11C]1 was highly taken up by the brain and trapped in the brain for at least 90 min.  The distribution pattern of radioactivity in the brain was striatum > thalamus > frontal cortex > cerebellum, which was same as the result of in vitro autoradiog.  Pre-treatment with non-radioactive 1 (1 mg/kg) produced a significant redn. of radioactivity in all the regions including the cerebellum.  Pre-treatment with (+)pentazocine (1 mg/kg), a selective σ1 receptor agonist, also reduced the radioactivity in the same regions to a similar extent.  These results indicate that [11C]1 may have some specific binding to the sigma1 receptors, which is consistent with the result of in vitro autoradiog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7WF1kc2dhV7Vg90H21EOLACvtfcHk0lhqhsh-lHH8rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVWjtbs%253D&md5=ff7c35e0078be30f82d91a34e46b4319</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900293-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900293-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DHaradahira%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DKawabe%26aufirst%3DK.%26aulast%3DKida%26aufirst%3DT.%26aulast%3DObayashi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DSuhara%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25203-%25284-chlorobenzyl%2529-8-%255B11C%255Dmethoxy-1%252C2%252C3%252C4-tetrahydrochromeno%255B3%252C4-c%255Dpyridin-5-one%253A%2520a%2520PET%2520tracer%2520for%2520imaging%2520sigma1%2520receptors%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2002%26volume%3D29%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Oh, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. T.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of fluorine-substituted 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine derivatives for dopamine D<sub>4</sub> receptor imaging</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5505-5513&author=S.+J.+Ohauthor=K.+C.+Leeauthor=S.+Y.+Leeauthor=E.+K.+Ryuauthor=H.+Sajiauthor=Y.+S.+Choeauthor=D.+Y.+Chiauthor=S.+E.+Kimauthor=J.+Leeauthor=B.+T.+Kim&title=Synthesis+and+evaluation+of+fluorine-substituted+1H-pyrrolo%5B2%2C3-b%5Dpyridine+derivatives+for+dopamine+D4+receptor+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DRyu%26aufirst%3DE.%2BK.%26aulast%3DSaji%26aufirst%3DH.%26aulast%3DChoe%26aufirst%3DY.%2BS.%26aulast%3DChi%26aufirst%3DD.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DB.%2BT.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520fluorine-substituted%25201H-pyrrolo%255B2%252C3-b%255Dpyridine%2520derivatives%2520for%2520dopamine%2520D4%2520receptor%2520imaging%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5505%26epage%3D5513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Prante, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-<i>a</i>]pyridine-based dopamine D<sub>4</sub> receptor ligands: discovery of an inverse agonist radioligand for PET</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701375u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1800-1810&author=O.+Pranteauthor=R.+Tietzeauthor=C.+Hockeauthor=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=T.+Kuwertauthor=P.+Gmeiner&title=Synthesis%2C+radiofluorination%2C+and+in+vitro+evaluation+of+pyrazolo%5B1%2C5-a%5Dpyridine-based+dopamine+D4+receptor+ligands%3A+discovery+of+an+inverse+agonist+radioligand+for+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm701375u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701375u%26sid%3Dliteratum%253Aachs%26aulast%3DPrante%26aufirst%3DO.%26aulast%3DTietze%26aufirst%3DR.%26aulast%3DHocke%26aufirst%3DC.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DKuwert%26aufirst%3DT.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520radiofluorination%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520pyrazolo%255B1%252C5-a%255Dpyridine-based%2520dopamine%2520D4%2520receptor%2520ligands%253A%2520discovery%2520of%2520an%2520inverse%2520agonist%2520radioligand%2520for%2520PET%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1800%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span> <span class="citation_source-book">ClogP</span>, version <span class="NLM_edition">4.0</span> (for Windows); <span class="NLM_publisher-name">BioByte Corp.</span>: <span class="NLM_publisher-loc">Claremont, CA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClogP%2C+version+4.0+%28for+Windows%29%3B+BioByte+Corp.%3A+Claremont%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DClogP%26pub%3DBioByte%2520Corp" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET radiotracers: crossing the blood−brain barrier and surviving metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-340&author=V.+W.+Pike&title=PET+radiotracers%3A+crossing+the+blood%E2%88%92brain+barrier+and+surviving+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520radiotracers%253A%2520crossing%2520the%2520blood%25E2%2588%2592brain%2520barrier%2520and%2520surviving%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-375&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+between+radiotracer+properties+and+image+quality+in+molecular+imaging+of+the+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eZa2eZ4bWbRMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520between%2520radiotracer%2520properties%2520and%2520image%2520quality%2520in%2520molecular%2520imaging%2520of%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Waterhouse, R. N.</span><span> </span><span class="NLM_article-title">Determination of lipophilicity and its use as a predictor of blood−brain barrier penetration of molecular imaging agents</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.mibio.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=14667492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=376-389&author=R.+N.+Waterhouse&title=Determination+of+lipophilicity+and+its+use+as+a+predictor+of+blood%E2%88%92brain+barrier+penetration+of+molecular+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span></div><div class="casAuthors">Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">376-89</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Compound lipophilicity is a fundamental physicochemical property that plays a pivotal role in the absorption, distribution, metabolism, and elimination (ADME) of therapeutic drugs.  Lipophilicity is expressed in several different ways, including terms such as Log P, clogP, delta Log P, and Log D.  Often a parabolic relationship exists between measured lipophilicity and in vivo brain penetration of drugs, where those moderate in lipophilicity often exhibit highest uptake.  Reduced brain extraction of more lipophilic compounds is associated with increased non-specific binding to plasma proteins.  More lipophilic compounds can also be more vulnerable to P450 metabolism, leading to faster clearance.  Very polar compounds normally exhibit high water solubility, fast clearance through the kidneys, and often contain ionizable functional groups that limit blood-brain barrier (BBB) penetration.  The brain penetration and specific to non-specific binding ratios exhibited in vivo by positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers involves a complex interplay between many critical factors, including lipophilicity, receptor affinity, metabolism, molecular size and shape, ionization potential, and specific binding to BBB efflux pumps or binding sites on albumin or other plasma proteins.  This paper explores situations in which lipophilicity is a good predictor of BBB penetration, as well as those where this correlation is poor.  The more commonly used methods for measuring lipophilicity are presented, and the various terms often found in the literature outlined.  An attempt is made to describe how this information can be used in optimizing the development of PET and SPECT tracers that target the central nervous system (CNS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8j0SWnHPWbmmfW6udTcc2eZa2eZ4bWbRMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D&md5=cfff94825034cffcce30e56d703745cf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26atitle%3DDetermination%2520of%2520lipophilicity%2520and%2520its%2520use%2520as%2520a%2520predictor%2520of%2520blood%25E2%2588%2592brain%2520barrier%2520penetration%2520of%2520molecular%2520imaging%2520agents%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D376%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">1-(2-Methoxyphenyl)-4-alkylpiperazines: effect of the N-4 substituent on the affinity and selectivity for dopamine D<sub>4</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=1327-1330&author=R.+Perroneauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Leopoldoauthor=V.+Tortorella&title=1-%282-Methoxyphenyl%29-4-alkylpiperazines%3A+effect+of+the+N-4+substituent+on+the+affinity+and+selectivity+for+dopamine+D4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3D1-%25282-Methoxyphenyl%2529-4-alkylpiperazines%253A%2520effect%2520of%2520the%2520N-4%2520substituent%2520on%2520the%2520affinity%2520and%2520selectivity%2520for%2520dopamine%2520D4%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D1327%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title"><i>N</i>-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide: a potent and selective dopamine D<sub>4</sub> ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4903</span><span class="NLM_x">–</span> <span class="NLM_lpage">4909</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981041x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4903-4909&author=R.+Perroneauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Leopoldoauthor=V.+Tortorella&title=N-%5B2-%5B4-%284-Chlorophenyl%29piperazin-1-yl%5Dethyl%5D-3-methoxybenzamide%3A+a+potent+and+selective+dopamine+D4+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm981041x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981041x%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DN-%255B2-%255B4-%25284-Chlorophenyl%2529piperazin-1-yl%255Dethyl%255D-3-methoxybenzamide%253A%2520a%2520potent%2520and%2520selective%2520dopamine%2520D4%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4903%26epage%3D4909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">A structure−affinity relationship study on derivatives of <i>N</i>-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a high-affinity and selective D<sub>4</sub> receptor ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm991138z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=270-277&author=R.+Perroneauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Leopoldoauthor=V.+Tortorella&title=A+structure%E2%88%92affinity+relationship+study+on+derivatives+of+N-%5B2-%5B4-%284-chlorophenyl%29piperazin-1-yl%5Dethyl%5D-3-methoxybenzamide%2C+a+high-affinity+and+selective+D4+receptor+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm991138z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991138z%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DA%2520structure%25E2%2588%2592affinity%2520relationship%2520study%2520on%2520derivatives%2520of%2520N-%255B2-%255B4-%25284-chlorophenyl%2529piperazin-1-yl%255Dethyl%255D-3-methoxybenzamide%252C%2520a%2520high-affinity%2520and%2520selective%2520D4%2520receptor%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D270%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Jung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddareddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pae, A. N.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel T-type Ca<sup>2+</sup> channel blockers</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3965</span><span class="NLM_x">–</span> <span class="NLM_lpage">3970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=3965-3970&author=H.+K.+Jungauthor=M.+R.+Doddareddyauthor=J.+H.+Chaauthor=H.+Rhimauthor=Y.+S.+Choauthor=H.+Y.+Kohauthor=B.+Y.+Jungauthor=A.+N.+Pae&title=Synthesis+and+biological+evaluation+of+novel+T-type+Ca2%2B+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DH.%2BK.%26aulast%3DDoddareddy%26aufirst%3DM.%2BR.%26aulast%3DCha%26aufirst%3DJ.%2BH.%26aulast%3DRhim%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DKoh%26aufirst%3DH.%2BY.%26aulast%3DJung%26aufirst%3DB.%2BY.%26aulast%3DPae%26aufirst%3DA.%2BN.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520T-type%2520Ca2%252B%2520channel%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D3965%26epage%3D3970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ishizumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoku, F.</span><span> </span><span class="NLM_article-title">Synthesis and anxiolytic activity of N-substituted cyclic imides (1<i>R</i>*,2<i>S</i>*,3<i>R</i>*,4<i>S</i>*)-<i>N</i>-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3-bicyclo[2.2.1]heptanedicarboximide (tandospirone) and related compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2288</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=2288-2300&author=K.+Ishizumiauthor=A.+Kojimaauthor=F.+Antoku&title=Synthesis+and+anxiolytic+activity+of+N-substituted+cyclic+imides+%281R*%2C2S*%2C3R*%2C4S*%29-N-%5B4-%5B4-%282-pyrimidinyl%29-1-piperazinyl%5Dbutyl%5D-2%2C3-bicyclo%5B2.2.1%5Dheptanedicarboximide+%28tandospirone%29+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshizumi%26aufirst%3DK.%26aulast%3DKojima%26aufirst%3DA.%26aulast%3DAntoku%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520anxiolytic%2520activity%2520of%2520N-substituted%2520cyclic%2520imides%2520%25281R%252A%252C2S%252A%252C3R%252A%252C4S%252A%2529-N-%255B4-%255B4-%25282-pyrimidinyl%2529-1-piperazinyl%255Dbutyl%255D-2%252C3-bicyclo%255B2.2.1%255Dheptanedicarboximide%2520%2528tandospirone%2529%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D2288%26epage%3D2300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">Structure−affinity relationship study on <i>N</i>-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D<sub>3</sub> receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5727</span><span class="NLM_x">–</span> <span class="NLM_lpage">5735</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020952a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5727-5735&author=M.+Leopoldoauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=P.+De+Giorgioauthor=E.+Lacivitaauthor=R.+Perroneauthor=V.+Tortorella&title=Structure%E2%88%92affinity+relationship+study+on+N-%5B4-%284-arylpiperazin-1-yl%29butyl%5Darylcarboxamides+as+potent+and+selective+dopamine+D3+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm020952a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020952a%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DDe%2BGiorgio%26aufirst%3DP.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DStructure%25E2%2588%2592affinity%2520relationship%2520study%2520on%2520N-%255B4-%25284-arylpiperazin-1-yl%2529butyl%255Darylcarboxamides%2520as%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5727%26epage%3D5735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Enguehard-Gueiffier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueiffier, A.</span><span> </span><span class="NLM_article-title">Recent progress in medicinal chemistry of D<sub>4</sub> agonists</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2981</span><span class="NLM_x">–</span> <span class="NLM_lpage">2993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.2174%2F092986706778521841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=17073641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVamsrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2981-2993&author=C.+Enguehard-Gueiffierauthor=A.+Gueiffier&title=Recent+progress+in+medicinal+chemistry+of+D4+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in medicinal chemistry of D4 agonists</span></div><div class="casAuthors">Enguehard-Gueiffier, Cecile; Gueiffier, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2981-2993</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the last decades, the physiol. and pharmacol. properties of dopamine receptors were controversial principally because of the lack of selective ligand for some receptor subtypes.  Since 1997, some specific D4 agonists have been described and have allowed a therapeutic approach.  We report here, compds. described as D4 agonist and when available the SAR.  The major studies for physiol. implications and their potential biol. applications are also reported and principally their interest in erectile dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZcw5PILzBfrVg90H21EOLACvtfcHk0lhFbp8t1JVMDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVamsrfL&md5=a7595ee588e420d9f12579e93e269941</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F092986706778521841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706778521841%26sid%3Dliteratum%253Aachs%26aulast%3DEnguehard-Gueiffier%26aufirst%3DC.%26aulast%3DGueiffier%26aufirst%3DA.%26atitle%3DRecent%2520progress%2520in%2520medicinal%2520chemistry%2520of%2520D4%2520agonists%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2981%26epage%3D2993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lee, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">An unambiguous assay for the cloned human sigma<sub>1</sub> receptor reveals high affinity interactions with dopamine D<sub>4</sub> receptor selective compounds and a distinct structure−affinity relationship for butyrophenones</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">578</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.ejphar.2007.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=17961544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFaitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=578&publication_year=2008&pages=123-136&author=I.+T.+Leeauthor=S.+Chenauthor=J.+A.+Schetz&title=An+unambiguous+assay+for+the+cloned+human+sigma1+receptor+reveals+high+affinity+interactions+with+dopamine+D4+receptor+selective+compounds+and+a+distinct+structure%E2%88%92affinity+relationship+for+butyrophenones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones</span></div><div class="casAuthors">Lee, Ivan T.; Chen, Shiuhwei; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">578</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">123-136</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability of the sigma1 receptor to interact with a huge range of drug structural classes coupled with its wide distribution in the body has contributed to it being implicated as a possible therapeutic target for a broad array of disorders ranging from substance abuse to depression to Alzheimer's disease.  Surprisingly, the reported affinity values for some sigma1 receptor ligands vary more than 50-fold.  The potential of the sigma1 receptor as a pharmacotherapeutic target prompted us to develop an unambiguous assay system for measuring the affinity of ligands to the cloned human sigma1 receptor.  In the course of characterizing this system and detg. the true affinity values for almost three dozen compds., it was discovered that some dopamine D4 receptor selective compds. bind sigma1 receptors with high affinity.  A systematic anal. of haloperidol-like compds. revealed a clear structure-affinity relationship amongst clin. relevant butyrophenones.  The antidepressant fluvoxamine, the drug of abuse methamphetamine, and the neurosteroid progesterone were amongst the many ligands whose interactions with the sigma1 receptor were confirmed with the screening assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6V71Qpygx17Vg90H21EOLACvtfcHk0lhFbp8t1JVMDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFaitw%253D%253D&md5=a5f025cd9d7c3f130544afb4e3140f56</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DI.%2BT.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DAn%2520unambiguous%2520assay%2520for%2520the%2520cloned%2520human%2520sigma1%2520receptor%2520reveals%2520high%2520affinity%2520interactions%2520with%2520dopamine%2520D4%2520receptor%2520selective%2520compounds%2520and%2520a%2520distinct%2520structure%25E2%2588%2592affinity%2520relationship%2520for%2520butyrophenones%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D578%26spage%3D123%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulyás, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Brain radioligands—state of the art and new trends</span> <span class="citation_source-journal">Q. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11476163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD3MvivVGhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=139-152&author=C.+Halldinauthor=B.+Guly%C3%A1sauthor=O.+Langerauthor=L.+Farde&title=Brain+radioligands%E2%80%94state+of+the+art+and+new+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Brain radioligands--state of the art and new trends</span></div><div class="casAuthors">Halldin C; Gulyas B; Langer O; Farde L</div><div class="citationInfo"><span class="NLM_cas:title">The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-52</span>
        ISSN:<span class="NLM_cas:issn">1125-0135</span>.
    </div><div class="casAbstract">Non-invasive radioligand imaging methods for brain receptor studies use either short-lived positron-emitting radionuclides such as 11C and 18F for positron emission tomography (PET) or single photon-emitting radionuclides such as 123I for single photon emission computed tomography (SPECT).  PET and SPECT use radioligands which are injected intravenously into experimental animals, human volunteers or patients.  The main applications of radioligands in brain research concern human neuropsychopharmacology and the discovery and development of novel drugs to be used in thetherapy of neurological and psychiatric disorders.  A basic problem in PET and SPECT brain receptor studies is the lack of useful radioligands with appropriate binding characteristics.  Prerequisite criteria need to be satisfied for a radioligand to reveal target binding sites in vivo.  This section will discuss these important criteria and also review recent examples in neuroreceptor radioligand development such as selective radioligands for brain monoamine transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgdxNRjf7VRfxQvRxYU81tfW6udTcc2eYkLGugbe4JHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvivVGhtw%253D%253D&md5=cfbdf01d11608e0b9f81f5550c0c9a37</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DGuly%25C3%25A1s%26aufirst%3DB.%26aulast%3DLanger%26aufirst%3DO.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DBrain%2520radioligands%25E2%2580%2594state%2520of%2520the%2520art%2520and%2520new%2520trends%26jtitle%3DQ.%2520J.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D45%26spage%3D139%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Primus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yevich, E..</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcinerney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallager, D. W.</span><span> </span><span class="NLM_article-title">Localization and characterization of dopamine D<sub>4</sub> binding sites in rat and human brain by use of the novel, D<sub>4</sub> receptor-selective ligand [<sup>3</sup>H]NGD 94-1</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1020</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9262371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK2sXltlSmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1997&pages=1020-1027&author=R.+Primusauthor=A.+Thurkaufauthor=J.+Xuauthor=E..+Yevichauthor=S.+Mcinerneyauthor=K.+Shawauthor=J.+F.+Tallmanauthor=D.+W.+Gallager&title=Localization+and+characterization+of+dopamine+D4+binding+sites+in+rat+and+human+brain+by+use+of+the+novel%2C+D4+receptor-selective+ligand+%5B3H%5DNGD+94-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1</span></div><div class="casAuthors">Primus, Renee J.; Thurkauf, Andrew; Xu, Jing; Yevich, Eileen; Mcinerney, Sean; Shaw, Kenneth; Tallman, John F.; Gallager, Dorothy W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1020-1027</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The dopamine D4 selective ligand, [3H]NGD 94-1, was used in these studies to characterize binding sites in rat and human brain tissue by membrane binding and autoradiog. techniques.  Autoradiog. anal. of rat brain showed that specific [3H]NGD 94-1 binding was greatest in entorhinal cortex, lateral septal nucleus, hippocampus and the medial preoptic area of the hypothalamus.  This nonstriatal distribution of [3H]NGD 94-1 binding was distinct from the autoradiog. distribution of dopamine D2 and D3 receptor subtypes.  In homogenate prepns. from rat brain regions, [3H]NGD 94-1 binding sites were low in d. (<30.0 fmol/mg protein).  The low d. of D4 binding sites was corroborated by autoradiog. comparisons in which binding d. for D4 receptors as measured by [3H]NGD 94-1 was only 1/7 of D2 and 1/5 of D3 receptor densities, despite corrections for differing radioligand binding characteristics.  Pharmacol. evaluation showed high affinity at rat [3H]NGD 94-1 binding sites for compds. with known D4 receptor affinity and little displacement by compds. with affinity for dopamine D1/D2/D3 receptor subtypes.  Specific, high-affinity [3H]NGD 94-1 binding was also present in several human brain regions, including hippocampus, hypothalamus, dorsal medial thalamus, entorhinal cortex, prefrontal cortex and lateral septal nucleus.  High-affinity [3H]NGD 94-1 binding was not present in any human striatal region examd.  The pharmacol. profile of [3H]NGD 94-1 binding sites in human brain was consistent with that previously demonstrated for cloned human D4 receptors expressed in mammalian cells.  These findings suggest that specific, high-affinity [3H]NGD 94-1 binding exists in rat and human brain and that these sites reflect populations of dopamine D4 receptors with a distribution unique among dopamine receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo59pLqDZx1IbVg90H21EOLACvtfcHk0licMBPXyK2mBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltlSmsr8%253D&md5=8775b51d2461afcae72d3ee1b9a63f43</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrimus%26aufirst%3DR.%26aulast%3DThurkauf%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYevich%26aufirst%3DE..%26aulast%3DMcinerney%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DK.%26aulast%3DTallman%26aufirst%3DJ.%2BF.%26aulast%3DGallager%26aufirst%3DD.%2BW.%26atitle%3DLocalization%2520and%2520characterization%2520of%2520dopamine%2520D4%2520binding%2520sites%2520in%2520rat%2520and%2520human%2520brain%2520by%2520use%2520of%2520the%2520novel%252C%2520D4%2520receptor-selective%2520ligand%2520%255B3H%255DNGD%252094-1%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D282%26spage%3D1020%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">De La Garza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madras, B. K.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]PNU-101958, a D<sub>4</sub> dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2000&pages=232-244&author=R.+De+La+Garzaauthor=B.+K.+Madras&title=%5B3H%5DPNU-101958%2C+a+D4+dopamine+receptor+probe%2C+accumulates+in+prefrontal+cortex+and+hippocampus+of+non-human+primate+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLa%2BGarza%26aufirst%3DR.%26aulast%3DMadras%26aufirst%3DB.%2BK.%26atitle%3D%255B3H%255DPNU-101958%252C%2520a%2520D4%2520dopamine%2520receptor%2520probe%252C%2520accumulates%2520in%2520prefrontal%2520cortex%2520and%2520hippocampus%2520of%2520non-human%2520primate%2520brain%26jtitle%3DSynapse%26date%3D2000%26volume%3D37%26spage%3D232%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Marazziti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masala, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannaccini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palego, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catena Dell’Osso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Consoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucacchini, A.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-YM-09151-2 binding sites in human brain postmortem</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.neuint.2009.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=19540292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2ru7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2009&pages=643-647&author=D.+Marazzitiauthor=S.+Baroniauthor=I.+Masalaauthor=G.+Giannacciniauthor=L.+Bettiauthor=L.+Palegoauthor=M.+Catena+Dell%E2%80%99Ossoauthor=G.+Consoliauthor=M.+Castagnaauthor=A.+Lucacchini&title=%5B3H%5D-YM-09151-2+binding+sites+in+human+brain+postmortem"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]-YM-09151-2 binding sites in human brain postmortem</span></div><div class="casAuthors">Marazziti, Donatella; Baroni, Stefano; Masala, Irene; Giannaccini, Gino; Betti, Laura; Palego, Lionella; Dell'Osso, Mario Catena; Consoli, Giorgio; Castagna, Maura; Lucacchini, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">643-647</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The controversial and limited data on the distribution of dopamine (DA) receptors of type 4 (D4) in the human brain prompted the authors to explore their d. and pharmacol. characteristics in the prefrontal cortex, striatum and hippocampus, through a series of binding assays.  Brain samples were taken during autopsy from seven subjects.  Tissue homogenates were incubated with increasing concn. of [3H]-YM-09151-2, a D2-like receptor antagonist, and L-745,870 and/or sulpiride to define the non-specific binding, while PPAP was used to block sigma receptors.  The results showed a low d. of D4 receptors in the hippocampus only, with a preponderance of D2/D3 and sigma receptors in the prefrontal cortex and striatum.  In conclusion, these findings underline that it is possible to label D4 receptors by [3H]-YM-09151-2, provided that D2, D3 and sigma receptors are blocked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ0CZX0MI2_rVg90H21EOLACvtfcHk0licMBPXyK2mBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2ru7fI&md5=133bd55a1b16a0d94a2f1eee3fad35f0</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2009.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2009.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DMarazziti%26aufirst%3DD.%26aulast%3DBaroni%26aufirst%3DS.%26aulast%3DMasala%26aufirst%3DI.%26aulast%3DGiannaccini%26aufirst%3DG.%26aulast%3DBetti%26aufirst%3DL.%26aulast%3DPalego%26aufirst%3DL.%26aulast%3DCatena%2BDell%25E2%2580%2599Osso%26aufirst%3DM.%26aulast%3DConsoli%26aufirst%3DG.%26aulast%3DCastagna%26aufirst%3DM.%26aulast%3DLucacchini%26aufirst%3DA.%26atitle%3D%255B3H%255D-YM-09151-2%2520binding%2520sites%2520in%2520human%2520brain%2520postmortem%26jtitle%3DNeurochem.%2520Int.%26date%3D2009%26volume%3D55%26spage%3D643%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Inoue, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A.</span><span> </span><span class="NLM_article-title">Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments</span> <span class="citation_source-journal">Crit. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=10512490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlyhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=199-225&author=O.+Inoueauthor=K.+Kobayashiauthor=A.+Gee&title=Changes+in+apparent+rates+of+receptor+binding+in+the+intact+brain+in+relation+to+the+heterogeneity+of+reaction+environments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments</span></div><div class="casAuthors">Inoue, Osamu; Kobayashi, Kaoru; Gee, Antony</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Neurobiology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-225</span>CODEN:
                <span class="NLM_cas:coden">CCNBE8</span>;
        ISSN:<span class="NLM_cas:issn">0892-0915</span>.
    
            (<span class="NLM_cas:orgname">Begell House, Inc.</span>)
        </div><div class="casAbstract">A review, with 189 refs.  Neuroreceptor imaging by PET or SPECT has been widely applied in the field of neurobiol., from basic to clin. investigations, and has the potential to reveal the neurochem. basis of various neurol. and psychiatric diseases as well as to provide new knowledge in the field of neuropharmacol.  In contrast to the static nature of in vitro systems, neurotransmission systems in the intact brain constitute part of a dynamic and communicating environment.  Thus, it is important to develop new functional imaging methods that reflect neural communications and the dynamism of signal transmission in the living brain.  In vivo receptor binding can be altered not only by competitive inhibition by endogenous neurotransmitters but by trans-synaptic effects, and investigation of neural interactions by detection of changes in receptor binding therefore presents a potential method for studying this phenomenon.  Recently, several PET studies on in vivo neural interactions using the D2 receptor ligand [11C]-raclopride concluded that the phenomenon was mediated by changes in synaptic endogenous dopamine concns. that compete with [11C]-raclopride binding for neuroreceptor occupancy.  However, a growing body of evidence indicates that these changes in in vivo receptor binding cannot be fully explained by competitive inhibition by endogenous ligand, and alternative mechanisms for the interneuronal modulation of receptor binding are addressed.  This review highlights some of the discrepancies obsd. between in vitro and in vivo receptor binding studies with respect to a no. of phenomena, including the heterogeneity of the reaction field surrounding receptors.  Quant. receptor binding studies are usually analyzed by using 'static' binding parameters, such as the Bmax and KD, which are normally detd. by in vitro assays.  In addn. to these parameters, the apparent assocn. and dissocn. rate consts. (kon, koff) play equally significant roles in receptor binding in the intact brain is expected.  The concepts of "diffusion boundary" and "reaction vol." are introduced, and discussions on some of the discrepancies between in vivo and in vitro receptor binding phenomena are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1K8QMOgstsbVg90H21EOLACvtfcHk0lj_zajKRMOr5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlyhu78%253D&md5=cd08e838fed1f9b96418a7ff672f43c0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DO.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DGee%26aufirst%3DA.%26atitle%3DChanges%2520in%2520apparent%2520rates%2520of%2520receptor%2520binding%2520in%2520the%2520intact%2520brain%2520in%2520relation%2520to%2520the%2520heterogeneity%2520of%2520reaction%2520environments%26jtitle%3DCrit.%2520Rev.%2520Neurobiol.%26date%3D1999%26volume%3D13%26spage%3D199%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Caccia, S.</span><span> </span><span class="NLM_article-title">N-Dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.2174%2F138920007781368908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=17691920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFeqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=612-622&author=S.+Caccia&title=N-Dealkylation+of+arylpiperazine+derivatives%3A+disposition+and+metabolism+of+the+1-aryl-piperazines+formed"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed</span></div><div class="casAuthors">Caccia, Silvio</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">612-622</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years several arylpiperazine derivs. have reached the stage of clin. application, mainly for the treatment of depression, psychosis or anxiety.  Examples are the pyrimidinylpiperazine buspirone, the chlorophenylpiperazine derivs. nefazodone and trazodone, the dichlorophenylpiperazine aripiprazole and the benzisothiazolyl derivs. perospirone and ziprasidone.  Most of them undergo extensive pre-systemic and systemic metab. including CYP3A4-dependent N-dealkylation to 1-aryl-piperazines.  These metabolites are best known for the variety of serotonin receptor-related effects they cause in man and animals, although some have affinity for other neurotransmitter receptors; others, however, are still largely unexplored despite uncontrolled use as amphetamine-like designer drugs.  Once formed they distribute extensively in tissues, including brain which is the target site of most arylpiperazine derivs., and are then primarily biotransformed by CYP2D6-dependent oxidn. to hydroxylates which are excreted as conjugates; only 1-(2-benzisothiazolyl)-piperazine is more susceptible to sulfur oxidn. than to arom. hydroxylation.  In studies analyzing animal brain and human blood, 1-aryl-piperazine concns. were either higher or lower than the parent compd.(s), although information is available only for some derivs.  At steady state, the metabolite-to-parent drug ratios varied widely among individuals taking the same dosage of the same arylpiperazine deriv.  This is consistent with the known individual variability in the expression and activity of CYP3A4 and CYP2D6.  This review also surveys current published information on physiol. and pathol. factors affecting the 1-aryl-piperazine-to-parent drug ratios and examines the potential role of 1-aryl-piperazine formation in the pharmacol. actions of the arylpiperazine derivs. that are already or will shortly be available in major markets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-2G3ghGBnD7Vg90H21EOLACvtfcHk0lj_zajKRMOr5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFeqtLo%253D&md5=1db99dec39f0774f4e8252abcfe8941b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F138920007781368908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007781368908%26sid%3Dliteratum%253Aachs%26aulast%3DCaccia%26aufirst%3DS.%26atitle%3DN-Dealkylation%2520of%2520arylpiperazine%2520derivatives%253A%2520disposition%2520and%2520metabolism%2520of%2520the%25201-aryl-piperazines%2520formed%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D612%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55a"><span><span class="NLM_contrib-group">Steuer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaworski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosshauer, B.</span><span> </span><span class="NLM_article-title">In vitro model of the outer blood−retina barrier</span> <span class="citation_source-journal">Brain Res. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.brainresprot.2003.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=15063838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisl2rsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=26-36&author=H.+Steuerauthor=A.+Jaworskiauthor=D.+Stollauthor=B.+Schlosshauer&title=In+vitro+model+of+the+outer+blood%E2%88%92retina+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55aR"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro model of the outer blood-retina barrier</span></div><div class="casAuthors">Steuer, H.; Jaworski, A.; Stoll, D.; Schlosshauer, B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Protocols</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-36</span>CODEN:
                <span class="NLM_cas:coden">BRPRFP</span>;
        ISSN:<span class="NLM_cas:issn">1385-299X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The outer blood-retina barrier (BRB) is formed by the retinal pigment epithelium (rpe) and functions similarly to the blood-brain barrier (BBB).  In contrast to the BBB, which is composed of a myriad of capillaries, the rpe can in principle be prepd. as an intact planar tissue sheet without disruption of its barrier and carrier functions.  Both a rapid and gentle procedure to isolate porcine rpe and a method to implement the harvested rpe in drug penetration testing are presented.  Enucleated eyes were flat-mounted and the RPE/choroid tissue sheets with or without the retina were isolated.  Fluorescence microscopy based on double-labeling with propidium iodide/calcein and SEM revealed well-preserved cell and tissue architecture.  For drug evaluation, specimens were immobilized as the interface between test compartments in a dual-chamber device.  Ten different test agents were added to one chamber at defined concns.  After an incubation time of 30 min at 37 permeated drug levels in both compartments were quantified by HPLC-tandem mass spectrometry or HPLC with fluorescence detection.  Sodium fluorescein used as a barrier marker indicated that the rpe model had excellent seal integrity.  The use of a representative subset of pharmaceuticals with known BBB permeability characteristics demonstrated that the rpe model had a large permeability dynamic range (factor >350).  These findings showed that the model represents a valuable tool for the investigation of the blood barrier penetration of test compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPP-Gj1FK9C7Vg90H21EOLACvtfcHk0lj_zajKRMOr5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisl2rsLc%253D&md5=ad88e1074a7e41894ff0cc852e53e9f0</span></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresprot.2003.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresprot.2003.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DSteuer%26aufirst%3DH.%26aulast%3DJaworski%26aufirst%3DA.%26aulast%3DStoll%26aufirst%3DD.%26aulast%3DSchlosshauer%26aufirst%3DB.%26atitle%3DIn%2520vitro%2520model%2520of%2520the%2520outer%2520blood%25E2%2588%2592retina%2520barrier%26jtitle%3DBrain%2520Res.%2520Protoc.%26date%3D2004%26volume%3D13%26spage%3D26%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56a"><span><span class="NLM_contrib-group">Kyle, D. J.; Sun, Q.</span><span> </span><span class="NLM_article-title">Preparation of Piperazine Compounds as VR1 Inhibitors</span>. PCT Int. Appl. WO 2005012287,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+J.+Kyle&author=Q.+Sun&title=Preparation+of+Piperazine+Compounds+as+VR1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKyle%26aufirst%3DD.%2BJ.%26atitle%3DPreparation%2520of%2520Piperazine%2520Compounds%2520as%2520VR1%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit56b"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span>, <span class="NLM_elocation-id">198104</span> <span class="citation_source-journal">.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2005%2C+142%2C+198104."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2005%26volume%3D142%26jtitle%3D." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D<sub>3</sub> receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><div class="note"><p class="first last"> and references cited therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm050734s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=358-365&author=M.+Leopoldoauthor=E.+Lacivitaauthor=P.+De+Giorgioauthor=N.+A.+Colabufoauthor=M.+Nisoauthor=F.+Berardiauthor=R.+Perrone&title=Design%2C+synthesis%2C+and+binding+affinities+of+potential+positron+emission+tomography+%28PET%29+ligands+for+visualization+of+brain+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm050734s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050734s%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DDe%2BGiorgio%26aufirst%3DP.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520binding%2520affinities%2520of%2520potential%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520for%2520visualization%2520of%2520brain%2520dopamine%2520D3%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D358%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K. Y.</span><span> </span><span class="NLM_article-title">pH-metric logP11. p<i>K</i><sub>a</sub> detrmination of water-insoluble drugs in organic solvent−water mixtures</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0731-7085%2898%2900235-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=10704132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=631-641&author=A.+Avdeefauthor=K.+J.+Boxauthor=J.+E.+Comerauthor=M.+Gilgesauthor=M.+Hadleyauthor=C.+Hibbertauthor=W.+Pattersonauthor=K.+Y.+Tam&title=pH-metric+logP11.+pKa+detrmination+of+water-insoluble+drugs+in+organic+solvent%E2%88%92water+mixtures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">pH-metric log P 11. pKa determination of water-insoluble drugs in organic solvent-water mixtures</span></div><div class="casAuthors">Avdeef, A.; Box, K. J.; Comer, J. E. A.; Gilges, M.; Hadley, M.; Hibbert, C.; Patterson, W.; Tam, K. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">631-641</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The apparent acid dissocn. consts. (psKa) of two water-insol. drugs, ibuprofen and quinine, were detd. pH-metrically in acetonitrile-water, dimethylformamide-water, dimethylsulfoxide-water, 1,4-dioxane-water, ethanol-water, ethylene glycol-water, methanol-water and tetrahydrofuran-water mixts.  A glass electrode calibration procedure based on a four-parameter equation (pH = α + SpcH + jH[H+] + jOH[OH-]) was used to obtain pH readings based on the concn. scale (pcH).  The authors have called this four-parameter method the Four-Plus technique.  The Yasuda-Shedlovsky extrapolation (psKa + log [H2O] = A/ε + B) was used to derive acid dissocn. consts. in aq. soln. (pKa).  It has been demonstrated that the pKa values extrapolated from such solvent-water mixts. are consistent with each other and with previously reported measurements.  The suggested method has also been applied with success to det. the pKa values of two pyridine derivs. of pharmaceutical interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSvjQ1FZDvALVg90H21EOLACvtfcHk0lgbmrjRDdc16w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCgur4%253D&md5=a2381abfa4b252497a12295e9158a8e7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2898%2900235-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252898%252900235-0%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DComer%26aufirst%3DJ.%2BE.%26aulast%3DGilges%26aufirst%3DM.%26aulast%3DHadley%26aufirst%3DM.%26aulast%3DHibbert%26aufirst%3DC.%26aulast%3DPatterson%26aufirst%3DW.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DpH-metric%2520logP11.%2520pKa%2520detrmination%2520of%2520water-insoluble%2520drugs%2520in%2520organic%2520solvent%25E2%2588%2592water%2520mixtures%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1999%26volume%3D20%26spage%3D631%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Noguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span> </span><span class="NLM_article-title">Automated synthesis of the ultra high specific activity of [<sup>11</sup>C]Ro15-4513 and its application in an extremely low concentration region to an ARG study</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0969-8051%2802%2900422-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=12745025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1Gjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=335-343&author=J.+Noguchiauthor=K.+Suzuki&title=Automated+synthesis+of+the+ultra+high+specific+activity+of+%5B11C%5DRo15-4513+and+its+application+in+an+extremely+low+concentration+region+to+an+ARG+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Automated synthesis of the ultra high specific activity of [11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study</span></div><div class="casAuthors">Noguchi, J.; Suzuki, K.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-343</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We have designed and constructed an automated device for the prodn. of ultra-high specific activity 11C-labeled compds. via [11C]CH3I synthesized by the single pass I2 method.  The optimum condition for the prodn. of [11C]CH3I was detd. to be 630°C for oven-1 (reaction column), 50°C for oven-2 (iodine column) and 50 mL/min for the He gas flow rate, and gave the max. conversion ratio of [11C]CH3I, 44%.  [11C]Ro15-4513, known as an inverse agonist of the benzodiazepine receptor, was produced under optimized conditions.  An i.v. injectable [11C]Ro15-4513 soln. of 1500 ± 490 MBq (n = 6) with specific activity 4700 ± 2500 GBq/μmol and a radiochem. purity of 98.2 ± 2% was obtained automatically within 25 min (from EOB) by irradiating nitrogen gas contg. 5% H2 with 18 MeV protons (14.2 MeV on target) at 20 μA for 20 min.  The highest specific activity of 9700 GBq/μmol (at EOS) could be achieved, although the radiochem. purity was 92.4%.  By the use of the ultra-high specific activity [11C]Ro15-4513, the super high affinity binding sites in the rat brain hippocampus could be clearly visualized even at the extremely low concn. of 0.66 pM Ro15-4513 by in vitro autoradiog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHDHYYHgqT87Vg90H21EOLACvtfcHk0lgbmrjRDdc16w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1Gjsro%253D&md5=3c8561a73ead083e49f08f60b0e8a6a6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900422-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900422-5%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DK.%26atitle%3DAutomated%2520synthesis%2520of%2520the%2520ultra%2520high%2520specific%2520activity%2520of%2520%255B11C%255DRo15-4513%2520and%2520its%2520application%2520in%2520an%2520extremely%2520low%2520concentration%2520region%2520to%2520an%2520ARG%2520study%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D335%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Ericksen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">Ligand selectivity of D<sub>2</sub> dopamine receptors is modulated by changes in local dynamics produced by sodium binding</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1124%2Fjpet.108.141531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=18849360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFymtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=40-54&author=S.+S.+Ericksenauthor=D.+F.+Cummingsauthor=H.+Weinsteinauthor=J.+A.+Schetz&title=Ligand+selectivity+of+D2+dopamine+receptors+is+modulated+by+changes+in+local+dynamics+produced+by+sodium+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand selectivity of D2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding</span></div><div class="casAuthors">Ericksen, Spencer S.; Cummings, David F.; Weinstein, Harel; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-54</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have uncovered a significant allosteric response of the D2 dopamine receptor to physiol. relevant concns. of sodium (140 mM), characterized by a sodium-enhanced binding affinity for a D4-selective class of agonists and antagonists.  This enhancement is significantly more pronounced in a D2-V2.61(91)F mutant and cannot be mimicked by an equiv. concn. of the sodium replacement cation N-methyl-D-glucamine.  This phenomenon was explored computationally at the mol. level by analyzing the effect of sodium binding on the dynamic properties of D2 receptor model constructs.  Normal mode anal. identified one mode (M19), which is involved in the open/closed motions of the binding cleft as being particularly sensitive to the sodium effect.  To examine the consequences for D2 receptor ligand recognition, one of the ligands, L-745,870 [3-{[4-(4-chlorophenyl) piperazin-1-yl]methyl}-1H-pyrrolo[2,3-b]pyridine or CPPMA, chlorophenylpiperazinyl methylazaindole], was docked into conformers along the M19 trajectory.  Structurally and pharmacol. well established ligand-receptor interactions, including the ionic interaction with D3.32(114) and interactions between the ligand aryl moieties and V2.61(91)F, were achieved only in "open" phase conformers.  The docking of (-)-raclopride [3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxybenzamide] suggests that the same binding cleft changes in response to sodium-binding perturbation account as well for the enhancements in binding affinity for substituted benzamides in the wild-type D2 receptor.  Our findings demonstrate how key interactions can be modulated by occupancy at an allosteric site and are consistent with a mechanism in which sodium binding enhances the affinity of selected ligands through dynamic changes that increase accessibility of substituted benzamides and 1,4-DAP ligands to the orthosteric site and accessibility of 1,4-DAPs to V2.61(91)F.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9peW37CIIRLVg90H21EOLACvtfcHk0lgbmrjRDdc16w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFymtw%253D%253D&md5=24298d041694b3fc97bb93a057d53357</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.141531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.141531%26sid%3Dliteratum%253Aachs%26aulast%3DEricksen%26aufirst%3DS.%2BS.%26aulast%3DCummings%26aufirst%3DD.%2BF.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DLigand%2520selectivity%2520of%2520D2%2520dopamine%2520receptors%2520is%2520modulated%2520by%2520changes%2520in%2520local%2520dynamics%2520produced%2520by%2520sodium%2520binding%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D40%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Cummings, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ericksen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">Three amino acids in the D<sub>2</sub> dopamine receptor regulate selective ligand function and affinity</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1111%2Fj.1471-4159.2009.06103.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=19486266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVCmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=45-57&author=D.+F.+Cummingsauthor=S.+S.+Ericksenauthor=J.+A.+Schetz&title=Three+amino+acids+in+the+D2+dopamine+receptor+regulate+selective+ligand+function+and+affinity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity</span></div><div class="casAuthors">Cummings, David F.; Ericksen, Spencer S.; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-57</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The D2 dopamine receptor is an important therapeutic target for the treatment of psychotic, agitated, and abnormal behavioral states.  To better understand the specific interactions of subtype-selective ligands with dopamine receptor subtypes, seven ligands with high selectivity (>120-fold) for the D4 subtype of dopamine receptor were tested on wild-type and mutant D2 receptors.  Five of the selective ligands were obsd. to have 21-fold to 293-fold increases in D2 receptor affinity when three non-conserved amino acids in TM2 and TM3 were mutated to the corresponding D4 amino acids.  The two ligands with the greatest improvement in affinity for the D2 mutant receptor [i.e., 3-([4-(4-iodophenyl) piperazin-1-yl]methyl)-1H-pyrrolo[2,3-b]pyridine (L-750,667) and 1-[4-iodobenzyl]-4-[N-(3-isopropoxy-2-pyridinyl)-N-methyl]- aminopiperidine (RBI-257)] were investigated in functional assays.  Consistent with their higher affinity for the mutant than for the wild-type receptor, concns. of L-750,667 or RBI-257 that produced large redns. in the potency of quinpirole's functional response in the mutant did not significantly reduce quinpirole's functional response in the wild-type D2 receptor.  In contrast to RBI-257 which is an antagonist at all receptors, L-750,667 is a partial agonist at the wild-type D2 but an antagonist at both the mutant D2 and wild-type D4 receptors.  Our study demonstrates for the first time that the TM2/3 microdomain of the D2 dopamine receptor not only regulates the selective affinity of ligands, but in selected cases can also regulate their function.  Utilizing a new docking technique that incorporates receptor backbone flexibility, the three non-conserved amino acids that encompass the TM2/3 microdomain were found to account in large part for the differences in intermol. steric contacts between the ligand and receptors.  Consistent with the exptl. data, this model illustrates the interactions between a variety of subtype-selective ligands and the wild-type D2, mutant D2, or wild-type D4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1abAv4akZELVg90H21EOLACvtfcHk0lhYz8LNLLgnGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVCmt70%253D&md5=d7c49185e1b5bd5451c962f561745bf0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06103.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06103.x%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DD.%2BF.%26aulast%3DEricksen%26aufirst%3DS.%2BS.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DThree%2520amino%2520acids%2520in%2520the%2520D2%2520dopamine%2520receptor%2520regulate%2520selective%2520ligand%2520function%2520and%2520affinity%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D110%26spage%3D45%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Cummings, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canseco, D. C..</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">Synthesis and structure−affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub> receptor subtypes</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4783</span><span class="NLM_x">–</span> <span class="NLM_lpage">4792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4783-4792&author=D.+F.+Cummingsauthor=D.+C..+Cansecoauthor=P.+Shethauthor=J.+E.+Johnsonauthor=J.+A.+Schetz&title=Synthesis+and+structure%E2%88%92affinity+relationships+of+novel+small+molecule+natural+product+derivatives+capable+of+discriminating+between+serotonin+5-HT1A%2C+5-HT2A%2C+5-HT2C+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DD.%2BF.%26aulast%3DCanseco%26aufirst%3DD.%2BC..%26aulast%3DSheth%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DJ.%2BE.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592affinity%2520relationships%2520of%2520novel%2520small%2520molecule%2520natural%2520product%2520derivatives%2520capable%2520of%2520discriminating%2520between%2520serotonin%25205-HT1A%252C%25205-HT2A%252C%25205-HT2C%2520receptor%2520subtypes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4783%26epage%3D4792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Kortagere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D<sub>4</sub> receptor interact with a common receptor microdomain</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1491-1499&author=S.+Kortagereauthor=P.+Gmeinerauthor=H.+Weinsteinauthor=J.+A.+Schetz&title=Certain+1%2C4-disubstituted+aromatic+piperidines+and+piperazines+with+extreme+selectivity+for+the+dopamine+D4+receptor+interact+with+a+common+receptor+microdomain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKortagere%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DCertain%25201%252C4-disubstituted%2520aromatic%2520piperidines%2520and%2520piperazines%2520with%2520extreme%2520selectivity%2520for%2520the%2520dopamine%2520D4%2520receptor%2520interact%2520with%2520a%2520common%2520receptor%2520microdomain%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1491%26epage%3D1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub>i</sub>) and the concentration of inhibitor which causes 50 per cent inhibition (IC<sub>50</sub>) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28IC50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span> </span><span class="NLM_article-title">A high resolution animal PET scanner using compact PS-PMT detectors</span> <span class="citation_source-journal">IEEE Trans. Nucl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1109%2F23.597001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK2sXksVGgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1997&pages=1277-1282&author=M.+Watanabeauthor=H.+Okadaauthor=K.+Shimizuauthor=T.+Omuraauthor=E.+Yoshikawaauthor=T.+Kosugiauthor=S.+Moriauthor=T.+Yamashita&title=A+high+resolution+animal+PET+scanner+using+compact+PS-PMT+detectors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A high resolution animal PET scanner using compact PS-PMT detectors</span></div><div class="casAuthors">Watanabe, M.; Okada, H.; Shimizu, K.; Omura, T.; Yoshikawa, E.; Kosugi, T.; Mori, S.; Yamashita, T.</div><div class="citationInfo"><span class="NLM_cas:title">IEEE Transactions on Nuclear Science</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3, Pt. 2</span>),
    <span class="NLM_cas:pages">1277-1282</span>CODEN:
                <span class="NLM_cas:coden">IETNAE</span>;
        ISSN:<span class="NLM_cas:issn">0018-9499</span>.
    
            (<span class="NLM_cas:orgname">Institute of Electrical and Electronics Engineers</span>)
        </div><div class="casAbstract">A new high resoln. PET scanner dedicated to animal studies has been designed, built and tested.  The system utilizes 240 block detectors, each of which consists of a new compact position-sensitive photomultiplier tube (PS-PMT) and an 8 × 4 BGO array.  A total no. of 7,680 crystals (480 per ring) are positioned to form a 508 mm diam. of 16 detector rings with 7.2 mm pitch and 114 mm axial field of view (FOV).  The system is designed to perform activation studies using a monkey in a sitting position.  The data can be acquired in either 2D or 3D mode, where the slice collimators are retracted in 3D mode.  The transaxial resoln. is 2.6 mm FWHM at the center of the FOV, and the av. axial resoln. on the axis of the ring is 3.3 mm FWHM in the direct slice and 3.2 mm FWHM in the cross slice.  The scatter fraction, sensitivity and count rate performance were evaluated for a 10 cm diam. cylindrical phantom.  The total system sensitivity is 2.3 kcps/kBq/mL in 2D mode and 22.8 kcps/kBq/mL in 3D mode.  The noise equiv. count rate with 3D mode is equiv. to that with 2D mode at five times higher radioactivity level.  The applicable imaging capabilities of the scanner was demonstrated by animal studies with a monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxacjiYl3SbVg90H21EOLACvtfcHk0lhYz8LNLLgnGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksVGgsrw%253D&md5=b05b207b02cc08181901d2712b31952b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1109%2F23.597001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1109%252F23.597001%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DH.%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DOmura%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DE.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DT.%26atitle%3DA%2520high%2520resolution%2520animal%2520PET%2520scanner%2520using%2520compact%2520PS-PMT%2520detectors%26jtitle%3DIEEE%2520Trans.%2520Nucl.%2520Sci.%26date%3D1997%26volume%3D44%26spage%3D1277%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hojo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span> </span><span class="NLM_article-title">Visualization of α5 subunit of GABA<sub>A</sub>/benzodiazepine receptor by [<sup>11</sup>C]Ro15-4513 using positron emission tomography</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2003&pages=200-208&author=J.+Maedaauthor=T.+Suharaauthor=K.+Kawabeauthor=T.+Okauchiauthor=S.+Obayashiauthor=J.+Hojoauthor=K.+Suzuki&title=Visualization+of+%CE%B15+subunit+of+GABAA%2Fbenzodiazepine+receptor+by+%5B11C%5DRo15-4513+using+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DKawabe%26aufirst%3DK.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DObayashi%26aufirst%3DS.%26aulast%3DHojo%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DK.%26atitle%3DVisualization%2520of%2520%25CE%25B15%2520subunit%2520of%2520GABAA%252Fbenzodiazepine%2520receptor%2520by%2520%255B11C%255DRo15-4513%2520using%2520positron%2520emission%2520tomography%26jtitle%3DSynapse%26date%3D2003%26volume%3D47%26spage%3D200%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55a'],'ref56':['cit56a','cit56b'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "><span class="perennialReviewAddition">Na</span><span class="perennialReviewAddition">Ye</span></span>, <span class="hlFld-ContribAuthor ">John L.  Neumeyer</span>, <span class="hlFld-ContribAuthor ">Ross J.  Baldessarini</span>, <span class="hlFld-ContribAuthor "><span class="perennialReviewAddition">Xuechu</span><span class="perennialReviewAddition">Zhen</span></span>, and <span class="hlFld-ContribAuthor ">Ao  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2013,</strong> <em>113 </em>
                                    (5)
                                     , PR123-PR178. <a href="https://doi.org/10.1021/cr300113a" title="DOI URL">https://doi.org/10.1021/cr300113a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr300113a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr300113a%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DUpdate%252B1%252Bof%25253A%252BRecent%252BProgress%252Bin%252BDevelopment%252Bof%252BDopamine%252BReceptor%252BSubtype-Selective%252BAgents%25253A%252BPotential%252BTherapeutics%252Bfor%252BNeurological%252Band%252BPsychiatric%252BDisorders%26aulast%3DYe%26aufirst%3DNa%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D16032012%26date%3D08052013%26volume%3D113%26issue%3D5%26spage%3DPR123%26epage%3DPR178%3Cspan+class%3D%22perennialReviewAddition%22%3E%3C%2Fspan%3E%3Cspan+class%3D%22perennialReviewAddition%22%3E%3C%2Fspan%3E%3Cspan+class%3D%22perennialReviewAddition%22%3E%3C%2Fspan%3E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Booij</span>, <span class="hlFld-ContribAuthor ">Jan-Peter  van Wieringen</span>, <span class="hlFld-ContribAuthor ">Elsmarieke  van de Giessen</span>, <span class="hlFld-ContribAuthor ">Remco J. J.  Knol</span>, <span class="hlFld-ContribAuthor ">Sjoerd J.  Finnema</span>. </span><span class="cited-content_cbyCitation_article-title">PET and SPECT Imaging of the Central Dopamine System in Humans. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 295-318. <a href="https://doi.org/10.1007/978-3-030-53176-8_11" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_11%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252Band%252BSPECT%252BImaging%252Bof%252Bthe%252BCentral%252BDopamine%252BSystem%252Bin%252BHumans%26aulast%3DBooij%26aufirst%3DJan%26date%3D2021%26date%3D2020%26spage%3D295%26epage%3D318%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Mercier</span>, <span class="hlFld-ContribAuthor ">L.  Provins</span>, <span class="hlFld-ContribAuthor ">J.  Hannestad</span>. </span><span class="cited-content_cbyCitation_article-title">Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 20-64. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12437-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12437-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12437-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12437-0%26sid%3Dliteratum%253Aachs%26atitle%3DProgress%252Band%252BChallenges%252Bin%252Bthe%252BDevelopment%252Bof%252BPET%252BLigands%252Bto%252BAid%252BCNS%252BDrug%252BDiscovery%26aulast%3DMercier%26aufirst%3DJ.%26date%3D2017%26spage%3D20%26epage%3D64%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Gu-Cai</span>, <span class="hlFld-ContribAuthor ">Zhang  Ru</span>, <span class="hlFld-ContribAuthor ">Xia  Jiao-yun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and
              in vitro
              evaluation of no-carrier-added 2-(3-(4-(4-[
              18
              F]fluorobenzyl)piperazin-1-yl)propyl)benzo[d]thiazole, a potential dopamine D
              4
              receptor radioligand. </span><span class="cited-content_cbyCitation_journal-name">Radiochimica Acta</span><span> <strong>2016,</strong> <em>104 </em>
                                    (12)
                                     , 897-903. <a href="https://doi.org/10.1515/ract-2016-2597" title="DOI URL">https://doi.org/10.1515/ract-2016-2597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/ract-2016-2597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fract-2016-2597%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiochimica%2520Acta%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252Bno-carrier-added%252B2-%2525283-%2525284-%2525284-%25255B%252B18%252BF%25255Dfluorobenzyl%252529piperazin-1-yl%252529propyl%252529benzo%25255Bd%25255Dthiazole%25252C%252Ba%252Bpotential%252Bdopamine%252BD%252B4%252Breceptor%252Bradioligand%26aulast%3DGu-Cai%26aufirst%3DLi%26date%3D2016%26date%3D2016%26volume%3D104%26issue%3D12%26spage%3D897%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Pérez-Fernández</span>, <span class="hlFld-ContribAuthor ">Manuel  Megías</span>, <span class="hlFld-ContribAuthor ">Manuel A.  Pombal</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of a Novel D4 Dopamine Receptor in the Lamprey Brain. Evolutionary Considerations about Dopamine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroanatomy</span><span> <strong>2016,</strong> <em>9 </em><a href="https://doi.org/10.3389/fnana.2015.00165" title="DOI URL">https://doi.org/10.3389/fnana.2015.00165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnana.2015.00165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnana.2015.00165%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroanatomy%26atitle%3DExpression%252Bof%252Ba%252BNovel%252BD4%252BDopamine%252BReceptor%252Bin%252Bthe%252BLamprey%252BBrain.%252BEvolutionary%252BConsiderations%252Babout%252BDopamine%252BReceptors%26aulast%3DP%25C3%25A9rez-Fern%25C3%25A1ndez%26aufirst%3DJuan%26date%3D2016%26date%3D2016%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Svetlana V.  Selivanova</span>, <span class="hlFld-ContribAuthor ">Adrienne  Müller</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">John A.  Schetz</span>, <span class="hlFld-ContribAuthor ">Simon M.  Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro
              and
              In Vivo
              Evaluation of
              N
              -{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[
              11
              C]methoxybenz­amide, a Positron Emission Tomography (PET) Radioligand for Dopamine D
              4
              Receptors, in Rodents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2014,</strong> <em>11 </em>
                                    (9)
                                     , 1298-1308. <a href="https://doi.org/10.1002/cbdv.201400178" title="DOI URL">https://doi.org/10.1002/cbdv.201400178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201400178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201400178%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DIn%252BVitro%252Band%252BIn%252BVivo%252BEvaluation%252Bof%252BN%252B-%25257B2-%25255B4-%2525283-Cyanopyridin-2-yl%252529piperazin-1-yl%25255Dethyl%25257D-3-%25255B%252B11%252BC%25255Dmethoxybenz%2525C2%2525ADamide%25252C%252Ba%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BRadioligand%252Bfor%252BDopamine%252BD%252B4%252BReceptors%25252C%252Bin%252BRodents%26aulast%3DLeopoldo%26aufirst%3DMarcello%26date%3D2014%26date%3D2014%26volume%3D11%26issue%3D9%26spage%3D1298%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Hanne D.  Hansen</span>, <span class="hlFld-ContribAuthor ">Pantaleo  Di Pilato</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Lehel</span>, <span class="hlFld-ContribAuthor ">Anders  Ettrup</span>, <span class="hlFld-ContribAuthor ">Lisa  Montenegro</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>, <span class="hlFld-ContribAuthor ">Francesco  Berardi</span>, <span class="hlFld-ContribAuthor ">Nicola A.  Colabufo</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT7 receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (5)
                                     , 1736-1750. <a href="https://doi.org/10.1016/j.bmc.2014.01.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bradiolabeling%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252Bpotential%252Bpositron%252Bemission%252Btomography%252B%252528PET%252529%252Bradioligands%252Bfor%252Bbrain%252Bimaging%252Bof%252Bthe%252B5-HT7%252Breceptor%26aulast%3DLacivita%26aufirst%3DEnza%26date%3D2014%26volume%3D22%26issue%3D5%26spage%3D1736%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Paola  De Giorgio</span>, <span class="hlFld-ContribAuthor ">Nicola A.  Colabufo</span>, <span class="hlFld-ContribAuthor ">Francesco  Berardi</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Lipophilic Properties, and Binding Affinities of Potential Ligands in Positron Emission Tomography (PET) for Visualization of Brain Dopamine D
              4
              Receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2014,</strong> <em>11 </em>
                                    (2)
                                     , 299-310. <a href="https://doi.org/10.1002/cbdv.201300194" title="DOI URL">https://doi.org/10.1002/cbdv.201300194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201300194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201300194%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BLipophilic%252BProperties%25252C%252Band%252BBinding%252BAffinities%252Bof%252BPotential%252BLigands%252Bin%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252Bfor%252BVisualization%252Bof%252BBrain%252BDopamine%252BD%252B4%252BReceptors%26aulast%3DLacivita%26aufirst%3DEnza%26date%3D2014%26date%3D2014%26volume%3D11%26issue%3D2%26spage%3D299%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Booij</span>, <span class="hlFld-ContribAuthor ">Jan-Peter  van Wieringen</span>, <span class="hlFld-ContribAuthor ">Elsmarieke  van de Giessen</span>, <span class="hlFld-ContribAuthor ">Remco J. J.  Knol</span>, <span class="hlFld-ContribAuthor ">Sjoerd J.  Finnema</span>. </span><span class="cited-content_cbyCitation_article-title">PET and SPECT Imaging of the Central Dopamine System in Humans. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 229-248. <a href="https://doi.org/10.1007/978-3-642-42014-6_10" title="DOI URL">https://doi.org/10.1007/978-3-642-42014-6_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-42014-6_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-42014-6_10%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252Band%252BSPECT%252BImaging%252Bof%252Bthe%252BCentral%252BDopamine%252BSystem%252Bin%252BHumans%26aulast%3DBooij%26aufirst%3DJan%26date%3D2014%26date%3D2014%26spage%3D229%26epage%3D248%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2014%26volume%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael B  Gatch</span>, <span class="hlFld-ContribAuthor ">Alexey  Kozlenkov</span>, <span class="hlFld-ContribAuthor ">Ren-Qi  Huang</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Yang</span>, <span class="hlFld-ContribAuthor ">Jacques D  Nguyen</span>, <span class="hlFld-ContribAuthor ">Javier  González-Maeso</span>, <span class="hlFld-ContribAuthor ">Kenner C  Rice</span>, <span class="hlFld-ContribAuthor ">Charles P  France</span>, <span class="hlFld-ContribAuthor ">Glenn H  Dillon</span>, <span class="hlFld-ContribAuthor ">Michael J  Forster</span>, <span class="hlFld-ContribAuthor ">John A  Schetz</span>. </span><span class="cited-content_cbyCitation_article-title">The HIV Antiretroviral Drug Efavirenz has LSD-Like Properties. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2013,</strong> <em>38 </em>
                                    (12)
                                     , 2373-2384. <a href="https://doi.org/10.1038/npp.2013.135" title="DOI URL">https://doi.org/10.1038/npp.2013.135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/npp.2013.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnpp.2013.135%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DThe%252BHIV%252BAntiretroviral%252BDrug%252BEfavirenz%252Bhas%252BLSD-Like%252BProperties%26aulast%3DGatch%26aufirst%3DMichael%2BB%26date%3D2013%26date%3D2013%26volume%3D38%26issue%3D12%26spage%3D2373%26epage%3D2384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olaf  Prante</span>, <span class="hlFld-ContribAuthor ">Simone  Maschauer</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Banerjee</span>. </span><span class="cited-content_cbyCitation_article-title">Radioligands for the dopamine receptor subtypes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2013,</strong> <em>56 </em>
                                    (3-4)
                                     , 130-148. <a href="https://doi.org/10.1002/jlcr.3000" title="DOI URL">https://doi.org/10.1002/jlcr.3000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3000%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DRadioligands%252Bfor%252Bthe%252Bdopamine%252Breceptor%252Bsubtypes%26aulast%3DPrante%26aufirst%3DOlaf%26date%3D2013%26date%3D2013%26volume%3D56%26issue%3D3-4%26spage%3D130%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Representative Selective Dopamine D<sub>4</sub> Receptor Ligands</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (A) 2-chloroethanol or 2-bromoethanol, K<sub>2</sub>CO<sub>3</sub>; (B) phthalimide, Ph<sub>3</sub>P, DEAD; (C) (i) hydrazine hydrate, (ii) conc HCl; (D) chloroacetonitrile, K<sub>2</sub>CO<sub>3</sub>; (E) borane−methyl sufide complex; (F) 3-methoxy- or 4-fluorobenzoic acid, CDI.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compounds <b>7</b> and <b>13</b> are agonists of the cloned D<sub>4</sub> dopamine receptor as determined by G<sub>i/o</sub>-mediated changes in intracellular cAMP. The D<sub>4</sub>-selective antagonist spiperone, the D<sub>4</sub>-selective agonist PD168,077, the D<sub>2</sub>-like agonist (−)-quinpirole, and dopamine are shown for comparison.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (A) 3-hydroxybenzoic acid, CDI; (B) [<sup>11</sup>C]CH<sub>3</sub>I, NaOH.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time−activity curves of [<sup>11</sup>C]<b>7</b> in seven CNS regions for 90 min in rhesus monkey.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/medium/jm-2010-00925m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PET imaging in rhesus monkey with [<sup>11</sup>C]<b>7</b> reveals time dependent and saturable binding that is most intense in the posterior regions of the eye. Importantly, there is an intense signal in the region of the retina with little or no background signal in other parts of the CNS. Note different scales used to capture data for retina and brain. Mean images of [<sup>11</sup>C]<b>7</b> from 30 to 90 min after ligand injection are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100925m/production/images/large/jm-2010-00925m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100925m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 66 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Van Tol, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunahara, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Cloning of the gene for a human dopamine D<sub>4</sub> receptor with high affinity for the antipsychotic clozapine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2F350610a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=1840645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK38XhsV2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1991&pages=610-614&author=H.+H.+Van+Tolauthor=J.+R.+Bunzowauthor=H.+C.+Guanauthor=R.+K.+Sunaharaauthor=P.+Seemanauthor=H.+B.+Niznikauthor=O.+Civelli&title=Cloning+of+the+gene+for+a+human+dopamine+D4+receptor+with+high+affinity+for+the+antipsychotic+clozapine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</span></div><div class="casAuthors">Van Tol, Hubert H. M.; Bunzow, James R.; Guan, Hong Chang; Sunahara, Roger K.; Seeman, Philip; Niznik, Hyman B.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6319</span>),
    <span class="NLM_cas:pages">610-14</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The cloning of a gene that encodes a clozapine-sensitive dopamine receptor, D4 is reported.  The D4 receptor gene has high homol. to the human dopamine D2 and D3 receptor genes.  The pharmacol. characteristics of this receptor resemble those of the D2 and D3 receptors, but its affinity for clozapine is one order of magnitude higher.  Recognition and characterization of this clozapine neuroleptic site may prove useful in the design of new types of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpneU9aH4jnoLVg90H21EOLACvtfcHk0ljC62G34n3Pkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsV2n&md5=de5f7ade54d85f54181c53d15d6af169</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F350610a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F350610a0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGuan%26aufirst%3DH.%2BC.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DCloning%2520of%2520the%2520gene%2520for%2520a%2520human%2520dopamine%2520D4%2520receptor%2520with%2520high%2520affinity%2520for%2520the%2520antipsychotic%2520clozapine%26jtitle%3DNature%26date%3D1991%26volume%3D350%26spage%3D610%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lahti, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figur, L. M.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> versus D<sub>2</sub> receptor selectivity of dopamine receptor antagonists: possible therapeutic implications</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2F0014-2999%2893%2990488-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=8102973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK3sXltVyrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1993&pages=483-486&author=R.+A.+Lahtiauthor=D.+L.+Evansauthor=N.+C.+Stratmanauthor=L.+M.+Figur&title=Dopamine+D4+versus+D2+receptor+selectivity+of+dopamine+receptor+antagonists%3A+possible+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: Possible therapeutic implications</span></div><div class="casAuthors">Lahti, Robert A.; Evans, Dawna L.; Stratman, Nancy C.; Figur, Lana M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">483-6</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The dopamine D4 receptor, which is considered a close variant of the dopamine D2 receptor, has recently been cloned.  Receptor binding studies demonstrated that clozapine, which is an effective antipsychotic agent but atypical in that it lacks the usual side effects of other antipsychotic agents, has high selectivity for the dopamine D4 receptor vs. the dopamine D2 receptor.  Comparative binding affinity studies have been carried out for a no. of interesting dopaminergic agents using membranes prepd. from cloned dopamine D2 and D4 receptor contg. cells.  It was found that clozapine is selective for the dopamine D4 vs. the D2 receptor by a factor of 2.8.  Other compds. with dopamine D4 receptor selectivity were (+)-apomorphine (8.7), (+)-N-propylnorapomorphine (NPA) (2.4) and melperone (1.3).  Compds. with considerable selectivity for the dopamine D2 receptor were haloperidol (0.31), chlorpromazine (0.084), trifluoperazine (0.034) and raclopride (0.001).  Overall, the results with the antipsychotic agents tested, support the concept that dopamine D4 receptor selectivity may confer clozapine-like antipsychotic efficacy and furthermore that dopamine D2 receptor selectivity may confer side effect liability (extrapyramidal side effects and tardive dyskinesia).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSanftB8vEaLVg90H21EOLACvtfcHk0ljC62G34n3Pkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltVyrtb4%253D&md5=4a44bcdae05b03355ef71a8f6278f7fb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990488-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990488-4%26sid%3Dliteratum%253Aachs%26aulast%3DLahti%26aufirst%3DR.%2BA.%26aulast%3DEvans%26aufirst%3DD.%2BL.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DFigur%26aufirst%3DL.%2BM.%26atitle%3DDopamine%2520D4%2520versus%2520D2%2520receptor%2520selectivity%2520of%2520dopamine%2520receptor%2520antagonists%253A%2520possible%2520therapeutic%2520implications%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D236%26spage%3D483%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardessarini, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarazi, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumeyer, J. L.</span><span> </span><span class="NLM_article-title">Selective dopamine D<sub>4</sub> receptor antagonists: review of structure−activity relationships</span> <span class="citation_source-journal">Curr. Med. Chem.: Cent. Nerv. Syst. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.2174%2F1568015023357914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslKlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=259-274&author=K.+Zhangauthor=R.+J.+Bardessariniauthor=F.+I.+Taraziauthor=J.+L.+Neumeyer&title=Selective+dopamine+D4+receptor+antagonists%3A+review+of+structure%E2%88%92activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Selective dopamine D4 receptor antagonists: Review of structure-activity relationships</span></div><div class="casAuthors">Zhang, Kehong; Baldessarini, Ross J.; Tarazi, Frank I.; Neumeyer, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Central Nervous System Agents</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-274</span>CODEN:
                <span class="NLM_cas:coden">CMCCCO</span>;
        ISSN:<span class="NLM_cas:issn">1568-0150</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cloned in 1991, the human dopamine D4 receptor is found mainly in cortical and limbic areas of brain.  Many chem. dissimilar D4 receptor-selective antagonists have been developed, initially stimulated by partial D4 receptor-selectivity of the clin. superior antipsychotic agent clozapine.  Implication of D4 receptor in the pathophysiol. or treatment of idiopathic psychotic disorders, however, remains elusive.  Moreover, L-745,870, a selective D4 antagonist, and fananserin, a mixed antagonist of D4 and 5-HT2 receptors, failed to show antipsychotic efficacy.  Interest in D4 receptor pharmacol. was re-kindled by the 1996 discovery that D4 receptor gene polymorphism is assocd. with attention deficit-hyperactivity disorder (ADHD) and related personality traits.  D4 receptors are also implicated in mood disorders and the actions of psychostimulants.  Development of many chem. dissimilar D4-selective antagonists has contributed to improved understanding of D4 receptor neurobiol.  This review summarizes recent advances in the synthetic chem. of D4 receptor antagonists, and considers selected neuropharmacol. studies suggestive of their potential clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps76M1Nwm1w7Vg90H21EOLACvtfcHk0ljC62G34n3Pkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslKlsL0%253D&md5=24b4ad9f0f6bcf4072582943cc7758ba</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568015023357914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568015023357914%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DBardessarini%26aufirst%3DR.%2BJ.%26aulast%3DTarazi%26aufirst%3DF.%2BI.%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26atitle%3DSelective%2520dopamine%2520D4%2520receptor%2520antagonists%253A%2520review%2520of%2520structure%25E2%2588%2592activity%2520relationships%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Cent.%2520Nerv.%2520Syst.%2520Agents%26date%3D2002%26volume%3D2%26spage%3D259%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bristow, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragan, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saywell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M.</span><span> </span><span class="NLM_article-title">L-745,870, a subtype selective dopamine D<sub>4</sub> receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9400001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1cXis1Cqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=1256-1263&author=L.+J.+Bristowauthor=N.+Collinsonauthor=G.+P.+Cookauthor=N.+Curtisauthor=S.+B.+Freedmanauthor=J.+J.+Kulagowskiauthor=P.+D.+Leesonauthor=S.+Patelauthor=C.+I.+Raganauthor=M.+Ridgillauthor=K.+L.+Saywellauthor=M.+Tricklebank&title=L-745%2C870%2C+a+subtype+selective+dopamine+D4+receptor+antagonist%2C+does+not+exhibit+a+neuroleptic-like+profile+in+rodent+behavioral+tests"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">L-745870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests</span></div><div class="casAuthors">Bristow, Linda J.; Collinson, Neil; Cook, Gina P.; Curtis, Neil; Freedman, Stephen B.; Kulagowski, Janusz J.; Leeson, Paul D.; Patel, Smita; Ragan, C. Ian; Ridgill, Mark; Saywell, Kay L.; Tricklebank, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1256-1263</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">This study examd. the high-affinity, selective dopamine D4 receptor antagonist, L-745870 (3-{[4-(4-chlorophenyl)piperazin-1-yl]methyl}-1H-pyrrolo[2,3-b]pyridine) in rodent behavioral models used to predict antipsychotic potential and side-effect liabilities in humans.  In contrast to the classical neuroleptic, haloperidol, and the atypical neuroleptic, clozapine, L-745870 failed to antagonize amphetamine-induced hyperactivity in mice or impair conditioned avoidance responding in the rat at doses selectively blocking D4 receptors.  Furthermore, L-745870 failed to reverse the deficit in prepulse inhibition of acoustic startle responding induced by the nonselective dopamine D2/3/4 receptor agonist apomorphine, an effect which was abolished in rats pretreated with the D2/3 receptor antagonist, raclopride (0.2 mg/kg s.c.).  L-745870 had no effect on apomorphine-induced stereotypy in the rat but did induce catalepsy in the mouse, albeit at a high dose of 100 mg/kg, which is likely to occupy dopamine D2 receptors in vivo.  High doses also impaired motor performance; in rats L-745870 significantly reduced spontaneous locomotor activity (min. ED = 30 mg/kg) and in mice, L-745870 reduced the time spent on a rotarod revolving at 15 rpm (min. ED = 100 mg/kg).  Altogether these results suggest that dopamine D4 receptor antagonism is not responsible for the ability of clozapine to attenuate amphetamine-induced hyperactivity and conditioned avoidance responding in rodents.  Furthermore, the lack of effect of L-745870 in these behavioral tests is consistent with the inability of the compd. to alleviate psychotic symptoms in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-i7KBCKHpxrVg90H21EOLACvtfcHk0lg9T1ywKRwwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1Cqtg%253D%253D&md5=6fa87b67fd755980d2c41851e444de1b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DCollinson%26aufirst%3DN.%26aulast%3DCook%26aufirst%3DG.%2BP.%26aulast%3DCurtis%26aufirst%3DN.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26aulast%3DRidgill%26aufirst%3DM.%26aulast%3DSaywell%26aufirst%3DK.%2BL.%26aulast%3DTricklebank%26aufirst%3DM.%26atitle%3DL-745%252C870%252C%2520a%2520subtype%2520selective%2520dopamine%2520D4%2520receptor%2520antagonist%252C%2520does%2520not%2520exhibit%2520a%2520neuroleptic-like%2520profile%2520in%2520rodent%2520behavioral%2520tests%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D1256%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kramer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Last, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reines, S. A.</span><span> </span><span class="NLM_article-title">The effects of a selective D<sub>4</sub> dopamine receptor antagonist (L-745,870) in acutely psychotic in patients with schizophrenia. D<sub>4</sub> dopamine antagonist group</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1001%2Farchpsyc.1997.01830180085011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9193198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK2sXksFWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=567-572&author=M.+S.+Kramerauthor=B.+Lastauthor=A.+Getsonauthor=S.+A.+Reines&title=The+effects+of+a+selective+D4+dopamine+receptor+antagonist+%28L-745%2C870%29+in+acutely+psychotic+in+patients+with+schizophrenia.+D4+dopamine+antagonist+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">the effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia</span></div><div class="casAuthors">Kramer, Mark S.; Last, Barbara; Getson, Albert; Reines, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-572</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Based mainly on the selective antagonism of clozapine at D4 compared with D2 dopamine receptors, hopes have run high that a selective D4 dopamine receptor antagonist might improve the pharmacol. treatment of patients with schizophrenia.  We report, to our knowledge, the first multicenter study of the antipsychotic potential of a highly specific D4 dopamine receptor antagonist (ie, L-745,870) in patients with acute schizophrenia.  Thirty-eight acutely psychotic and neuroleptic responsive (by history) newly admitted inpatients with schizophrenia were randomized to 4 wk of double-blind treatment (2:1) with either L-745,870 (n = 26), 15 mg/d, or placebo (n = 12) after 3- to 5-day placebo run-in period.  Overall, a greater percentage of patients receiving L-745,870 compared with patients receiving placebo discontinued the study for insufficient therapeutic response (32% vs 16%).  At the end of 4 wk by last observation carried forward anal., the mean change from baseline to week 4 on the total Brief Psychiatric Rating Scale favored placebo (ie, -8 points [-15% change from baseline] vs -1 point [-2% change from baseline] from placebo vs L-745,870, P = 0.09).  Similar differences in favor of placebo in changes from baseline mean scores were obsd. for the not carried forward anal. on the total Brief Psychiatric Rating Scale (P < 0.03), for not carried forward and last observation carried forward analyses on the sum of selected pos. symptom items of the Brief Psychiatric Rating Scale, and for the Clin. Global Impression anal. (P = 0.03, last observation carried forward).  A greater percentage of patients receiving L-745,870 had scores indicative of some level of worsening (compared with baseline) on the total Brief Psychiatric Rating Scale and the Clin. Global Impressions' Severity of Illness Scale as well as pos. symptoms compared with those receiving placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOzPyP-d8vUrVg90H21EOLACvtfcHk0lg9T1ywKRwwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFWhsLk%253D&md5=1491ce3ea914e3cf85cf4025dd2bd2ba</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1997.01830180085011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1997.01830180085011%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DM.%2BS.%26aulast%3DLast%26aufirst%3DB.%26aulast%3DGetson%26aufirst%3DA.%26aulast%3DReines%26aufirst%3DS.%2BA.%26atitle%3DThe%2520effects%2520of%2520a%2520selective%2520D4%2520dopamine%2520receptor%2520antagonist%2520%2528L-745%252C870%2529%2520in%2520acutely%2520psychotic%2520in%2520patients%2520with%2520schizophrenia.%2520D4%2520dopamine%2520antagonist%2520group%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1997%26volume%3D54%26spage%3D567%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Gazi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobirnac, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danzeisen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schupbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruinvels, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeffter, P.</span><span> </span><span class="NLM_article-title">The agonist activities of the putative antipsychotic agents, L745,870 and U-101958 in HEK293 cells expressing the human dopamine D<sub>4.4</sub> receptor</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2Fsj.bjp.0701921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9692773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1cXksFSntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1998&pages=889-896&author=L.+Gaziauthor=I.+Bobirnacauthor=M.+Danzeisenauthor=E.+Schupbachauthor=A.+T.+Bruinvelsauthor=S.+Geisseauthor=B.+Sommerauthor=D.+Hoyerauthor=M.+Tricklebankauthor=P.+Schoeffter&title=The+agonist+activities+of+the+putative+antipsychotic+agents%2C+L745%2C870+and+U-101958+in+HEK293+cells+expressing+the+human+dopamine+D4.4+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor</span></div><div class="casAuthors">Gazi, L.; Bobirnac, I.; Danzeisen, M.; Schupbach, E.; Bruinvels, A. T.; Geisse, S.; Sommer, B.; Hoyer, D.; Tricklebank, M.; Schoeffter, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">889-896</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Dopamine D4 receptor antagonists are being developed by several pharmaceutical companies as putative novel antipsychotics, possibly with low propensity to side-effects.  Two such compds., L-745,870 and U-101958 have been recently introduced.  The radioligand binding and functional activities of L-745,870 and U-101958 were investigated in human embryonic kidney (HEK)293 cells expressing the human recombinant dopamine D4.4 receptor (HEK293/D4 cells).  [3H]-spiperone binding expts. were performed and inhibition of forskolin-stimulated cAMP accumulation was used as the functional response.  [3H]-spiperone was found to label a homogeneous and saturable population of specific binding sites in HEK293/D4 cell homogenates (Bmax 505±90 fmol mg-1 protein, pKD 9.5±0.1, n=3).  Inhibition of specific [3H]-spiperone binding was obsd. with spiperone (pKi 9.6±0.1, n=3), clozapine (pKi 7.4±0.1, n=4), L-745,870 (pKi 8.5±0.1, n=3) and U-101958 (pKi 8.9±0.1, n=3).  By contrast, raclopride was very weak (pKi<5, n=3).  Dopamine inhibited forskolin-stimulated cAMP accumulation in HEK293/D4 cells in a concn.-dependent fashion (Emax 71±2% inhibition of forskolin-stimulated levels, pEC50 8.7±0.1, n=10).  This effect was mimicked by the dopamine D2-like receptor agonists, quinpirole and 7-hydroxy-2-dipropylaminotetralin (7-OH-DPAT).  L-745,870 and U-101958 also inhibited forskolin-stimulated cAMP accumulation in HEK293/D4 cells in a concn.-dependent way.  L-745,870 was less efficacious than dopamine (71% the efficacy of dopamine), whereas U-101958 behaved as a full agonist compared to dopamine.  Potencies (pEC50) values of L-745,870 and U-101958 were 9.0±0.2 (n=4) and 8.7±0.3 (n=3), consistent with pKi values detd. in radioligand binding studies.  Dopamine, L-745,870 and U-101958 (up to 1 μM) were devoid of effect on forskolin-stimulated cAMP accumulation in control, non-transfected HEK293 cells.  The agonist effects of dopamine, L-745,870 and U-101958 in HEK293/D4 cells could be antagonized by spiperone (pKB 8.2-8.8) and clozapine (pKB 7.1), but not by raclopride (pKB<5).  None of these antagonists had any significant agonist activity at concns. up to 10 μM.  These results show that the putative dopamine D4 receptor antagonists, L-745,870 and U-101958 are not devoid of intrinsic activity at human recombinant dopamine D4.4 receptors.  Therefore, they may not represent the most appropriate drugs for testing the benefit of D4 receptor antagonism in schizophrenic patients, if agonism should translate in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7I9SZhh3SKLVg90H21EOLACvtfcHk0lg9T1ywKRwwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksFSntrw%253D&md5=0912e6b596be02fad5c2bc5038cf8727</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701921%26sid%3Dliteratum%253Aachs%26aulast%3DGazi%26aufirst%3DL.%26aulast%3DBobirnac%26aufirst%3DI.%26aulast%3DDanzeisen%26aufirst%3DM.%26aulast%3DSchupbach%26aufirst%3DE.%26aulast%3DBruinvels%26aufirst%3DA.%2BT.%26aulast%3DGeisse%26aufirst%3DS.%26aulast%3DSommer%26aufirst%3DB.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DTricklebank%26aufirst%3DM.%26aulast%3DSchoeffter%26aufirst%3DP.%26atitle%3DThe%2520agonist%2520activities%2520of%2520the%2520putative%2520antipsychotic%2520agents%252C%2520L745%252C870%2520and%2520U-101958%2520in%2520HEK293%2520cells%2520expressing%2520the%2520human%2520dopamine%2520D4.4%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D124%26spage%3D889%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gazi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozulak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeffter, P.</span><span> </span><span class="NLM_article-title">NGD 94-1 as an agonist at human recombinant dopamine D<sub>4.4</sub> receptors expressed in HEK293 cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">R9</span><span class="NLM_x">–</span> <span class="NLM_lpage">R10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1999&pages=R9-R10&author=L.+Gaziauthor=B.+Sommerauthor=J.+Nozulakauthor=P.+Schoeffter&title=NGD+94-1+as+an+agonist+at+human+recombinant+dopamine+D4.4+receptors+expressed+in+HEK293+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGazi%26aufirst%3DL.%26aulast%3DSommer%26aufirst%3DB.%26aulast%3DNozulak%26aufirst%3DJ.%26aulast%3DSchoeffter%26aufirst%3DP.%26atitle%3DNGD%252094-1%2520as%2520an%2520agonist%2520at%2520human%2520recombinant%2520dopamine%2520D4.4%2520receptors%2520expressed%2520in%2520HEK293%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D372%26spage%3DR9%26epage%3DR10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lober, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Rationally based efficacy tuning of selective dopamine D4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-<i>a</i>]pyridine (FAUC 213)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2691</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm015522j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2691-2694&author=S.+Loberauthor=H.+Hubnerauthor=W.+Utzauthor=P.+Gmeiner&title=Rationally+based+efficacy+tuning+of+selective+dopamine+D4+receptor+ligands+leading+to+the+complete+antagonist+2-%5B4-%284-chlorophenyl%29piperazin-1-ylmethyl%5Dpyrazolo%5B1%2C5-a%5Dpyridine+%28FAUC+213%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm015522j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm015522j%26sid%3Dliteratum%253Aachs%26aulast%3DLober%26aufirst%3DS.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRationally%2520based%2520efficacy%2520tuning%2520of%2520selective%2520dopamine%2520D4%2520receptor%2520ligands%2520leading%2520to%2520the%2520complete%2520antagonist%25202-%255B4-%25284-chlorophenyl%2529piperazin-1-ylmethyl%255Dpyrazolo%255B1%252C5-a%255Dpyridine%2520%2528FAUC%2520213%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2691%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Boeckler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldon, J.</span><span> </span><span class="NLM_article-title">FAUC 213, a highly selective dopamine D<sub>4</sub> receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2004&pages=7-17&author=F.+Boecklerauthor=H.+Russigauthor=W.+Zhangauthor=S.+L%C3%B6berauthor=J.+Schetzauthor=H.+H%C3%BCbnerauthor=B.+Fergerauthor=P.+Gmeinerauthor=J.+Feldon&title=FAUC+213%2C+a+highly+selective+dopamine+D4+receptor+full+antagonist%2C+exhibits+atypical+antipsychotic+properties+in+behavioural+and+neurochemical+models+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckler%26aufirst%3DF.%26aulast%3DRussig%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DSchetz%26aufirst%3DJ.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DFeldon%26aufirst%3DJ.%26atitle%3DFAUC%2520213%252C%2520a%2520highly%2520selective%2520dopamine%2520D4%2520receptor%2520full%2520antagonist%252C%2520exhibits%2520atypical%2520antipsychotic%2520properties%2520in%2520behavioural%2520and%2520neurochemical%2520models%2520of%2520schizophrenia%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D175%26spage%3D7%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Corrigan, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonura, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, K. M.</span><span> </span><span class="NLM_article-title">Effectiveness of the selective D<sub>4</sub> antagonist sonepiprazole in schizophrenia: a placebo-controlled trial. Sonepiprazole study group</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.biopsych.2003.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=15023570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=445-451&author=M.+H.+Corriganauthor=C.+C.+Gallenauthor=M.+L.+Bonuraauthor=K.+M.+Merchant&title=Effectiveness+of+the+selective+D4+antagonist+sonepiprazole+in+schizophrenia%3A+a+placebo-controlled+trial.+Sonepiprazole+study+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial</span></div><div class="casAuthors">Corrigan, Mark H.; Gallen, Christopher C.; Bonura, M. Luisa; Merchant, Kalpana M.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-451</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Selective localization of dopamine D4 receptors in the prefrontal cortex and preferential affinity of clozapine for the dopamine D4 receptor over the D2 receptor led to the hypothesis that the superior efficacy of clozapine may be mediated via blockade of the D4 receptor.  This hypothesis was tested by evaluating sonepiprazole, a selective D4 dopamine antagonist, in schizophrenia patients.  Methods: We treated 467 hospitalized schizophrenia patients with scores of ≥ 60 on the Pos. and Neg. Syndrome Scale (PANSS) with sonepiprazole (U-101387G/ PNU-101387G), olanzapine, or placebo once daily for 6 wk.  The primary efficacy end point was the mean change from baseline in the PANSS total score at 6 wk.  Secondary efficacy end points were the mean change from baseline in the PANSS factor scores, the Brief Psychiatric Rating Scale score, the Clin. Global Impressions Severity of Illness score, and the Calgary Depression Scale score.  Results: No statistically significant differences were obsd. between placebo and any sonepiprazole dose on the primary or any secondary end point after 6 wk of treatment.  Statistically significant differences, favoring olanzapine over placebo, were obsd. on all efficacy end points but the Calgary Depression Scale.  Conclusions: Sonepiprazole was ineffective for the treatment of patients with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltnMZ4pnVarVg90H21EOLACvtfcHk0lj2H54_HC8UoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFCiurw%253D&md5=63a033c1ea77434e18f158a0fa8dd85f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2003.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2003.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCorrigan%26aufirst%3DM.%2BH.%26aulast%3DGallen%26aufirst%3DC.%2BC.%26aulast%3DBonura%26aufirst%3DM.%2BL.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26atitle%3DEffectiveness%2520of%2520the%2520selective%2520D4%2520antagonist%2520sonepiprazole%2520in%2520schizophrenia%253A%2520a%2520placebo-controlled%2520trial.%2520Sonepiprazole%2520study%2520group%26jtitle%3DBiol.%2520Psychiatry%26date%3D2004%26volume%3D55%26spage%3D445%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ebstein, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novick, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umansky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osher, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belmaker, R. H.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor (D<sub>4</sub>DR) exon III polymorphism associated with the human personality trait of novelty seeking</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2Fng0196-78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=8528256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK28XhsV2htw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1996&pages=78-80&author=R.+P.+Ebsteinauthor=O.+Novickauthor=R.+Umanskyauthor=B.+Prielauthor=Y.+Osherauthor=D.+Blaineauthor=E.+R.+Bennettauthor=L.+Nemanovauthor=M.+Katzauthor=R.+H.+Belmaker&title=Dopamine+D4+receptor+%28D4DR%29+exon+III+polymorphism+associated+with+the+human+personality+trait+of+novelty+seeking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking</span></div><div class="casAuthors">Ebstein, Richard P.; Novick, Olga; Umansky, Roberto; Priel, Beatrice; Osher, Yamima; Blaine, Darren; Bennet, , Estelle R.; Nemanov, Lubov; Katz, Miri; Belmaker, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-80</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Higher than av. Novelty Seeking test scores on the tridimensional personality questionnaire in a group of 124 unrelated Israeli subjects were significantly assocd. with a particular exonic polymorphism, the 7-repeat allele in the D4 dopamine receptor gene (D4DR).  The assocn. of high Novelty Seeking and the 7-repeat allele was independent of ethnicity, sex or age of the subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-BzcPKeJjZLVg90H21EOLACvtfcHk0lj2H54_HC8UoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsV2htw%253D%253D&md5=fd30717fb970ae4474a29aa6b9b840ad</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fng0196-78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0196-78%26sid%3Dliteratum%253Aachs%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26aulast%3DNovick%26aufirst%3DO.%26aulast%3DUmansky%26aufirst%3DR.%26aulast%3DPriel%26aufirst%3DB.%26aulast%3DOsher%26aufirst%3DY.%26aulast%3DBlaine%26aufirst%3DD.%26aulast%3DBennett%26aufirst%3DE.%2BR.%26aulast%3DNemanov%26aufirst%3DL.%26aulast%3DKatz%26aufirst%3DM.%26aulast%3DBelmaker%26aufirst%3DR.%2BH.%26atitle%3DDopamine%2520D4%2520receptor%2520%2528D4DR%2529%2520exon%2520III%2520polymorphism%2520associated%2520with%2520the%2520human%2520personality%2520trait%2520of%2520novelty%2520seeking%26jtitle%3DNat.%2520Genet.%26date%3D1996%26volume%3D12%26spage%3D78%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ebstein, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjamin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belmaker, R. H.</span><span> </span><span class="NLM_article-title">Personality and polymorphisms of genes involved in aminergic neurotransmission</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0014-2999%2800%2900852-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11134670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFKjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2000&pages=205-214&author=R.+P.+Ebsteinauthor=J.+Benjaminauthor=R.+H.+Belmaker&title=Personality+and+polymorphisms+of+genes+involved+in+aminergic+neurotransmission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Personality and polymorphisms of genes involved in aminergic neurotransmission</span></div><div class="casAuthors">Ebstein, R. P.; Benjamin, J.; Belmaker, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with ∼120 refs.  Genetic factors significantly contribute to the detn. of human personality traits assessed by self-report questionnaires.  However, only in the past few years have common genetic polymorphisms esp. the dopamine D4 receptor and the serotonin transporter promoter region been assocd. with specific personality traits such as novelty seeking and harm avoidance, resp.  The effects of these genes are modest and several genes are likely accounting for individual differences in personality dimensions that can be attributed to genetic factors.  Mol. genetic studies of adult personality have also been extended to investigations of early human temperament and some of the genes assocd. with adult personality traits are also contributing to the earliest developmental expressions of human behavior.  Addnl., some of these same genes have also been implicated in various types of abnormal behavior including addiction, obsessive-compulsive disorder, attention deficit, depression, aggression and psychosis.  Future research directions will no doubt take advantage of the bioinformatics revolution coinciding with the completion of the first phase of the human genome project.  It should soon be possible to identify many of the genes contributing to specific personality traits and to better define their role in detg. normal and abnormal behavior from early development through adulthood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp604dZVgrZDbVg90H21EOLACvtfcHk0lhF9E87VdZnzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFKjuro%253D&md5=574c38e41802105d7c62c60f75b7e009</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900852-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900852-9%26sid%3Dliteratum%253Aachs%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26aulast%3DBenjamin%26aufirst%3DJ.%26aulast%3DBelmaker%26aufirst%3DR.%2BH.%26atitle%3DPersonality%2520and%2520polymorphisms%2520of%2520genes%2520involved%2520in%2520aminergic%2520neurotransmission%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D410%26spage%3D205%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Dulawa, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulus, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M. A.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor-knock-out mice exhibit reduced exploration of novel stimuli</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">9550</span><span class="NLM_x">–</span> <span class="NLM_lpage">9556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1523%2FJNEUROSCI.19-21-09550.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=10531457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=9550-9556&author=S.+C.+Dulawaauthor=D.+K.+Grandyauthor=M.+J.+Lowauthor=M.+P.+Paulusauthor=M.+A.+Geyer&title=Dopamine+D4+receptor-knock-out+mice+exhibit+reduced+exploration+of+novel+stimuli"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli</span></div><div class="casAuthors">Dulawa, Stephanie C.; Grandy, David K.; Low, Malcolm J.; Paulus, Martin P.; Geyer, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9550-9556</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The involvement of dopamine neurotransmission in behavioral responses to novelty is suggested by reports that reward is related to increased dopamine activity, that dopamine modulates exploratory behavior in animals, and that Parkinson's disease patients report diminished responses to novelty.  Some studies have reported that polymorphisms of the human dopamine D4 receptor (D4R) gene are assocd. with personality inventory measures of the trait called "novelty-seeking".  To explore a potential role for the D4R in behavioral responses to novelty, the authors evaluated D4R-knock-out (D4R-/-) and wild-type (D4R+/+) mice in three approach-avoidance paradigms: the open field, emergence, and novel object tests.  These three paradigms differ in the degree to which they elicit approach, or exploratory behavior, and avoidance, or anxiety-related behavior.  Thus, the authors used these three tests to det. whether the D4R primarily influences the exploratory or the anxious component of responses to approach-avoidance conflicts.  D4R-/- mice were significantly less behaviorally responsive to novelty than D4R+/+ mice in all three tests.  The largest phenotypic differences were obsd. in the novel object test, which maximizes approach behavior, and the smallest phenotypic differences were found in the open field test, which maximizes avoidance behavior.  Hence, D4R-/- mice exhibit redns. in behavioral responses to novelty, reflecting a decrease in novelty-related exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2jXdkLWYVlLVg90H21EOLACvtfcHk0lhF9E87VdZnzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyhsrs%253D&md5=e1add51d912b10438d34b921cfa2cbf9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-21-09550.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-21-09550.1999%26sid%3Dliteratum%253Aachs%26aulast%3DDulawa%26aufirst%3DS.%2BC.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DLow%26aufirst%3DM.%2BJ.%26aulast%3DPaulus%26aufirst%3DM.%2BP.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26atitle%3DDopamine%2520D4%2520receptor-knock-out%2520mice%2520exhibit%2520reduced%2520exploration%2520of%2520novel%2520stimuli%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D9550%26epage%3D9556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Powell, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulus, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M. A.</span><span> </span><span class="NLM_article-title">RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=473-481&author=S.+B.+Powellauthor=M.+P.+Paulusauthor=D.+S.+Hartmanauthor=T.+Godelauthor=M.+A.+Geyer&title=RO-10-5824+is+a+selective+dopamine+D4+receptor+agonist+that+increases+novel+object+exploration+in+C57+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DS.%2BB.%26aulast%3DPaulus%26aufirst%3DM.%2BP.%26aulast%3DHartman%26aufirst%3DD.%2BS.%26aulast%3DGodel%26aufirst%3DT.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26atitle%3DRO-10-5824%2520is%2520a%2520selective%2520dopamine%2520D4%2520receptor%2520agonist%2520that%2520increases%2520novel%2520object%2520exploration%2520in%2520C57%2520mice%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D44%26spage%3D473%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Faraone, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biederman, J.</span><span> </span><span class="NLM_article-title">Meta-analysis of the association between the 7-repeat allele of the dopamine D<sub>4</sub> receptor gene and attention deficit hyperactivity disorder</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1176%2Fappi.ajp.158.7.1052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11431226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD3MznsVegtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=1052-1057&author=S.+V.+Faraoneauthor=A.+E.+Doyleauthor=E.+Mickauthor=J.+Biederman&title=Meta-analysis+of+the+association+between+the+7-repeat+allele+of+the+dopamine+D4+receptor+gene+and+attention+deficit+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder</span></div><div class="casAuthors">Faraone S V; Doyle A E; Mick E; Biederman J</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1052-7</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Family, twin, and adoption studies show attention deficit hyperactivity disorder (ADHD) to have a substantial genetic component.  Although several studies have shown an association between ADHD and the 7-repeat allele of the dopamine D(4) receptor gene (DRD4), several studies have not.  Thus, the status of the ADHD-DRD4 association is uncertain.  METHOD:  Meta-analysis was applied to case-control and family-based studies of the association between ADHD and DRD4 to assess the joint evidence for the association, the influence of individual studies, and evidence for publication bias.  RESULTS:  For both the case-control and family-based studies, the authors found 1) support for the association between ADHD and DRD4, 2) no evidence that this association was accounted for by any one study, and 3) no evidence for publication bias.  CONCLUSIONS:  Although the association between ADHD and DRD4 is small, these results suggest that it is real.  Further studies are needed to clarify what variant of DRD4 (or some nearby gene) accounts for this association.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcx_1FDHwS4RLDWw4HIq2sfW6udTcc2eYPVZWPnqajL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MznsVegtw%253D%253D&md5=1b494e0b3597559b6fe0ca3e905d0be3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.158.7.1052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.158.7.1052%26sid%3Dliteratum%253Aachs%26aulast%3DFaraone%26aufirst%3DS.%2BV.%26aulast%3DDoyle%26aufirst%3DA.%2BE.%26aulast%3DMick%26aufirst%3DE.%26aulast%3DBiederman%26aufirst%3DJ.%26atitle%3DMeta-analysis%2520of%2520the%2520association%2520between%2520the%25207-repeat%2520allele%2520of%2520the%2520dopamine%2520D4%2520receptor%2520gene%2520and%2520attention%2520deficit%2520hyperactivity%2520disorder%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2001%26volume%3D158%26spage%3D1052%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Grady, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flodman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyzis, R. K.</span><span> </span><span class="NLM_article-title">High prevalence of rare dopamine receptor D<sub>4</sub> alleles in children diagnosed with attention-deficit hyperactivity disorder</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2Fsj.mp.4001350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=12808433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFKmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=536-545&author=D.+L.+Gradyauthor=H.+C.+Chiauthor=Y.+C.+Dingauthor=M.+Smithauthor=E.+Wangauthor=S.+Schuckauthor=P.+Flodmanauthor=M.+A.+Spenceauthor=J.+M.+Swansonauthor=R.+K.+Moyzis&title=High+prevalence+of+rare+dopamine+receptor+D4+alleles+in+children+diagnosed+with+attention-deficit+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder</span></div><div class="casAuthors">Grady, D. L.; Chi, H.-C.; Ding, Y-C.; Smith, M.; Wang, E.; Schuck, S.; Flodman, P.; Spence, M. A.; Swanson, J. M.; Moyzis, R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">536-545</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Assocns. have been reported of the 7-repeat (7R) allele of the human dopamine receptor D4 (DRD4) gene with both the personality trait of novelty seeking and attention-deficit/hyperactivity disorder (ADHD).  The increased prevalence of the 7R allele in ADHD probands is consistent with the common variant-common disorder hypothesis, which proposes that the high frequency of many complex genetic disorders is related to common DNA variants.  Recently, based on the unusual DNA sequence organization and strong linkage disequil. surrounding the DRD4 7R allele, we proposed that this allele originated as a rare mutational event, which nevertheless increased to high prevalence in human populations by pos. selection.  We have now detd., by DNA resequencing of 250 DRD4 alleles obtained from 132 ADHD probands, that most ADHD 7R alleles are of the conserved haplotype found in our previous 600 allele worldwide DNA sample.  Interestingly, however, half of the 24 haplotypes uncovered in ADHD probands were novel (not one of the 56 haplotypes found in our prior population studies).  Over 10 percent of the ADHD probands had these novel haplotypes, most of which were 7R allele derived.  The probability that this high incidence of novel alleles occurred by chance in our ADHD sample is much less than 0.0001.  These results suggest that allelic heterogeneity at the DRD4 locus may also contribute to the obsd. assocn. with ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnIXh9LNwhFrVg90H21EOLACvtfcHk0liH6ory1duQdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFKmu74%253D&md5=146c5543c239583d2d1c25b7ad1791ae</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001350%26sid%3Dliteratum%253Aachs%26aulast%3DGrady%26aufirst%3DD.%2BL.%26aulast%3DChi%26aufirst%3DH.%2BC.%26aulast%3DDing%26aufirst%3DY.%2BC.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DSchuck%26aufirst%3DS.%26aulast%3DFlodman%26aufirst%3DP.%26aulast%3DSpence%26aufirst%3DM.%2BA.%26aulast%3DSwanson%26aufirst%3DJ.%2BM.%26aulast%3DMoyzis%26aufirst%3DR.%2BK.%26atitle%3DHigh%2520prevalence%2520of%2520rare%2520dopamine%2520receptor%2520D4%2520alleles%2520in%2520children%2520diagnosed%2520with%2520attention-deficit%2520hyperactivity%2520disorder%26jtitle%3DMol.%2520Psychiatry%26date%3D2003%26volume%3D8%26spage%3D536%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">LaHoste, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigal, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. L.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor gene polymorphism is associated with attention deficit hyperactivity disorder</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9118321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADyaK2s3jtlartg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=121-124&author=G.+J.+LaHosteauthor=J.+M.+Swansonauthor=S.+B.+Wigalauthor=C.+Glabeauthor=T.+Wigalauthor=N.+Kingauthor=J.+L.+Kennedy&title=Dopamine+D4+receptor+gene+polymorphism+is+associated+with+attention+deficit+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder</span></div><div class="casAuthors">LaHoste G J; Swanson J M; Wigal S B; Glabe C; Wigal T; King N; Kennedy J L</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-4</span>
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    </div><div class="casAbstract">Dopamine is believed to play a major role in the manifestation of attention deficit hyperactivity disorder (ADHD), which affects 3-6% of school-age children and shows evidence of familiarity.  The dopamine D4 receptor, which is preferentially distributed in cortical and limbic regions of the brain, is currently of major interest because of the high degree of functionally relevant variability in its gene (DRD4), and the association of this gene with Novelty Seeking behavior.  We examined the variability in the length of a region of DRD4 that contains a 48-bp repeat sequence in children with ADHD and controls matched for ethnicity.  ADHD children differed from controls in that the 7-fold repeat form of DRD4 occurred significantly more frequently than in the control sample.  This form of the receptor has previously been shown to mediate a blunted intracellular response to dopamine.  Although ADHD is likely to be multifactorial in its etiology and its heritability is likely to be polygenetic, the present findings suggest that polymorphic variation in the gene encoding the D4 dopamine receptor may be a contributing factor in the expression of symptoms associated with ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN_l8s_261K2lSCSgBhwJFfW6udTcc2eYMj6PiJ3cNdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3jtlartg%253D%253D&md5=ce39ec8adf6503bb18524d566f891988</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaHoste%26aufirst%3DG.%2BJ.%26aulast%3DSwanson%26aufirst%3DJ.%2BM.%26aulast%3DWigal%26aufirst%3DS.%2BB.%26aulast%3DGlabe%26aufirst%3DC.%26aulast%3DWigal%26aufirst%3DT.%26aulast%3DKing%26aufirst%3DN.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26atitle%3DDopamine%2520D4%2520receptor%2520gene%2520polymorphism%2520is%2520associated%2520with%2520attention%2520deficit%2520hyperactivity%2520disorder%26jtitle%3DMol.%2520Psychiatry%26date%3D1996%26volume%3D1%26spage%3D121%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Swanson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunohara, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fineberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaHoste, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigal, S.</span><span> </span><span class="NLM_article-title">Association of the dopamine receptor D<sub>4</sub> (DRD<sub>4</sub>) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1038%2Fsj.mp.4000354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9491811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls1Gls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=38-41&author=J.+M.+Swansonauthor=G.+A.+Sunoharaauthor=J.+L.+Kennedyauthor=R.+Reginoauthor=E.+Finebergauthor=T.+Wigalauthor=M.+Lernerauthor=L.+Williamsauthor=G.+J.+LaHosteauthor=S.+Wigal&title=Association+of+the+dopamine+receptor+D4+%28DRD4%29+gene+with+a+refined+phenotype+of+attention+deficit+hyperactivity+disorder+%28ADHD%29%3A+a+family-based+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach</span></div><div class="casAuthors">Swanson, J. M.; Sunohara, G. A.; Kennedy, J. L.; Regino, R.; Fineberg, E.; Wigal, T.; Lerner, M.; Williams, L.; LaHoste, G. J.; Wigal, S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-41</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Previously in this journal, we reported an assocn. of the dopamine D4 receptor gene (DRD4) and attention deficit hyperactivity disorder (ADHD).  In a population-assocn. (case-control) study of 39 children with a refined phenotype of ADHD and 39 ethnically matched controls, we obsd. an increased percentage of the 7 repeat allele (29% vs 12%) and the 7+ genotype (49% vs 21%) in the ADHD group compared to the control group.  In a replication and an extension of our initial study, we recruited another sample of ADHD subjects and found percentages of the 7 repeat allele (28%) and the 7+ genotype (48%) consistent with our previous findings.  We used a family-based approach to evaluate a predicted assocn. of DRD4 and ADHD based on a test of allele transmission focused on the 7 repeat allele.  We identified 52 families based on the diagnosis of the refined phenotype of ADHD in the proband and the availability of DNA from both biol. parents as well as the proband.  Haplotype relative risk (HRR) anal. was performed to test our a priori hypothesis and produced significant results (chi-square = 4.65, P < 0.035).  This provides addnl. evidence that the DRD4 gene is assocd. with a refined phenotype of ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXa1p8iCTavLVg90H21EOLACvtfcHk0lig1NzVdpZd-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls1Gls7w%253D&md5=265f8eb286348a4ec43f2df66b4fc1ed</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4000354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4000354%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DJ.%2BM.%26aulast%3DSunohara%26aufirst%3DG.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26aulast%3DRegino%26aufirst%3DR.%26aulast%3DFineberg%26aufirst%3DE.%26aulast%3DWigal%26aufirst%3DT.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DLaHoste%26aufirst%3DG.%2BJ.%26aulast%3DWigal%26aufirst%3DS.%26atitle%3DAssociation%2520of%2520the%2520dopamine%2520receptor%2520D4%2520%2528DRD4%2529%2520gene%2520with%2520a%2520refined%2520phenotype%2520of%2520attention%2520deficit%2520hyperactivity%2520disorder%2520%2528ADHD%2529%253A%2520a%2520family-based%2520approach%26jtitle%3DMol.%2520Psychiatry%26date%3D1998%26volume%3D3%26spage%3D38%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Johansson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halleland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmøy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landaas, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dramsdahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasmer, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsholm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundervold, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugdahl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knappskog, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haavik, J.</span><span> </span><span class="NLM_article-title">Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD<sub>4</sub> or SLC6A3 VNTRs</span> <span class="citation_source-journal">Am. J. Med. Genet., Part B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">1470</span><span class="NLM_x">–</span> <span class="NLM_lpage">1475</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1002%2Fajmg.b.30662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2008&pages=1470-1475&author=S.+Johanssonauthor=H.+Hallelandauthor=A.+Halm%C3%B8yauthor=K.+K.+Jacobsenauthor=E.+T.+Landaasauthor=M.+Dramsdahlauthor=O.+B.+Fasmerauthor=P.+Bergsholmauthor=A.+J.+Lundervoldauthor=C.+Gillbergauthor=K.+Hugdahlauthor=P.+M.+Knappskogauthor=J.+Haavik&title=Genetic+analyses+of+dopamine+related+genes+in+adult+ADHD+patients+suggest+an+association+with+the+DRD5-microsatellite+repeat%2C+but+not+with+DRD4+or+SLC6A3+VNTRs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs</span></div><div class="casAuthors">Johansson, S.; Halleland, H.; Halmoey, A.; Jacobsen, K. K.; Landaas, E. T.; Dramsdahl, M.; Fasmer, O. B.; Bergsholm, P.; Lundervold, A. J.; Gillberg, C.; Hugdahl, K.; Knappskog, P. M.; Haavik, J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">147B</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1470-1475</span>CODEN:
                <span class="NLM_cas:coden">AJMGC9</span>;
        ISSN:<span class="NLM_cas:issn">1552-4841</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Attention deficit hyperactivity disorder (ADHD) is a common and highly heritable psychiatric disorder in children and adults.  Recent meta-analyses have indicated an assocn. between genes involved in dopaminergic signaling and childhood ADHD, but little is known about their possible role in adult ADHD.  In this study of adults with ADHD, we evaluated the three most commonly studied ADHD candidate genetic polymorphisms; the dopamine receptor D4 (DRD4) exon 3 VNTR repeat, a microsatellite repeat 18.5 kb upstream of the DRD5 locus and the 3'UTR dopamine transporter SLC6A3 (DAT 1) VNTR.  We examd. 358 clin. diagnosed adult Norwegian ADHD patients (51% males) and 340 ethnically matched controls.  We found a nominally significant overall assocn. with adult ADHD for the DRD5 microsatellite marker (P = 0.04), and a trend toward increased risk assocd. with the 148-bp allele consistent with recent meta-analyses.  The strongest overall assocn. (P = 0.02) and increased risk for the 148-bp allele [odds ratio (OR) = 1.27 (95% CI: 1.00-1.61)] were seen in the inattentive and combined inattentive/hyperactive group as previously reported for childhood ADHD.  No assocn. was found for the DRD4 or SLC6A3 polymorphisms in this patient sample.  In conclusion, our results among adults with a clin. diagnosis of ADHD support an assocn. between ADHD and the DRD5 locus, but not the DRD4 or SLC6A3 loci.  It is possible that the latter polymorphisms are assocd. with a transient form of ADHD with better long-term clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwK-rBIMt2GrVg90H21EOLACvtfcHk0lig1NzVdpZd-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktLjO&md5=c3fe8f5d952121cc2ae0d377de1502ea</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fajmg.b.30662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.b.30662%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DS.%26aulast%3DHalleland%26aufirst%3DH.%26aulast%3DHalm%25C3%25B8y%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DK.%2BK.%26aulast%3DLandaas%26aufirst%3DE.%2BT.%26aulast%3DDramsdahl%26aufirst%3DM.%26aulast%3DFasmer%26aufirst%3DO.%2BB.%26aulast%3DBergsholm%26aufirst%3DP.%26aulast%3DLundervold%26aufirst%3DA.%2BJ.%26aulast%3DGillberg%26aufirst%3DC.%26aulast%3DHugdahl%26aufirst%3DK.%26aulast%3DKnappskog%26aufirst%3DP.%2BM.%26aulast%3DHaavik%26aufirst%3DJ.%26atitle%3DGenetic%2520analyses%2520of%2520dopamine%2520related%2520genes%2520in%2520adult%2520ADHD%2520patients%2520suggest%2520an%2520association%2520with%2520the%2520DRD5-microsatellite%2520repeat%252C%2520but%2520not%2520with%2520DRD4%2520or%2520SLC6A3%2520VNTRs%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520B%26date%3D2008%26volume%3D147%26spage%3D1470%26epage%3D1475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Shaw, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gornick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addington, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giedd, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellanos, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapoport, J. L.</span><span> </span><span class="NLM_article-title">Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1001%2Farchpsyc.64.8.921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=17679637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD2svmt1Sitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=921-931&author=P.+Shawauthor=M.+Gornickauthor=J.+Lerchauthor=A.+Addingtonauthor=J.+Sealauthor=D.+Greensteinauthor=W.+Sharpauthor=A.+Evansauthor=J.+N.+Gieddauthor=F.+X.+Castellanosauthor=J.+L.+Rapoport&title=Polymorphisms+of+the+dopamine+D4+receptor%2C+clinical+outcome%2C+and+cortical+structure+in+attention-deficit%2Fhyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder</span></div><div class="casAuthors">Shaw Philip; Gornick Michele; Lerch Jason; Addington Anjene; Seal Jeffrey; Greenstein Deanna; Sharp Wendy; Evans Alan; Giedd Jay N; Castellanos F Xavier; Rapoport Judith L</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-31</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">CONTEXT:  Attention-deficit/hyperactivity disorder (ADHD) is one of the most heritable neuropsychiatric disorders, and a polymorphism within the dopamine D4 receptor (DRD4) gene has been frequently implicated in its pathogenesis.  OBJECTIVE:  To examine the effects of the 7-repeat microsatellite in the DRD4 gene on clinical outcome and cortical development in ADHD.  We drew comparisons with a single nucleotide polymorphism in the dopamine D1 receptor (DRD1) gene, which was associated with ADHD within our cohort, and a polymorphism within the dopamine transporter (DAT1) gene, reported to have additive effects with the DRD4 7-repeat allele.  DESIGN:  Longitudinal cohort study.  SETTING:  National Institutes of Health, Bethesda, Maryland.  PARTICIPANTS:  One hundred five children (with 222 neuroanatomical magnetic resonance images) with ADHD (mean age at entry, 10.1 years) and 103 healthy controls (total of 220 magnetic resonance images).  Sixty-seven subjects with ADHD (64%) had follow-up clinical evaluations (mean follow-up, 6 years).  MAIN OUTCOME MEASURES:  Cortical thickness across the cerebrum and presence of DSM-IV-defined ADHD at follow-up.  RESULTS:  Possession of the DRD4 7-repeat allele was associated with a thinner right orbitofrontal/inferior prefrontal and posterior parietal cortex.  This overlapped with regions that were generally thinner in subjects with ADHD compared with controls.  Participants with ADHD carrying the DRD4 7-repeat allele had a better clinical outcome and a distinct trajectory of cortical development.  This group showed normalization of the right parietal cortical region, a pattern that we have previously linked with better clinical outcome.  By contrast, there were no significant effects of the DRD1 or DAT1 polymorphisms on clinical outcome or cortical development.  CONCLUSIONS:  The DRD4 7-repeat allele, which is widely associated with a diagnosis of ADHD, and in our cohort with better clinical outcome, is associated with cortical thinning in regions important in attentional control.  This regional thinning is most apparent in childhood and largely resolves during adolescence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUXFWCGa_7WxLDWw4HIq2sfW6udTcc2eZna8WvUAfAe7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svmt1Sitw%253D%253D&md5=591d5aafd957c4f5a440904e2706e367</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.64.8.921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.64.8.921%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DP.%26aulast%3DGornick%26aufirst%3DM.%26aulast%3DLerch%26aufirst%3DJ.%26aulast%3DAddington%26aufirst%3DA.%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DGreenstein%26aufirst%3DD.%26aulast%3DSharp%26aufirst%3DW.%26aulast%3DEvans%26aufirst%3DA.%26aulast%3DGiedd%26aufirst%3DJ.%2BN.%26aulast%3DCastellanos%26aufirst%3DF.%2BX.%26aulast%3DRapoport%26aufirst%3DJ.%2BL.%26atitle%3DPolymorphisms%2520of%2520the%2520dopamine%2520D4%2520receptor%252C%2520clinical%2520outcome%252C%2520and%2520cortical%2520structure%2520in%2520attention-deficit%252Fhyperactivity%2520disorder%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2007%26volume%3D64%26spage%3D921%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Schetz, J. A.; Sibley, D. R.</span><span> </span><span class="NLM_article-title">Dopaminergic Neurotransmission</span>. In  <span class="citation_source-book">Handbook of Contemporary Neuropharmacology</span>; <span class="NLM_contrib-group">Sibley, D.; Hanin, I.; Kuhar, M.; Skolnick, P.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">221</span>− <span class="NLM_lpage">256</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=221-256&author=J.+A.+Schetz&author=D.+R.+Sibleyauthor=D.+Sibley&author=I.+Hanin&author=M.+Kuhar&author=P.+Skolnick&title=Handbook+of+Contemporary+Neuropharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DDopaminergic%2520Neurotransmission%26btitle%3DHandbook%2520of%2520Contemporary%2520Neuropharmacology%26aulast%3DSibley%26aufirst%3DD.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2007%26spage%3D221%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarazi, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldessarini, R. J.</span><span> </span><span class="NLM_article-title">Role of dopamine D<sub>4</sub> receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0893-133X%2801%2900262-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11682245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnslCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=624-632&author=K.+Zhangauthor=F.+I.+Taraziauthor=R.+J.+Baldessarini&title=Role+of+dopamine+D4+receptors+in+motor+hyperactivity+induced+by+neonatal+6-hydroxydopamine+lesions+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats</span></div><div class="casAuthors">Zhang, Kehong; Tarazi, Frank I.; Baldessarini, Ross J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">624-632</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The role of dopamine D4 receptors in behavioral hyperactivity was investigated by assessing D4 receptor expression in brain regions and behavioral effects of D4 receptor-selective ligands in juvenile rats with neonatal 6-hydroxydopamine lesions, a lab. model for attention deficit-hyperactivity disorder (ADHD).  Autoradiog. anal. indicated that motor hyperactivity in lesioned rats was closely correlated with increases in D4 but not D2 receptor levels in caudate-putamen.  D4-selective antagonist CP-293,019 dose-dependently reversed lesion-induced hyperactivity, and D4-agonist CP-226,269 increased it.  These results indicate a physiol. role of dopamine D4 receptors in motor behavior, and may suggest much-needed innovative treatments for ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLwJLfQQgg3bVg90H21EOLACvtfcHk0ljw0eUUaXVyfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnslCjsLY%253D&md5=22ce93f3b654bee58d47552e6057bd1c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0893-133X%2801%2900262-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0893-133X%252801%252900262-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DTarazi%26aufirst%3DF.%2BI.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26atitle%3DRole%2520of%2520dopamine%2520D4%2520receptors%2520in%2520motor%2520hyperactivity%2520induced%2520by%2520neonatal%25206-hydroxydopamine%2520lesions%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2001%26volume%3D25%26spage%3D624%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davids, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarazi, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldessarini, R. J.</span><span> </span><span class="NLM_article-title">Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity</span> <span class="citation_source-journal">Dev. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0165-3806%2802%2900436-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=135-138&author=K.+Zhangauthor=E.+Davidsauthor=F.+I.+Taraziauthor=R.+J.+Baldessarini&title=Serotonin+transporter+binding+increases+in+caudate-putamen+and+nucleus+accumbens+after+neonatal+6-hydroxydopamine+lesions+in+rats%3A+implications+for+motor+hyperactivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0165-3806%2802%2900436-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-3806%252802%252900436-4%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DDavids%26aufirst%3DE.%26aulast%3DTarazi%26aufirst%3DF.%2BI.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26atitle%3DSerotonin%2520transporter%2520binding%2520increases%2520in%2520caudate-putamen%2520and%2520nucleus%2520accumbens%2520after%2520neonatal%25206-hydroxydopamine%2520lesions%2520in%2520rats%253A%2520implications%2520for%2520motor%2520hyperactivity%26jtitle%3DDev.%2520Brain%2520Res.%26date%3D2002%26volume%3D30%26spage%3D135%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molesky, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komater, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span> </span><span class="NLM_article-title">A-412997, a selective dopamine D<sub>4</sub> agonist, improves cognitive performance in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2005&pages=148-155&author=K.+E.+Browmanauthor=P.+Curzonauthor=J.+B.+Panauthor=A.+L.+Moleskyauthor=V.+A.+Komaterauthor=M.+W.+Deckerauthor=J.+D.+Brioniauthor=R.+B.+Morelandauthor=G.+B.+Fox&title=A-412997%2C+a+selective+dopamine+D4+agonist%2C+improves+cognitive+performance+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DMolesky%26aufirst%3DA.%2BL.%26aulast%3DKomater%26aufirst%3DV.%2BA.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DMoreland%26aufirst%3DR.%2BB.%26aulast%3DFox%26aufirst%3DG.%2BB.%26atitle%3DA-412997%252C%2520a%2520selective%2520dopamine%2520D4%2520agonist%252C%2520improves%2520cognitive%2520performance%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2005%26volume%3D82%26spage%3D148%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly- Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakowski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, K.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span> </span><span class="NLM_article-title">Activation of dopamine D<sub>4</sub> receptors by ABT-724 induces penile erection in rats</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">6758</span><span class="NLM_x">–</span> <span class="NLM_lpage">6763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1073%2Fpnas.0308292101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=15087502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVyhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=6758-6763&author=J.+D.+Brioniauthor=R.+B.+Morelandauthor=M.+Cowartauthor=G.+C.+Hsiehauthor=A.+O.+Stewartauthor=P.+Hedlundauthor=D.+L.+Donnelly-+Robertsauthor=M.+Nakaneauthor=J.+J.+Lynchauthor=T.+Kolasaauthor=J.+S.+Polakowskiauthor=M.+A.+Osinskiauthor=K.+Marshauthor=K.-E.+Anderssonauthor=J.+P.+Sullivan&title=Activation+of+dopamine+D4+receptors+by+ABT-724+induces+penile+erection+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats</span></div><div class="casAuthors">Brioni, Jorge D.; Moreland, Robert B.; Cowart, Marlon; Hsieh, Gin C.; Stewart, Andrew O.; Hedlund, Petter; Donnelly-Roberts, Diana L.; Nakane, Masaki; Lynch, James J., III; Kolasa, Teodozyi; Polakowski, James S.; Osinski, Mark A.; Marsh, Kennan; Andersson, Karl-Erik; Sullivan, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6758-6763</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apomorphine, a nonselective dopamine receptor agonist, facilitates penile erection and is effective in patients suffering from erectile dysfunction.  The specific dopamine receptor subtype(s) responsible for its erectogenic effect is not known.  Here we report that the dopamine D4 receptor plays a role in the regulation of penile function.  ABT-724 is a selective dopamine D4 receptor agonist that activates human dopamine D4 receptors with an EC50 of 12.4 nM and 61% efficacy, with no effect on dopamine D1, D2, D3, or D5 receptors.  ABT-724 dose-dependently facilitates penile erection when given s.c. to conscious rats, an effect that is blocked by haloperidol and clozapine but not by domperidone.  A proerectile effect is obsd. after intracerebroventricular but not intrathecal administration, suggesting a supraspinal site of action.  S.c. injections of ABT-724 increase intracavernosal pressure in awake freely moving rats.  In the presence of sildenafil, a potentiation of the proerectile effect of ABT-724 is obsd. in conscious rats.  The ability of ABT-724 to facilitate penile erection together with the favorable side-effect profile indicates that ABT-724 could be useful for the treatment of erectile dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_CPLyHqtzJ7Vg90H21EOLACvtfcHk0ljRSx568NfYqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVyhs7g%253D&md5=b37690221970ae889a6589e9177cf321</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308292101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308292101%26sid%3Dliteratum%253Aachs%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DMoreland%26aufirst%3DR.%2BB.%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DHedlund%26aufirst%3DP.%26aulast%3DDonnelly-%2BRoberts%26aufirst%3DD.%2BL.%26aulast%3DNakane%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DPolakowski%26aufirst%3DJ.%2BS.%26aulast%3DOsinski%26aufirst%3DM.%2BA.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DAndersson%26aufirst%3DK.-E.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26atitle%3DActivation%2520of%2520dopamine%2520D4%2520receptors%2520by%2520ABT-724%2520induces%2520penile%2520erection%2520in%2520rats%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D6758%26epage%3D6763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truccone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haji-Abdi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greedy, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enguehard-Gueiffier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueiffier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunahara, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">Proerectile effects of dopamine D<sub>2</sub>-like agonists are mediated by the D<sub>3</sub> receptor in rats and mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1124%2Fjpet.108.144048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=19136638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=210-217&author=G.+T.+Collinsauthor=A.+Trucconeauthor=F.+Haji-Abdiauthor=A.+H.+Newmanauthor=P.+Grundtauthor=K.+C.+Riceauthor=S.+M.+Husbandsauthor=B.+M.+Greedyauthor=C.+Enguehard-Gueiffierauthor=A.+Gueiffierauthor=J.+Chenauthor=S.+Wangauthor=J.+L.+Katzauthor=D.+K.+Grandyauthor=R.+K.+Sunaharaauthor=J.+H.+Woods&title=Proerectile+effects+of+dopamine+D2-like+agonists+are+mediated+by+the+D3+receptor+in+rats+and+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice</span></div><div class="casAuthors">Collins, Gregory T.; Truccone, Andrew; Haji-Abdi, Faiza; Newman, Amy Hauck; Grundt, Peter; Rice, Kenner C.; Husbands, Stephen M.; Greedy, Benjamin M.; Enguehard-Gueiffier, Cecile; Gueiffier, Alain; Chen, Jianyong; Wang, Shaomeng; Katz, Jonathan L.; Grandy, David K.; Sunahara, Roger K.; Woods, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210-217</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine D2-like agonists induce penile erection (PE) and yawning in a variety of species, effects that have been suggested recently to be specifically mediated by the D4 and D3 receptors, resp.  The current studies were aimed at characterizing a series of D2, D3, and D4 agonists with respect to their capacity to induce PE and yawning in the rat and the proerectile effects of apomorphine [(R)-(-)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride] in wild-type and D4 receptor (R) knockout (KO) mice.  All D3 agonists induced dose-dependent increases in PE and yawning over a similar range of doses, whereas significant increases in PE or yawning were not obsd. with any of the D4 agonists.  Likewise, D2, D3, and D4 antagonists were assessed for their capacity to alter apomorphine- and pramipexole (N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride)-induced PE and yawning.  The D3 antagonist, PG01037 inhibited the induction of PE and yawning, whereas the D2 antagonist, L-741,626, reversed the inhibition of PE and yawning obsd. at higher doses.  The D4 antagonist, L-745,870 did not alter apomorphine- or pramipexole-induced PE or yawning.  A role for the D3 receptor was further supported because apomorphine was equipotent at inducing PE in wild-type and D4R KO mice, effects that were inhibited by the D3 antagonist, PG01037, in both wild-type and D4R KO mice.  Together, these studies provide strong support that D2-like agonist-induced PE and yawning are differentially mediated by the D3 (induction) and D2 (inhibition) receptors.  These studies fail to support a role for the D4 receptor in the regulation of PE or yawning by D2-like agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMBqypmUs6YrVg90H21EOLACvtfcHk0ljRSx568NfYqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKnu78%253D&md5=42514c75312cd5ac99611a9d55619fd1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.144048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.144048%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DTruccone%26aufirst%3DA.%26aulast%3DHaji-Abdi%26aufirst%3DF.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DGreedy%26aufirst%3DB.%2BM.%26aulast%3DEnguehard-Gueiffier%26aufirst%3DC.%26aulast%3DGueiffier%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DProerectile%2520effects%2520of%2520dopamine%2520D2-like%2520agonists%2520are%2520mediated%2520by%2520the%2520D3%2520receptor%2520in%2520rats%2520and%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D210%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragan, C. I.</span><span> </span><span class="NLM_article-title">Pharmacological and functional characterisation of dopamine D<sub>4</sub> receptors in the rat retina</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=1038-1046&author=S.+Patelauthor=K.+L.+Chapmanauthor=D.+Marstonauthor=P.+H.+Hutsonauthor=C.+I.+Ragan&title=Pharmacological+and+functional+characterisation+of+dopamine+D4+receptors+in+the+rat+retina"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DK.%2BL.%26aulast%3DMarston%26aufirst%3DD.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26atitle%3DPharmacological%2520and%2520functional%2520characterisation%2520of%2520dopamine%2520D4%2520receptors%2520in%2520the%2520rat%2520retina%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D44%26spage%3D1038%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Cohen, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, K. L.</span><span> </span><span class="NLM_article-title">Photoreceptors of the mouse retina possess D<sub>4</sub> receptors coupled to adenylyl cyclase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">12093</span><span class="NLM_x">–</span> <span class="NLM_lpage">12097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=12093-12097&author=A.+I.+Cohenauthor=R.+D.+Toddauthor=S.+Harmonauthor=K.+L.+O%E2%80%99Malley&title=Photoreceptors+of+the+mouse+retina+possess+D4+receptors+coupled+to+adenylyl+cyclase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DA.%2BI.%26aulast%3DTodd%26aufirst%3DR.%2BD.%26aulast%3DHarmon%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DK.%2BL.%26atitle%3DPhotoreceptors%2520of%2520the%2520mouse%2520retina%2520possess%2520D4%2520receptors%2520coupled%2520to%2520adenylyl%2520cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1992%26volume%3D89%26spage%3D12093%26epage%3D12097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Nir, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haque, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuvone, P. M.</span><span> </span><span class="NLM_article-title">Dysfunctional light-evoked regulation of cAMP in photoreceptors and abnormal retinal adaptation in mice lacking dopamine D<sub>4</sub> receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2063</span><span class="NLM_x">–</span> <span class="NLM_lpage">2073</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11896146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVegtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2063-2073&author=I.+Nirauthor=J.+M.+Harrisonauthor=R.+Haqueauthor=M.+J.+Lowauthor=D.+K.+Grandyauthor=M.+Rubinsteinauthor=P.+M.+Iuvone&title=Dysfunctional+light-evoked+regulation+of+cAMP+in+photoreceptors+and+abnormal+retinal+adaptation+in+mice+lacking+dopamine+D4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dysfunctional light-evoked regulation of cAMP in photoreceptors and abnormal retinal adaptation in mice lacking dopamine D4 receptors</span></div><div class="casAuthors">Nir, Izhak; Harrison, Joseph M.; Haque, Rashidul; Low, Malcolm J.; Grandy, David K.; Rubinstein, Marcelo; Luvone, P. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2063-2073</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Dopamine is a retinal neuromodulator that has been implicated in many aspects of retinal physiol.  Photoreceptor cells express dopamine D4 receptors that regulate cAMP metab.  To assess the effects of dopamine on photoreceptor physiol., we examd. the morphol., electrophysiol., and regulation of cAMP metab. in mice with targeted disruption of the dopamine D4 receptor gene.  Photoreceptor morphol. and outer segment disk shedding after light onset were normal in D4 knock-out (D4KO) mice.  Quinpirole, a dopamine D2/D3/D4 receptor agonist, decreased cAMP synthesis in retinas of wild-type (WT) mice but not in retinas of D4KO mice.  In WT retinas, the photoreceptors of which were functionally isolated by incubation in the presence of exogenous glutamate, light also suppressed cAMP synthesis.  Despite the similar inhibition of cAMP synthesis, the effect of light is directly on the photoreceptors and independent of dopamine modulation, because it was unaffected by application of the D4 receptor antagonist L-745870.  Nevertheless, compared with WT retinas, basal cAMP formation was reduced in the photoreceptors of D4KO retinas, and light had no addnl. inhibitory effect.  The results suggest that dopamine, via D4 receptors, normally modulates the cascade that couples light responses to adenylyl cyclase activity in photoreceptor cells, and the absence of this modulation results in dysfunction of the cascade.  Dark-adapted electroretinogram (ERG) responses were normal in D4KO mice.  However, ERG b-wave responses were greatly suppressed during both light adaptation and early stages of dark adaptation.  Thus, the absence of D4 receptors affects adaptation, altering transmission of light responses from photoreceptors to inner retinal neurons.  These findings indicate that dopamine D4 receptors normally play a major role in regulating photoreceptor cAMP metab. and adaptive retinal responses to changing environmental illumination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEmWw0jICytrVg90H21EOLACvtfcHk0lgyFvb3gsoEhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVegtro%253D&md5=177ddb2267abce9a71bd9d1a1ce0dfcf</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNir%26aufirst%3DI.%26aulast%3DHarrison%26aufirst%3DJ.%2BM.%26aulast%3DHaque%26aufirst%3DR.%26aulast%3DLow%26aufirst%3DM.%2BJ.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DRubinstein%26aufirst%3DM.%26aulast%3DIuvone%26aufirst%3DP.%2BM.%26atitle%3DDysfunctional%2520light-evoked%2520regulation%2520of%2520cAMP%2520in%2520photoreceptors%2520and%2520abnormal%2520retinal%2520adaptation%2520in%2520mice%2520lacking%2520dopamine%2520D4%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D2063%26epage%3D2073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Matarrese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soloviev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moresco, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli Kienle, M.</span><span> </span><span class="NLM_article-title">Synthesis and in vivo evaluation of 3-[<sup>11</sup>C]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D<sub>4</sub> receptors antagonist for PET</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1002%2F%28SICI%291099-1344%2820000330%2943%3A4%3C359%3A%3AAID-JLCR323%3E3.0.CO%3B2-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=359-374&author=M.+Matarreseauthor=D.+Solovievauthor=R.+M.+Morescoauthor=S.+Toddeauthor=P.+Simonelliauthor=D.+Colomboauthor=F.+Magniauthor=A.+Carpinelliauthor=F.+Fazioauthor=M.+Galli+Kienle&title=Synthesis+and+in+vivo+evaluation+of+3-%5B11C%5Dmethyl-%283-methoxy-naphthalen%29-2-yl-%281-benzyl-piperidin%29-4-yl-acetate+%28SB-235753%29%2C+as+a+putative+dopamine+D4+receptors+antagonist+for+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vivo evaluation of 1-(Phenylmethyl)-4-piperidine acetic acid 3-(methoxy-11C)-2-naphthalenyl ester (SB-235753), as a putative dopamine D4 receptors antagonist for PET</span></div><div class="casAuthors">Matarrese, M.; Soloviev, D.; Moresco, R. M.; Todde, S.; Simonelli, P.; Colombo, D.; Magni, F.; Carpinelli, A.; Fazio, F.; Kienle, M. Galli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-374</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">1-(Phenylmethyl)-4-piperidine acetic acid 3-(methoxy-11C)-2-naphthalenyl ester ester (SB-235753) (t1/2=20.4 min) was prepd. as a putative radioligand for the non-invasive assessment of Dopamine D4 receptors in vivo with positron emission tomog. (PET).  The precursor for the radiosynthesis 1-(Phenylmethyl)-4-piperidineacetic acid 3-hydroxy-2-naphthalenyl ester hydrochloride was prepd. by a four-step synthesis starting from 4-pyridineacetic acid Et ester.  The radiolabeling consisted of methylation with trifluoromethanesulfonic acid methyl-11C ester in DMF in the presence of potassium hydroxide.  [11C]SB-235753, was synthesized in 30 min with a radiochem. yield of 10 ± 5% (EOS, non-decay cor.) with 99% radiochem. purity and specific radioactivity of 10 ± 3 Ci/μmol.  Biodistribution studies in rats with [11C]SB-235753 showed the uniform distribution of the tracer within different areas of the murine brain.  At 30 min after injection 99% of the radioligand in plasma and 100% in cerebellum was metabolized.  These findings suggest that [11C]SB-235753 can not be a suitable tracer for dopamine D4 receptor studies with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg5zURP4hJkbVg90H21EOLACvtfcHk0lgyFvb3gsoEhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlajtb4%253D&md5=b731698ca1cbe347b1b4b64a58b0c898</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1344%2820000330%2943%3A4%3C359%3A%3AAID-JLCR323%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1344%252820000330%252943%253A4%253C359%253A%253AAID-JLCR323%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DMatarrese%26aufirst%3DM.%26aulast%3DSoloviev%26aufirst%3DD.%26aulast%3DMoresco%26aufirst%3DR.%2BM.%26aulast%3DTodde%26aufirst%3DS.%26aulast%3DSimonelli%26aufirst%3DP.%26aulast%3DColombo%26aufirst%3DD.%26aulast%3DMagni%26aufirst%3DF.%26aulast%3DCarpinelli%26aufirst%3DA.%26aulast%3DFazio%26aufirst%3DF.%26aulast%3DGalli%2BKienle%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520in%2520vivo%2520evaluation%2520of%25203-%255B11C%255Dmethyl-%25283-methoxy-naphthalen%2529-2-yl-%25281-benzyl-piperidin%2529-4-yl-acetate%2520%2528SB-235753%2529%252C%2520as%2520a%2520putative%2520dopamine%2520D4%2520receptors%2520antagonist%2520for%2520PET%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2000%26volume%3D43%26spage%3D359%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Eskola, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehikoinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaparanta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grönroos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsback, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solin, O.</span><span> </span><span class="NLM_article-title">Synthesis of 3-[[4-(4-[<sup>18</sup>F]fluorophenyl)piperazin-1-yl]methyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1002%2Fjlcr.597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmtlersb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=687-696&author=O.+Eskolaauthor=J.+Bergmanauthor=P.+Lehikoinenauthor=M.+Haaparantaauthor=T.+Gr%C3%B6nroosauthor=S.+Forsbackauthor=O.+Solin&title=Synthesis+of+3-%5B%5B4-%284-%5B18F%5Dfluorophenyl%29piperazin-1-yl%5Dmethyl%5D-1H-pyrrolo%5B2%2C3-b%5Dpyridine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3-[[4-(4-[18F]fluorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine</span></div><div class="casAuthors">Eskola, Olli; Bergman, Jorgen; Lehikoinen, Pertti; Haaparanta, Merja; Gronroos, Tove; Forsback, Sarita; Solin, Olof</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">687-696</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">3-[[4-(4-[18F]fluorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine, a candidate to image dopamine D4 receptors, was synthesized via electrophilic fluorination of a trimethylstannyl precursor with high specific radioactivity [18F]F2.  The precursor was obtained by a facile four-step synthetic approach; the trimethylstannyl leaving group was introduced by displacement of iodine utilizing palladium catalysis and hexamethyldistannane in an inert solvent.  The total radiosynthesis time was 50 min, including purifn. and formulation for injection.  Decay cor. radiochem. yield was <1% as calcd. from the amt. of [18F]F- produced.  Specific radioactivity at the end of synthesis was 12.8-16.4 GBq/μmol.  Radiochem. purity was 88-92%.  Ex vivo studies in rats showed homogeneous distribution of radioactivity within rat brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMWY5YQDSH9rVg90H21EOLACvtfcHk0lgH8J5hhf5g8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmtlersb4%253D&md5=ed5ebb557e09dc56cf28aac0f94708db</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.597%26sid%3Dliteratum%253Aachs%26aulast%3DEskola%26aufirst%3DO.%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DLehikoinen%26aufirst%3DP.%26aulast%3DHaaparanta%26aufirst%3DM.%26aulast%3DGr%25C3%25B6nroos%26aufirst%3DT.%26aulast%3DForsback%26aufirst%3DS.%26aulast%3DSolin%26aufirst%3DO.%26atitle%3DSynthesis%2520of%25203-%255B%255B4-%25284-%255B18F%255Dfluorophenyl%2529piperazin-1-yl%255Dmethyl%255D-1H-pyrrolo%255B2%252C3-b%255Dpyridine%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2002%26volume%3D45%26spage%3D687%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Langer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Någren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Carbon-11 PB-12: an attempt to visualize the dopamine D<sub>4</sub> receptor in the primate brain with positron emission tomography</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0969-8051%2800%2900154-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11150701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVWmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=707-714&author=O.+Langerauthor=C.+Halldinauthor=Y.+Chouauthor=J.+Sandellauthor=C.+Swahnauthor=K.+N%C3%A5grenauthor=R.+Perroneauthor=F.+Berardiauthor=M.+Leopoldoauthor=L.+Farde&title=Carbon-11+PB-12%3A+an+attempt+to+visualize+the+dopamine+D4+receptor+in+the+primate+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-11 PB-12: an attempt to visualize the dopamine D4 receptor in the primate brain with positron emission tomography</span></div><div class="casAuthors">Langer, O.; Halldin, C.; Chou, Y.-H.; Sandell, J.; Swahn, C.-G.; Nagren, K.; Perrone, R.; Berardi, F.; Leopoldo, M.; Farde, L.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">707-714</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The dopamine D4 receptor (D4R) is expressed in low d. in various extrastriatal brain regions.  This receptor subtype is discussed in relation to the pathophysiol. and treatment of schizophrenia but no selective positron emission tomog. (PET) ligand is available to date to study the distribution in vivo.  The arylpiperazine deriv. N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (PB-12) is a novel, high-affinity ( Ki=0.040 nM) and selective D4R ligand.  We radiolabeled PB-12 with carbon-11 (t1/2 20.4 min) by O-methylation of the corresponding desmethyl analog N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-hydroxybenzamide (LM-190) with [11C]methyl triflate.  Deriv. LM-190 was prepd. by condensing 3-hydroxybenzoic acid with the appropriate amine.  For the radiolabeling, the incorporation yield was >90% and the total synthesis time including high performance liq. chromatog. (HPLC) purifn. was about 35 min.  The specific radioactivity of [11C]PB-12 at time of injection was 67-118 GBq·μmol-1.  PET studies in a cynomolgus monkey showed a high uptake and widespread distribution of radioactivity in the brain, including the neocortex and thalamus.  About 40% of total radioactivity in plasma represented unchanged radioligand at 60 min after injection as detd. by HPLC.  Pretreatment with the D4R ligand 3-{[4-(4-chlorophenyl)piperazin-1-yl]methyl}-1H-pyrollo[2,3-b]pyridine (L-745,870) prior to radioligand injection failed to demonstrate receptor-specific binding in the monkey brain.  Furthermore, the brain radioactivity distribution was left unaffected by pretreating with unlabeled PB-12.  This failure to detect a D4R-specific signal may be related to a very low d. of the D4R in primate brain, insufficient binding affinity of the radioligand, and a high background of nonspecific binding.  It can be concluded from these findings that [11C]PB-12 is not suitable to visualize the D4R in the primate brain with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2LacRmVVPWrVg90H21EOLACvtfcHk0lgH8J5hhf5g8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVWmuw%253D%253D&md5=c4a3d85a356eeaa5336a29e778ccb2ea</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2800%2900154-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252800%252900154-2%26sid%3Dliteratum%253Aachs%26aulast%3DLanger%26aufirst%3DO.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DY.%26aulast%3DSandell%26aufirst%3DJ.%26aulast%3DSwahn%26aufirst%3DC.%26aulast%3DN%25C3%25A5gren%26aufirst%3DK.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DCarbon-11%2520PB-12%253A%2520an%2520attempt%2520to%2520visualize%2520the%2520dopamine%2520D4%2520receptor%2520in%2520the%2520primate%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2000%26volume%3D27%26spage%3D707%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Zhang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haradahira, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span> </span><span class="NLM_article-title">Syntheses and pharmacological evaluation of two potent antagonists for dopamine D<sub>4</sub> receptors: [<sup>11</sup>C]YM-50001 and <i>N</i>-[2-[4-(4-chlorophenyl)-piperizin-1-yl]ethyl]-3-[<sup>11</sup>C]methoxybenzamide</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0969-8051%2801%2900301-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11823129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=233-241&author=M.+R.+Zhangauthor=T.+Haradahiraauthor=J.+Maedaauthor=T.+Okauchiauthor=K.+Kawabeauthor=J.+Noguchiauthor=T.+Kidaauthor=K.+Suzukiauthor=T.+Suhara&title=Syntheses+and+pharmacological+evaluation+of+two+potent+antagonists+for+dopamine+D4+receptors%3A+%5B11C%5DYM-50001+and+N-%5B2-%5B4-%284-chlorophenyl%29-piperizin-1-yl%5Dethyl%5D-3-%5B11C%5Dmethoxybenzamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide</span></div><div class="casAuthors">Zhang, Ming-Rong; Haradahira, Terushi; Maeda, Jun; Okauchi, Takashi; Kawabe, Kouichi; Noguchi, Junko; Kida, Takayo; Suzuki, Kazutoshi; Suhara, Tetsuya</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-241</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Two benzamide derivs. as dopamine D4 receptor antagonists, YM-50001 (4) and N- [2-[4-(4-chlorophenyl)piperizin-1-yl]ethyl]-3-methoxybenzamide (9), were labeled by positron-emitter (11C), and their pharmacol. specificities to dopamine D4 receptors were examd. by quant. autoradiog. and positron emission tomog. (PET).  Radiosyntheses were accomplished by O-methylation of corresponding phenol precursors (5 and 10) with [11C]CH3I followed by HPLC purifications.  In vitro binding on rat brain slices showed different distribution patterns and pharmacol. properties between the two radioligands.  The [11C]4 showed the highest binding in the striatum, which was inhibited not only by 10 μM 4 but also by 10 μM raclopride, a selective dopamine D2 receptor antagonist.  In contrast, [11C]9 showed the highest binding in the cerebral cortex, which was inhibited by several D4 receptor antagonists (9, RBI-254, L-745,870), but not by any other receptor ligands (D1/D5, D2/D3, 5-HT1A, 5-HT2A, σ1 and α1) tested.  In vivo brain distribution of [11C]9 in rat showed the highest uptake in the frontal cortex, a region that has a high d. of D4 receptors.  These results indicate that the pharmacol. property of [11C]9 matches the rat brain D4 receptors, but that of [11C]4 rather appears to match the rat brain D2 receptors.  The results for the benzamide [11C]9 prompted us to further evaluate its potential as a PET radioligand for D4 receptors by employing PET on monkey brain.  Unfortunately, in contrast to rats, neither specific binding nor differences in regional uptake of radioactivity were obsd. in monkey brain after i.v.[11C]9 injection.  Based on that specific activities of radioligands might be crit. in mapping the neurotransmitter receptors if they are only faintly expressed in the brain, [11C]9 with an extremely high specific activity (1810 GBq/μmol) was used for PET study.  However, the effort to det. the specific binding for D4 failed.  These results indicate that both of the benzamide derivs. would not be suitable radioligands for D4 receptors with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2qkB2aMa0pLVg90H21EOLACvtfcHk0lgH8J5hhf5g8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFCmsA%253D%253D&md5=8ded703bad2950f17148b59fc9294a4a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900301-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900301-8%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DHaradahira%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DKawabe%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DJ.%26aulast%3DKida%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DSuhara%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520pharmacological%2520evaluation%2520of%2520two%2520potent%2520antagonists%2520for%2520dopamine%2520D4%2520receptors%253A%2520%255B11C%255DYM-50001%2520and%2520N-%255B2-%255B4-%25284-chlorophenyl%2529-piperizin-1-yl%255Dethyl%255D-3-%255B11C%255Dmethoxybenzamide%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2002%26volume%3D29%26spage%3D233%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zhang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haradahira, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[<sup>11</sup>C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-<i>c</i>]pyridin-5-one: a PET tracer for imaging sigma<sub>1</sub> receptors</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0969-8051%2802%2900293-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=12031882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVWjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=469-476&author=M.+R.+Zhangauthor=T.+Haradahiraauthor=J.+Maedaauthor=T.+Okauchiauthor=K.+Kawabeauthor=T.+Kidaauthor=S.+Obayashiauthor=K.+Suzukiauthor=T.+Suhara&title=Synthesis+and+evaluation+of+3-%284-chlorobenzyl%29-8-%5B11C%5Dmethoxy-1%2C2%2C3%2C4-tetrahydrochromeno%5B3%2C4-c%5Dpyridin-5-one%3A+a+PET+tracer+for+imaging+sigma1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma1 receptors</span></div><div class="casAuthors">Zhang, Ming-Rong; Haradahira, Terushi; Maeda, Jun; Okauchi, Takashi; Kawabe, Kouichi; Kida, Takayo; Suzuki, Kazutoshi; Suhara, Tetsuya</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-476</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">3-(4-Chlorobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one (1), a putative dopamine D4 receptor antagonist (ki = 8.7 nM), was labeled by positron-emitter (11C) and its pharmacol. evaluation was carried out with in vitro quant. autoradiog. and positron emission tomog. (PET).  11C-Methylation of a corresponding desmethyl precursor with [11C]CH3I gave [11C]1 with ≥98% of radiochem. purity after HPLC purifn. and 67-90 GBq/μmol of specific activity at the end of synthesis.  The in vitro autoradiog. using rat brain sections demonstrated that [11C]1 shows no specific binding to the D4 receptors, but a high specific binding to sigma1 receptors (IC50 = 105 nM).  In the PET study with monkey brain, [11C]1 was highly taken up by the brain and trapped in the brain for at least 90 min.  The distribution pattern of radioactivity in the brain was striatum > thalamus > frontal cortex > cerebellum, which was same as the result of in vitro autoradiog.  Pre-treatment with non-radioactive 1 (1 mg/kg) produced a significant redn. of radioactivity in all the regions including the cerebellum.  Pre-treatment with (+)pentazocine (1 mg/kg), a selective σ1 receptor agonist, also reduced the radioactivity in the same regions to a similar extent.  These results indicate that [11C]1 may have some specific binding to the sigma1 receptors, which is consistent with the result of in vitro autoradiog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7WF1kc2dhV7Vg90H21EOLACvtfcHk0lg-JRMhhB-ntA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVWjtbs%253D&md5=ff7c35e0078be30f82d91a34e46b4319</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900293-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900293-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DHaradahira%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DKawabe%26aufirst%3DK.%26aulast%3DKida%26aufirst%3DT.%26aulast%3DObayashi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DSuhara%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25203-%25284-chlorobenzyl%2529-8-%255B11C%255Dmethoxy-1%252C2%252C3%252C4-tetrahydrochromeno%255B3%252C4-c%255Dpyridin-5-one%253A%2520a%2520PET%2520tracer%2520for%2520imaging%2520sigma1%2520receptors%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2002%26volume%3D29%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Oh, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. T.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of fluorine-substituted 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine derivatives for dopamine D<sub>4</sub> receptor imaging</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5505-5513&author=S.+J.+Ohauthor=K.+C.+Leeauthor=S.+Y.+Leeauthor=E.+K.+Ryuauthor=H.+Sajiauthor=Y.+S.+Choeauthor=D.+Y.+Chiauthor=S.+E.+Kimauthor=J.+Leeauthor=B.+T.+Kim&title=Synthesis+and+evaluation+of+fluorine-substituted+1H-pyrrolo%5B2%2C3-b%5Dpyridine+derivatives+for+dopamine+D4+receptor+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BC.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DRyu%26aufirst%3DE.%2BK.%26aulast%3DSaji%26aufirst%3DH.%26aulast%3DChoe%26aufirst%3DY.%2BS.%26aulast%3DChi%26aufirst%3DD.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DB.%2BT.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520fluorine-substituted%25201H-pyrrolo%255B2%252C3-b%255Dpyridine%2520derivatives%2520for%2520dopamine%2520D4%2520receptor%2520imaging%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5505%26epage%3D5513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Prante, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-<i>a</i>]pyridine-based dopamine D<sub>4</sub> receptor ligands: discovery of an inverse agonist radioligand for PET</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701375u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1800-1810&author=O.+Pranteauthor=R.+Tietzeauthor=C.+Hockeauthor=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=T.+Kuwertauthor=P.+Gmeiner&title=Synthesis%2C+radiofluorination%2C+and+in+vitro+evaluation+of+pyrazolo%5B1%2C5-a%5Dpyridine-based+dopamine+D4+receptor+ligands%3A+discovery+of+an+inverse+agonist+radioligand+for+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm701375u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701375u%26sid%3Dliteratum%253Aachs%26aulast%3DPrante%26aufirst%3DO.%26aulast%3DTietze%26aufirst%3DR.%26aulast%3DHocke%26aufirst%3DC.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DKuwert%26aufirst%3DT.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520radiofluorination%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520pyrazolo%255B1%252C5-a%255Dpyridine-based%2520dopamine%2520D4%2520receptor%2520ligands%253A%2520discovery%2520of%2520an%2520inverse%2520agonist%2520radioligand%2520for%2520PET%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1800%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span> <span class="citation_source-book">ClogP</span>, version <span class="NLM_edition">4.0</span> (for Windows); <span class="NLM_publisher-name">BioByte Corp.</span>: <span class="NLM_publisher-loc">Claremont, CA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClogP%2C+version+4.0+%28for+Windows%29%3B+BioByte+Corp.%3A+Claremont%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DClogP%26pub%3DBioByte%2520Corp" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET radiotracers: crossing the blood−brain barrier and surviving metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-340&author=V.+W.+Pike&title=PET+radiotracers%3A+crossing+the+blood%E2%88%92brain+barrier+and+surviving+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520radiotracers%253A%2520crossing%2520the%2520blood%25E2%2588%2592brain%2520barrier%2520and%2520surviving%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-375&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+between+radiotracer+properties+and+image+quality+in+molecular+imaging+of+the+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eaqX_rX7YoxZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520between%2520radiotracer%2520properties%2520and%2520image%2520quality%2520in%2520molecular%2520imaging%2520of%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Waterhouse, R. N.</span><span> </span><span class="NLM_article-title">Determination of lipophilicity and its use as a predictor of blood−brain barrier penetration of molecular imaging agents</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.mibio.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=14667492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=376-389&author=R.+N.+Waterhouse&title=Determination+of+lipophilicity+and+its+use+as+a+predictor+of+blood%E2%88%92brain+barrier+penetration+of+molecular+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span></div><div class="casAuthors">Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">376-89</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Compound lipophilicity is a fundamental physicochemical property that plays a pivotal role in the absorption, distribution, metabolism, and elimination (ADME) of therapeutic drugs.  Lipophilicity is expressed in several different ways, including terms such as Log P, clogP, delta Log P, and Log D.  Often a parabolic relationship exists between measured lipophilicity and in vivo brain penetration of drugs, where those moderate in lipophilicity often exhibit highest uptake.  Reduced brain extraction of more lipophilic compounds is associated with increased non-specific binding to plasma proteins.  More lipophilic compounds can also be more vulnerable to P450 metabolism, leading to faster clearance.  Very polar compounds normally exhibit high water solubility, fast clearance through the kidneys, and often contain ionizable functional groups that limit blood-brain barrier (BBB) penetration.  The brain penetration and specific to non-specific binding ratios exhibited in vivo by positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers involves a complex interplay between many critical factors, including lipophilicity, receptor affinity, metabolism, molecular size and shape, ionization potential, and specific binding to BBB efflux pumps or binding sites on albumin or other plasma proteins.  This paper explores situations in which lipophilicity is a good predictor of BBB penetration, as well as those where this correlation is poor.  The more commonly used methods for measuring lipophilicity are presented, and the various terms often found in the literature outlined.  An attempt is made to describe how this information can be used in optimizing the development of PET and SPECT tracers that target the central nervous system (CNS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8j0SWnHPWbmmfW6udTcc2eaqX_rX7YoxZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D&md5=cfff94825034cffcce30e56d703745cf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26atitle%3DDetermination%2520of%2520lipophilicity%2520and%2520its%2520use%2520as%2520a%2520predictor%2520of%2520blood%25E2%2588%2592brain%2520barrier%2520penetration%2520of%2520molecular%2520imaging%2520agents%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D376%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">1-(2-Methoxyphenyl)-4-alkylpiperazines: effect of the N-4 substituent on the affinity and selectivity for dopamine D<sub>4</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=1327-1330&author=R.+Perroneauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Leopoldoauthor=V.+Tortorella&title=1-%282-Methoxyphenyl%29-4-alkylpiperazines%3A+effect+of+the+N-4+substituent+on+the+affinity+and+selectivity+for+dopamine+D4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3D1-%25282-Methoxyphenyl%2529-4-alkylpiperazines%253A%2520effect%2520of%2520the%2520N-4%2520substituent%2520on%2520the%2520affinity%2520and%2520selectivity%2520for%2520dopamine%2520D4%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D1327%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title"><i>N</i>-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide: a potent and selective dopamine D<sub>4</sub> ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4903</span><span class="NLM_x">–</span> <span class="NLM_lpage">4909</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981041x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4903-4909&author=R.+Perroneauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Leopoldoauthor=V.+Tortorella&title=N-%5B2-%5B4-%284-Chlorophenyl%29piperazin-1-yl%5Dethyl%5D-3-methoxybenzamide%3A+a+potent+and+selective+dopamine+D4+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm981041x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981041x%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DN-%255B2-%255B4-%25284-Chlorophenyl%2529piperazin-1-yl%255Dethyl%255D-3-methoxybenzamide%253A%2520a%2520potent%2520and%2520selective%2520dopamine%2520D4%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4903%26epage%3D4909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">A structure−affinity relationship study on derivatives of <i>N</i>-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a high-affinity and selective D<sub>4</sub> receptor ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm991138z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=270-277&author=R.+Perroneauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Leopoldoauthor=V.+Tortorella&title=A+structure%E2%88%92affinity+relationship+study+on+derivatives+of+N-%5B2-%5B4-%284-chlorophenyl%29piperazin-1-yl%5Dethyl%5D-3-methoxybenzamide%2C+a+high-affinity+and+selective+D4+receptor+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm991138z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991138z%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DA%2520structure%25E2%2588%2592affinity%2520relationship%2520study%2520on%2520derivatives%2520of%2520N-%255B2-%255B4-%25284-chlorophenyl%2529piperazin-1-yl%255Dethyl%255D-3-methoxybenzamide%252C%2520a%2520high-affinity%2520and%2520selective%2520D4%2520receptor%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D270%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Jung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddareddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pae, A. N.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel T-type Ca<sup>2+</sup> channel blockers</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3965</span><span class="NLM_x">–</span> <span class="NLM_lpage">3970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=3965-3970&author=H.+K.+Jungauthor=M.+R.+Doddareddyauthor=J.+H.+Chaauthor=H.+Rhimauthor=Y.+S.+Choauthor=H.+Y.+Kohauthor=B.+Y.+Jungauthor=A.+N.+Pae&title=Synthesis+and+biological+evaluation+of+novel+T-type+Ca2%2B+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DH.%2BK.%26aulast%3DDoddareddy%26aufirst%3DM.%2BR.%26aulast%3DCha%26aufirst%3DJ.%2BH.%26aulast%3DRhim%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DKoh%26aufirst%3DH.%2BY.%26aulast%3DJung%26aufirst%3DB.%2BY.%26aulast%3DPae%26aufirst%3DA.%2BN.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520T-type%2520Ca2%252B%2520channel%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D3965%26epage%3D3970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ishizumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoku, F.</span><span> </span><span class="NLM_article-title">Synthesis and anxiolytic activity of N-substituted cyclic imides (1<i>R</i>*,2<i>S</i>*,3<i>R</i>*,4<i>S</i>*)-<i>N</i>-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3-bicyclo[2.2.1]heptanedicarboximide (tandospirone) and related compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2288</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=2288-2300&author=K.+Ishizumiauthor=A.+Kojimaauthor=F.+Antoku&title=Synthesis+and+anxiolytic+activity+of+N-substituted+cyclic+imides+%281R*%2C2S*%2C3R*%2C4S*%29-N-%5B4-%5B4-%282-pyrimidinyl%29-1-piperazinyl%5Dbutyl%5D-2%2C3-bicyclo%5B2.2.1%5Dheptanedicarboximide+%28tandospirone%29+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshizumi%26aufirst%3DK.%26aulast%3DKojima%26aufirst%3DA.%26aulast%3DAntoku%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520anxiolytic%2520activity%2520of%2520N-substituted%2520cyclic%2520imides%2520%25281R%252A%252C2S%252A%252C3R%252A%252C4S%252A%2529-N-%255B4-%255B4-%25282-pyrimidinyl%2529-1-piperazinyl%255Dbutyl%255D-2%252C3-bicyclo%255B2.2.1%255Dheptanedicarboximide%2520%2528tandospirone%2529%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D2288%26epage%3D2300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">Structure−affinity relationship study on <i>N</i>-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D<sub>3</sub> receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5727</span><span class="NLM_x">–</span> <span class="NLM_lpage">5735</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020952a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5727-5735&author=M.+Leopoldoauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=P.+De+Giorgioauthor=E.+Lacivitaauthor=R.+Perroneauthor=V.+Tortorella&title=Structure%E2%88%92affinity+relationship+study+on+N-%5B4-%284-arylpiperazin-1-yl%29butyl%5Darylcarboxamides+as+potent+and+selective+dopamine+D3+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm020952a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020952a%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DDe%2BGiorgio%26aufirst%3DP.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DStructure%25E2%2588%2592affinity%2520relationship%2520study%2520on%2520N-%255B4-%25284-arylpiperazin-1-yl%2529butyl%255Darylcarboxamides%2520as%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5727%26epage%3D5735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Enguehard-Gueiffier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueiffier, A.</span><span> </span><span class="NLM_article-title">Recent progress in medicinal chemistry of D<sub>4</sub> agonists</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2981</span><span class="NLM_x">–</span> <span class="NLM_lpage">2993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.2174%2F092986706778521841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=17073641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVamsrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2981-2993&author=C.+Enguehard-Gueiffierauthor=A.+Gueiffier&title=Recent+progress+in+medicinal+chemistry+of+D4+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in medicinal chemistry of D4 agonists</span></div><div class="casAuthors">Enguehard-Gueiffier, Cecile; Gueiffier, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2981-2993</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the last decades, the physiol. and pharmacol. properties of dopamine receptors were controversial principally because of the lack of selective ligand for some receptor subtypes.  Since 1997, some specific D4 agonists have been described and have allowed a therapeutic approach.  We report here, compds. described as D4 agonist and when available the SAR.  The major studies for physiol. implications and their potential biol. applications are also reported and principally their interest in erectile dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZcw5PILzBfrVg90H21EOLACvtfcHk0livuZEOHtkCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVamsrfL&md5=a7595ee588e420d9f12579e93e269941</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F092986706778521841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706778521841%26sid%3Dliteratum%253Aachs%26aulast%3DEnguehard-Gueiffier%26aufirst%3DC.%26aulast%3DGueiffier%26aufirst%3DA.%26atitle%3DRecent%2520progress%2520in%2520medicinal%2520chemistry%2520of%2520D4%2520agonists%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2981%26epage%3D2993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lee, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">An unambiguous assay for the cloned human sigma<sub>1</sub> receptor reveals high affinity interactions with dopamine D<sub>4</sub> receptor selective compounds and a distinct structure−affinity relationship for butyrophenones</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">578</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.ejphar.2007.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=17961544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFaitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=578&publication_year=2008&pages=123-136&author=I.+T.+Leeauthor=S.+Chenauthor=J.+A.+Schetz&title=An+unambiguous+assay+for+the+cloned+human+sigma1+receptor+reveals+high+affinity+interactions+with+dopamine+D4+receptor+selective+compounds+and+a+distinct+structure%E2%88%92affinity+relationship+for+butyrophenones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones</span></div><div class="casAuthors">Lee, Ivan T.; Chen, Shiuhwei; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">578</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">123-136</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability of the sigma1 receptor to interact with a huge range of drug structural classes coupled with its wide distribution in the body has contributed to it being implicated as a possible therapeutic target for a broad array of disorders ranging from substance abuse to depression to Alzheimer's disease.  Surprisingly, the reported affinity values for some sigma1 receptor ligands vary more than 50-fold.  The potential of the sigma1 receptor as a pharmacotherapeutic target prompted us to develop an unambiguous assay system for measuring the affinity of ligands to the cloned human sigma1 receptor.  In the course of characterizing this system and detg. the true affinity values for almost three dozen compds., it was discovered that some dopamine D4 receptor selective compds. bind sigma1 receptors with high affinity.  A systematic anal. of haloperidol-like compds. revealed a clear structure-affinity relationship amongst clin. relevant butyrophenones.  The antidepressant fluvoxamine, the drug of abuse methamphetamine, and the neurosteroid progesterone were amongst the many ligands whose interactions with the sigma1 receptor were confirmed with the screening assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6V71Qpygx17Vg90H21EOLACvtfcHk0livuZEOHtkCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFaitw%253D%253D&md5=a5f025cd9d7c3f130544afb4e3140f56</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DI.%2BT.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DAn%2520unambiguous%2520assay%2520for%2520the%2520cloned%2520human%2520sigma1%2520receptor%2520reveals%2520high%2520affinity%2520interactions%2520with%2520dopamine%2520D4%2520receptor%2520selective%2520compounds%2520and%2520a%2520distinct%2520structure%25E2%2588%2592affinity%2520relationship%2520for%2520butyrophenones%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D578%26spage%3D123%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulyás, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Brain radioligands—state of the art and new trends</span> <span class="citation_source-journal">Q. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=11476163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A280%3ADC%252BD3MvivVGhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=139-152&author=C.+Halldinauthor=B.+Guly%C3%A1sauthor=O.+Langerauthor=L.+Farde&title=Brain+radioligands%E2%80%94state+of+the+art+and+new+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Brain radioligands--state of the art and new trends</span></div><div class="casAuthors">Halldin C; Gulyas B; Langer O; Farde L</div><div class="citationInfo"><span class="NLM_cas:title">The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-52</span>
        ISSN:<span class="NLM_cas:issn">1125-0135</span>.
    </div><div class="casAbstract">Non-invasive radioligand imaging methods for brain receptor studies use either short-lived positron-emitting radionuclides such as 11C and 18F for positron emission tomography (PET) or single photon-emitting radionuclides such as 123I for single photon emission computed tomography (SPECT).  PET and SPECT use radioligands which are injected intravenously into experimental animals, human volunteers or patients.  The main applications of radioligands in brain research concern human neuropsychopharmacology and the discovery and development of novel drugs to be used in thetherapy of neurological and psychiatric disorders.  A basic problem in PET and SPECT brain receptor studies is the lack of useful radioligands with appropriate binding characteristics.  Prerequisite criteria need to be satisfied for a radioligand to reveal target binding sites in vivo.  This section will discuss these important criteria and also review recent examples in neuroreceptor radioligand development such as selective radioligands for brain monoamine transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgdxNRjf7VRfxQvRxYU81tfW6udTcc2eaM3c2IbL0jrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvivVGhtw%253D%253D&md5=cfbdf01d11608e0b9f81f5550c0c9a37</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DGuly%25C3%25A1s%26aufirst%3DB.%26aulast%3DLanger%26aufirst%3DO.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DBrain%2520radioligands%25E2%2580%2594state%2520of%2520the%2520art%2520and%2520new%2520trends%26jtitle%3DQ.%2520J.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D45%26spage%3D139%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Primus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yevich, E..</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcinerney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallager, D. W.</span><span> </span><span class="NLM_article-title">Localization and characterization of dopamine D<sub>4</sub> binding sites in rat and human brain by use of the novel, D<sub>4</sub> receptor-selective ligand [<sup>3</sup>H]NGD 94-1</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1020</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=9262371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK2sXltlSmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1997&pages=1020-1027&author=R.+Primusauthor=A.+Thurkaufauthor=J.+Xuauthor=E..+Yevichauthor=S.+Mcinerneyauthor=K.+Shawauthor=J.+F.+Tallmanauthor=D.+W.+Gallager&title=Localization+and+characterization+of+dopamine+D4+binding+sites+in+rat+and+human+brain+by+use+of+the+novel%2C+D4+receptor-selective+ligand+%5B3H%5DNGD+94-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1</span></div><div class="casAuthors">Primus, Renee J.; Thurkauf, Andrew; Xu, Jing; Yevich, Eileen; Mcinerney, Sean; Shaw, Kenneth; Tallman, John F.; Gallager, Dorothy W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1020-1027</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The dopamine D4 selective ligand, [3H]NGD 94-1, was used in these studies to characterize binding sites in rat and human brain tissue by membrane binding and autoradiog. techniques.  Autoradiog. anal. of rat brain showed that specific [3H]NGD 94-1 binding was greatest in entorhinal cortex, lateral septal nucleus, hippocampus and the medial preoptic area of the hypothalamus.  This nonstriatal distribution of [3H]NGD 94-1 binding was distinct from the autoradiog. distribution of dopamine D2 and D3 receptor subtypes.  In homogenate prepns. from rat brain regions, [3H]NGD 94-1 binding sites were low in d. (<30.0 fmol/mg protein).  The low d. of D4 binding sites was corroborated by autoradiog. comparisons in which binding d. for D4 receptors as measured by [3H]NGD 94-1 was only 1/7 of D2 and 1/5 of D3 receptor densities, despite corrections for differing radioligand binding characteristics.  Pharmacol. evaluation showed high affinity at rat [3H]NGD 94-1 binding sites for compds. with known D4 receptor affinity and little displacement by compds. with affinity for dopamine D1/D2/D3 receptor subtypes.  Specific, high-affinity [3H]NGD 94-1 binding was also present in several human brain regions, including hippocampus, hypothalamus, dorsal medial thalamus, entorhinal cortex, prefrontal cortex and lateral septal nucleus.  High-affinity [3H]NGD 94-1 binding was not present in any human striatal region examd.  The pharmacol. profile of [3H]NGD 94-1 binding sites in human brain was consistent with that previously demonstrated for cloned human D4 receptors expressed in mammalian cells.  These findings suggest that specific, high-affinity [3H]NGD 94-1 binding exists in rat and human brain and that these sites reflect populations of dopamine D4 receptors with a distribution unique among dopamine receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo59pLqDZx1IbVg90H21EOLACvtfcHk0ljGj9apH_t3dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltlSmsr8%253D&md5=8775b51d2461afcae72d3ee1b9a63f43</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrimus%26aufirst%3DR.%26aulast%3DThurkauf%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYevich%26aufirst%3DE..%26aulast%3DMcinerney%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DK.%26aulast%3DTallman%26aufirst%3DJ.%2BF.%26aulast%3DGallager%26aufirst%3DD.%2BW.%26atitle%3DLocalization%2520and%2520characterization%2520of%2520dopamine%2520D4%2520binding%2520sites%2520in%2520rat%2520and%2520human%2520brain%2520by%2520use%2520of%2520the%2520novel%252C%2520D4%2520receptor-selective%2520ligand%2520%255B3H%255DNGD%252094-1%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D282%26spage%3D1020%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">De La Garza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madras, B. K.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]PNU-101958, a D<sub>4</sub> dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2000&pages=232-244&author=R.+De+La+Garzaauthor=B.+K.+Madras&title=%5B3H%5DPNU-101958%2C+a+D4+dopamine+receptor+probe%2C+accumulates+in+prefrontal+cortex+and+hippocampus+of+non-human+primate+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLa%2BGarza%26aufirst%3DR.%26aulast%3DMadras%26aufirst%3DB.%2BK.%26atitle%3D%255B3H%255DPNU-101958%252C%2520a%2520D4%2520dopamine%2520receptor%2520probe%252C%2520accumulates%2520in%2520prefrontal%2520cortex%2520and%2520hippocampus%2520of%2520non-human%2520primate%2520brain%26jtitle%3DSynapse%26date%3D2000%26volume%3D37%26spage%3D232%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Marazziti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masala, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannaccini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palego, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catena Dell’Osso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Consoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucacchini, A.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-YM-09151-2 binding sites in human brain postmortem</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.neuint.2009.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=19540292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2ru7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2009&pages=643-647&author=D.+Marazzitiauthor=S.+Baroniauthor=I.+Masalaauthor=G.+Giannacciniauthor=L.+Bettiauthor=L.+Palegoauthor=M.+Catena+Dell%E2%80%99Ossoauthor=G.+Consoliauthor=M.+Castagnaauthor=A.+Lucacchini&title=%5B3H%5D-YM-09151-2+binding+sites+in+human+brain+postmortem"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]-YM-09151-2 binding sites in human brain postmortem</span></div><div class="casAuthors">Marazziti, Donatella; Baroni, Stefano; Masala, Irene; Giannaccini, Gino; Betti, Laura; Palego, Lionella; Dell'Osso, Mario Catena; Consoli, Giorgio; Castagna, Maura; Lucacchini, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">643-647</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The controversial and limited data on the distribution of dopamine (DA) receptors of type 4 (D4) in the human brain prompted the authors to explore their d. and pharmacol. characteristics in the prefrontal cortex, striatum and hippocampus, through a series of binding assays.  Brain samples were taken during autopsy from seven subjects.  Tissue homogenates were incubated with increasing concn. of [3H]-YM-09151-2, a D2-like receptor antagonist, and L-745,870 and/or sulpiride to define the non-specific binding, while PPAP was used to block sigma receptors.  The results showed a low d. of D4 receptors in the hippocampus only, with a preponderance of D2/D3 and sigma receptors in the prefrontal cortex and striatum.  In conclusion, these findings underline that it is possible to label D4 receptors by [3H]-YM-09151-2, provided that D2, D3 and sigma receptors are blocked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ0CZX0MI2_rVg90H21EOLACvtfcHk0ljHcnW3lHaGIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2ru7fI&md5=133bd55a1b16a0d94a2f1eee3fad35f0</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2009.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2009.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DMarazziti%26aufirst%3DD.%26aulast%3DBaroni%26aufirst%3DS.%26aulast%3DMasala%26aufirst%3DI.%26aulast%3DGiannaccini%26aufirst%3DG.%26aulast%3DBetti%26aufirst%3DL.%26aulast%3DPalego%26aufirst%3DL.%26aulast%3DCatena%2BDell%25E2%2580%2599Osso%26aufirst%3DM.%26aulast%3DConsoli%26aufirst%3DG.%26aulast%3DCastagna%26aufirst%3DM.%26aulast%3DLucacchini%26aufirst%3DA.%26atitle%3D%255B3H%255D-YM-09151-2%2520binding%2520sites%2520in%2520human%2520brain%2520postmortem%26jtitle%3DNeurochem.%2520Int.%26date%3D2009%26volume%3D55%26spage%3D643%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Inoue, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A.</span><span> </span><span class="NLM_article-title">Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments</span> <span class="citation_source-journal">Crit. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=10512490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlyhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=199-225&author=O.+Inoueauthor=K.+Kobayashiauthor=A.+Gee&title=Changes+in+apparent+rates+of+receptor+binding+in+the+intact+brain+in+relation+to+the+heterogeneity+of+reaction+environments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments</span></div><div class="casAuthors">Inoue, Osamu; Kobayashi, Kaoru; Gee, Antony</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Neurobiology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-225</span>CODEN:
                <span class="NLM_cas:coden">CCNBE8</span>;
        ISSN:<span class="NLM_cas:issn">0892-0915</span>.
    
            (<span class="NLM_cas:orgname">Begell House, Inc.</span>)
        </div><div class="casAbstract">A review, with 189 refs.  Neuroreceptor imaging by PET or SPECT has been widely applied in the field of neurobiol., from basic to clin. investigations, and has the potential to reveal the neurochem. basis of various neurol. and psychiatric diseases as well as to provide new knowledge in the field of neuropharmacol.  In contrast to the static nature of in vitro systems, neurotransmission systems in the intact brain constitute part of a dynamic and communicating environment.  Thus, it is important to develop new functional imaging methods that reflect neural communications and the dynamism of signal transmission in the living brain.  In vivo receptor binding can be altered not only by competitive inhibition by endogenous neurotransmitters but by trans-synaptic effects, and investigation of neural interactions by detection of changes in receptor binding therefore presents a potential method for studying this phenomenon.  Recently, several PET studies on in vivo neural interactions using the D2 receptor ligand [11C]-raclopride concluded that the phenomenon was mediated by changes in synaptic endogenous dopamine concns. that compete with [11C]-raclopride binding for neuroreceptor occupancy.  However, a growing body of evidence indicates that these changes in in vivo receptor binding cannot be fully explained by competitive inhibition by endogenous ligand, and alternative mechanisms for the interneuronal modulation of receptor binding are addressed.  This review highlights some of the discrepancies obsd. between in vitro and in vivo receptor binding studies with respect to a no. of phenomena, including the heterogeneity of the reaction field surrounding receptors.  Quant. receptor binding studies are usually analyzed by using 'static' binding parameters, such as the Bmax and KD, which are normally detd. by in vitro assays.  In addn. to these parameters, the apparent assocn. and dissocn. rate consts. (kon, koff) play equally significant roles in receptor binding in the intact brain is expected.  The concepts of "diffusion boundary" and "reaction vol." are introduced, and discussions on some of the discrepancies between in vivo and in vitro receptor binding phenomena are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1K8QMOgstsbVg90H21EOLACvtfcHk0ljHcnW3lHaGIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlyhu78%253D&md5=cd08e838fed1f9b96418a7ff672f43c0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DO.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DGee%26aufirst%3DA.%26atitle%3DChanges%2520in%2520apparent%2520rates%2520of%2520receptor%2520binding%2520in%2520the%2520intact%2520brain%2520in%2520relation%2520to%2520the%2520heterogeneity%2520of%2520reaction%2520environments%26jtitle%3DCrit.%2520Rev.%2520Neurobiol.%26date%3D1999%26volume%3D13%26spage%3D199%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Caccia, S.</span><span> </span><span class="NLM_article-title">N-Dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.2174%2F138920007781368908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=17691920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFeqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=612-622&author=S.+Caccia&title=N-Dealkylation+of+arylpiperazine+derivatives%3A+disposition+and+metabolism+of+the+1-aryl-piperazines+formed"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed</span></div><div class="casAuthors">Caccia, Silvio</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">612-622</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years several arylpiperazine derivs. have reached the stage of clin. application, mainly for the treatment of depression, psychosis or anxiety.  Examples are the pyrimidinylpiperazine buspirone, the chlorophenylpiperazine derivs. nefazodone and trazodone, the dichlorophenylpiperazine aripiprazole and the benzisothiazolyl derivs. perospirone and ziprasidone.  Most of them undergo extensive pre-systemic and systemic metab. including CYP3A4-dependent N-dealkylation to 1-aryl-piperazines.  These metabolites are best known for the variety of serotonin receptor-related effects they cause in man and animals, although some have affinity for other neurotransmitter receptors; others, however, are still largely unexplored despite uncontrolled use as amphetamine-like designer drugs.  Once formed they distribute extensively in tissues, including brain which is the target site of most arylpiperazine derivs., and are then primarily biotransformed by CYP2D6-dependent oxidn. to hydroxylates which are excreted as conjugates; only 1-(2-benzisothiazolyl)-piperazine is more susceptible to sulfur oxidn. than to arom. hydroxylation.  In studies analyzing animal brain and human blood, 1-aryl-piperazine concns. were either higher or lower than the parent compd.(s), although information is available only for some derivs.  At steady state, the metabolite-to-parent drug ratios varied widely among individuals taking the same dosage of the same arylpiperazine deriv.  This is consistent with the known individual variability in the expression and activity of CYP3A4 and CYP2D6.  This review also surveys current published information on physiol. and pathol. factors affecting the 1-aryl-piperazine-to-parent drug ratios and examines the potential role of 1-aryl-piperazine formation in the pharmacol. actions of the arylpiperazine derivs. that are already or will shortly be available in major markets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-2G3ghGBnD7Vg90H21EOLACvtfcHk0ljHcnW3lHaGIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFeqtLo%253D&md5=1db99dec39f0774f4e8252abcfe8941b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F138920007781368908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007781368908%26sid%3Dliteratum%253Aachs%26aulast%3DCaccia%26aufirst%3DS.%26atitle%3DN-Dealkylation%2520of%2520arylpiperazine%2520derivatives%253A%2520disposition%2520and%2520metabolism%2520of%2520the%25201-aryl-piperazines%2520formed%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D612%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55a"><span><span class="NLM_contrib-group">Steuer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaworski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosshauer, B.</span><span> </span><span class="NLM_article-title">In vitro model of the outer blood−retina barrier</span> <span class="citation_source-journal">Brain Res. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2Fj.brainresprot.2003.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=15063838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisl2rsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=26-36&author=H.+Steuerauthor=A.+Jaworskiauthor=D.+Stollauthor=B.+Schlosshauer&title=In+vitro+model+of+the+outer+blood%E2%88%92retina+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55aR"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro model of the outer blood-retina barrier</span></div><div class="casAuthors">Steuer, H.; Jaworski, A.; Stoll, D.; Schlosshauer, B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Protocols</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-36</span>CODEN:
                <span class="NLM_cas:coden">BRPRFP</span>;
        ISSN:<span class="NLM_cas:issn">1385-299X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The outer blood-retina barrier (BRB) is formed by the retinal pigment epithelium (rpe) and functions similarly to the blood-brain barrier (BBB).  In contrast to the BBB, which is composed of a myriad of capillaries, the rpe can in principle be prepd. as an intact planar tissue sheet without disruption of its barrier and carrier functions.  Both a rapid and gentle procedure to isolate porcine rpe and a method to implement the harvested rpe in drug penetration testing are presented.  Enucleated eyes were flat-mounted and the RPE/choroid tissue sheets with or without the retina were isolated.  Fluorescence microscopy based on double-labeling with propidium iodide/calcein and SEM revealed well-preserved cell and tissue architecture.  For drug evaluation, specimens were immobilized as the interface between test compartments in a dual-chamber device.  Ten different test agents were added to one chamber at defined concns.  After an incubation time of 30 min at 37 permeated drug levels in both compartments were quantified by HPLC-tandem mass spectrometry or HPLC with fluorescence detection.  Sodium fluorescein used as a barrier marker indicated that the rpe model had excellent seal integrity.  The use of a representative subset of pharmaceuticals with known BBB permeability characteristics demonstrated that the rpe model had a large permeability dynamic range (factor >350).  These findings showed that the model represents a valuable tool for the investigation of the blood barrier penetration of test compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPP-Gj1FK9C7Vg90H21EOLACvtfcHk0ljuad8Hclqviw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisl2rsLc%253D&md5=ad88e1074a7e41894ff0cc852e53e9f0</span></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresprot.2003.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresprot.2003.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DSteuer%26aufirst%3DH.%26aulast%3DJaworski%26aufirst%3DA.%26aulast%3DStoll%26aufirst%3DD.%26aulast%3DSchlosshauer%26aufirst%3DB.%26atitle%3DIn%2520vitro%2520model%2520of%2520the%2520outer%2520blood%25E2%2588%2592retina%2520barrier%26jtitle%3DBrain%2520Res.%2520Protoc.%26date%3D2004%26volume%3D13%26spage%3D26%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56a"><span><span class="NLM_contrib-group">Kyle, D. J.; Sun, Q.</span><span> </span><span class="NLM_article-title">Preparation of Piperazine Compounds as VR1 Inhibitors</span>. PCT Int. Appl. WO 2005012287,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+J.+Kyle&author=Q.+Sun&title=Preparation+of+Piperazine+Compounds+as+VR1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKyle%26aufirst%3DD.%2BJ.%26atitle%3DPreparation%2520of%2520Piperazine%2520Compounds%2520as%2520VR1%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit56b"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span>, <span class="NLM_elocation-id">198104</span> <span class="citation_source-journal">.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2005%2C+142%2C+198104."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2005%26volume%3D142%26jtitle%3D." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D<sub>3</sub> receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><div class="note"><p class="first last"> and references cited therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm050734s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=358-365&author=M.+Leopoldoauthor=E.+Lacivitaauthor=P.+De+Giorgioauthor=N.+A.+Colabufoauthor=M.+Nisoauthor=F.+Berardiauthor=R.+Perrone&title=Design%2C+synthesis%2C+and+binding+affinities+of+potential+positron+emission+tomography+%28PET%29+ligands+for+visualization+of+brain+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm050734s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050734s%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DDe%2BGiorgio%26aufirst%3DP.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520binding%2520affinities%2520of%2520potential%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520for%2520visualization%2520of%2520brain%2520dopamine%2520D3%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D358%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Avdeef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K. Y.</span><span> </span><span class="NLM_article-title">pH-metric logP11. p<i>K</i><sub>a</sub> detrmination of water-insoluble drugs in organic solvent−water mixtures</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0731-7085%2898%2900235-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=10704132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=631-641&author=A.+Avdeefauthor=K.+J.+Boxauthor=J.+E.+Comerauthor=M.+Gilgesauthor=M.+Hadleyauthor=C.+Hibbertauthor=W.+Pattersonauthor=K.+Y.+Tam&title=pH-metric+logP11.+pKa+detrmination+of+water-insoluble+drugs+in+organic+solvent%E2%88%92water+mixtures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">pH-metric log P 11. pKa determination of water-insoluble drugs in organic solvent-water mixtures</span></div><div class="casAuthors">Avdeef, A.; Box, K. J.; Comer, J. E. A.; Gilges, M.; Hadley, M.; Hibbert, C.; Patterson, W.; Tam, K. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">631-641</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The apparent acid dissocn. consts. (psKa) of two water-insol. drugs, ibuprofen and quinine, were detd. pH-metrically in acetonitrile-water, dimethylformamide-water, dimethylsulfoxide-water, 1,4-dioxane-water, ethanol-water, ethylene glycol-water, methanol-water and tetrahydrofuran-water mixts.  A glass electrode calibration procedure based on a four-parameter equation (pH = α + SpcH + jH[H+] + jOH[OH-]) was used to obtain pH readings based on the concn. scale (pcH).  The authors have called this four-parameter method the Four-Plus technique.  The Yasuda-Shedlovsky extrapolation (psKa + log [H2O] = A/ε + B) was used to derive acid dissocn. consts. in aq. soln. (pKa).  It has been demonstrated that the pKa values extrapolated from such solvent-water mixts. are consistent with each other and with previously reported measurements.  The suggested method has also been applied with success to det. the pKa values of two pyridine derivs. of pharmaceutical interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSvjQ1FZDvALVg90H21EOLACvtfcHk0ljuad8Hclqviw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCgur4%253D&md5=a2381abfa4b252497a12295e9158a8e7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2898%2900235-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252898%252900235-0%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DComer%26aufirst%3DJ.%2BE.%26aulast%3DGilges%26aufirst%3DM.%26aulast%3DHadley%26aufirst%3DM.%26aulast%3DHibbert%26aufirst%3DC.%26aulast%3DPatterson%26aufirst%3DW.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DpH-metric%2520logP11.%2520pKa%2520detrmination%2520of%2520water-insoluble%2520drugs%2520in%2520organic%2520solvent%25E2%2588%2592water%2520mixtures%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1999%26volume%3D20%26spage%3D631%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Noguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span> </span><span class="NLM_article-title">Automated synthesis of the ultra high specific activity of [<sup>11</sup>C]Ro15-4513 and its application in an extremely low concentration region to an ARG study</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1016%2FS0969-8051%2802%2900422-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=12745025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1Gjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=335-343&author=J.+Noguchiauthor=K.+Suzuki&title=Automated+synthesis+of+the+ultra+high+specific+activity+of+%5B11C%5DRo15-4513+and+its+application+in+an+extremely+low+concentration+region+to+an+ARG+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Automated synthesis of the ultra high specific activity of [11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study</span></div><div class="casAuthors">Noguchi, J.; Suzuki, K.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-343</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We have designed and constructed an automated device for the prodn. of ultra-high specific activity 11C-labeled compds. via [11C]CH3I synthesized by the single pass I2 method.  The optimum condition for the prodn. of [11C]CH3I was detd. to be 630°C for oven-1 (reaction column), 50°C for oven-2 (iodine column) and 50 mL/min for the He gas flow rate, and gave the max. conversion ratio of [11C]CH3I, 44%.  [11C]Ro15-4513, known as an inverse agonist of the benzodiazepine receptor, was produced under optimized conditions.  An i.v. injectable [11C]Ro15-4513 soln. of 1500 ± 490 MBq (n = 6) with specific activity 4700 ± 2500 GBq/μmol and a radiochem. purity of 98.2 ± 2% was obtained automatically within 25 min (from EOB) by irradiating nitrogen gas contg. 5% H2 with 18 MeV protons (14.2 MeV on target) at 20 μA for 20 min.  The highest specific activity of 9700 GBq/μmol (at EOS) could be achieved, although the radiochem. purity was 92.4%.  By the use of the ultra-high specific activity [11C]Ro15-4513, the super high affinity binding sites in the rat brain hippocampus could be clearly visualized even at the extremely low concn. of 0.66 pM Ro15-4513 by in vitro autoradiog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHDHYYHgqT87Vg90H21EOLACvtfcHk0lgUlPM88Y7Uqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1Gjsro%253D&md5=3c8561a73ead083e49f08f60b0e8a6a6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900422-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900422-5%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DK.%26atitle%3DAutomated%2520synthesis%2520of%2520the%2520ultra%2520high%2520specific%2520activity%2520of%2520%255B11C%255DRo15-4513%2520and%2520its%2520application%2520in%2520an%2520extremely%2520low%2520concentration%2520region%2520to%2520an%2520ARG%2520study%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D335%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Ericksen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">Ligand selectivity of D<sub>2</sub> dopamine receptors is modulated by changes in local dynamics produced by sodium binding</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1124%2Fjpet.108.141531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=18849360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFymtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=40-54&author=S.+S.+Ericksenauthor=D.+F.+Cummingsauthor=H.+Weinsteinauthor=J.+A.+Schetz&title=Ligand+selectivity+of+D2+dopamine+receptors+is+modulated+by+changes+in+local+dynamics+produced+by+sodium+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand selectivity of D2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding</span></div><div class="casAuthors">Ericksen, Spencer S.; Cummings, David F.; Weinstein, Harel; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-54</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have uncovered a significant allosteric response of the D2 dopamine receptor to physiol. relevant concns. of sodium (140 mM), characterized by a sodium-enhanced binding affinity for a D4-selective class of agonists and antagonists.  This enhancement is significantly more pronounced in a D2-V2.61(91)F mutant and cannot be mimicked by an equiv. concn. of the sodium replacement cation N-methyl-D-glucamine.  This phenomenon was explored computationally at the mol. level by analyzing the effect of sodium binding on the dynamic properties of D2 receptor model constructs.  Normal mode anal. identified one mode (M19), which is involved in the open/closed motions of the binding cleft as being particularly sensitive to the sodium effect.  To examine the consequences for D2 receptor ligand recognition, one of the ligands, L-745,870 [3-{[4-(4-chlorophenyl) piperazin-1-yl]methyl}-1H-pyrrolo[2,3-b]pyridine or CPPMA, chlorophenylpiperazinyl methylazaindole], was docked into conformers along the M19 trajectory.  Structurally and pharmacol. well established ligand-receptor interactions, including the ionic interaction with D3.32(114) and interactions between the ligand aryl moieties and V2.61(91)F, were achieved only in "open" phase conformers.  The docking of (-)-raclopride [3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxybenzamide] suggests that the same binding cleft changes in response to sodium-binding perturbation account as well for the enhancements in binding affinity for substituted benzamides in the wild-type D2 receptor.  Our findings demonstrate how key interactions can be modulated by occupancy at an allosteric site and are consistent with a mechanism in which sodium binding enhances the affinity of selected ligands through dynamic changes that increase accessibility of substituted benzamides and 1,4-DAP ligands to the orthosteric site and accessibility of 1,4-DAPs to V2.61(91)F.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9peW37CIIRLVg90H21EOLACvtfcHk0lgUlPM88Y7Uqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFymtw%253D%253D&md5=24298d041694b3fc97bb93a057d53357</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.141531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.141531%26sid%3Dliteratum%253Aachs%26aulast%3DEricksen%26aufirst%3DS.%2BS.%26aulast%3DCummings%26aufirst%3DD.%2BF.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DLigand%2520selectivity%2520of%2520D2%2520dopamine%2520receptors%2520is%2520modulated%2520by%2520changes%2520in%2520local%2520dynamics%2520produced%2520by%2520sodium%2520binding%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D40%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Cummings, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ericksen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">Three amino acids in the D<sub>2</sub> dopamine receptor regulate selective ligand function and affinity</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1111%2Fj.1471-4159.2009.06103.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm100925m&amp;key=19486266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVCmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=45-57&author=D.+F.+Cummingsauthor=S.+S.+Ericksenauthor=J.+A.+Schetz&title=Three+amino+acids+in+the+D2+dopamine+receptor+regulate+selective+ligand+function+and+affinity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity</span></div><div class="casAuthors">Cummings, David F.; Ericksen, Spencer S.; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-57</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The D2 dopamine receptor is an important therapeutic target for the treatment of psychotic, agitated, and abnormal behavioral states.  To better understand the specific interactions of subtype-selective ligands with dopamine receptor subtypes, seven ligands with high selectivity (>120-fold) for the D4 subtype of dopamine receptor were tested on wild-type and mutant D2 receptors.  Five of the selective ligands were obsd. to have 21-fold to 293-fold increases in D2 receptor affinity when three non-conserved amino acids in TM2 and TM3 were mutated to the corresponding D4 amino acids.  The two ligands with the greatest improvement in affinity for the D2 mutant receptor [i.e., 3-([4-(4-iodophenyl) piperazin-1-yl]methyl)-1H-pyrrolo[2,3-b]pyridine (L-750,667) and 1-[4-iodobenzyl]-4-[N-(3-isopropoxy-2-pyridinyl)-N-methyl]- aminopiperidine (RBI-257)] were investigated in functional assays.  Consistent with their higher affinity for the mutant than for the wild-type receptor, concns. of L-750,667 or RBI-257 that produced large redns. in the potency of quinpirole's functional response in the mutant did not significantly reduce quinpirole's functional response in the wild-type D2 receptor.  In contrast to RBI-257 which is an antagonist at all receptors, L-750,667 is a partial agonist at the wild-type D2 but an antagonist at both the mutant D2 and wild-type D4 receptors.  Our study demonstrates for the first time that the TM2/3 microdomain of the D2 dopamine receptor not only regulates the selective affinity of ligands, but in selected cases can also regulate their function.  Utilizing a new docking technique that incorporates receptor backbone flexibility, the three non-conserved amino acids that encompass the TM2/3 microdomain were found to account in large part for the differences in intermol. steric contacts between the ligand and receptors.  Consistent with the exptl. data, this model illustrates the interactions between a variety of subtype-selective ligands and the wild-type D2, mutant D2, or wild-type D4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1abAv4akZELVg90H21EOLACvtfcHk0lgUlPM88Y7Uqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVCmt70%253D&md5=d7c49185e1b5bd5451c962f561745bf0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06103.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06103.x%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DD.%2BF.%26aulast%3DEricksen%26aufirst%3DS.%2BS.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DThree%2520amino%2520acids%2520in%2520the%2520D2%2520dopamine%2520receptor%2520regulate%2520selective%2520ligand%2520function%2520and%2520affinity%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D110%26spage%3D45%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Cummings, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canseco, D. C..</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">Synthesis and structure−affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub> receptor subtypes</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4783</span><span class="NLM_x">–</span> <span class="NLM_lpage">4792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4783-4792&author=D.+F.+Cummingsauthor=D.+C..+Cansecoauthor=P.+Shethauthor=J.+E.+Johnsonauthor=J.+A.+Schetz&title=Synthesis+and+structure%E2%88%92affinity+relationships+of+novel+small+molecule+natural+product+derivatives+capable+of+discriminating+between+serotonin+5-HT1A%2C+5-HT2A%2C+5-HT2C+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DD.%2BF.%26aulast%3DCanseco%26aufirst%3DD.%2BC..%26aulast%3DSheth%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DJ.%2BE.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592affinity%2520relationships%2520of%2520novel%2520small%2520molecule%2520natural%2520product%2520derivatives%2520capable%2520of%2520discriminating%2520between%2520serotonin%25205-HT1A%252C%25205-HT2A%252C%25205-HT2C%2520receptor%2520subtypes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4783%26epage%3D4792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Kortagere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span> </span><span class="NLM_article-title">Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D<sub>4</sub> receptor interact with a common receptor microdomain</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1491-1499&author=S.+Kortagereauthor=P.+Gmeinerauthor=H.+Weinsteinauthor=J.+A.+Schetz&title=Certain+1%2C4-disubstituted+aromatic+piperidines+and+piperazines+with+extreme+selectivity+for+the+dopamine+D4+receptor+interact+with+a+common+receptor+microdomain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKortagere%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DCertain%25201%252C4-disubstituted%2520aromatic%2520piperidines%2520and%2520piperazines%2520with%2520extreme%2520selectivity%2520for%2520the%2520dopamine%2520D4%2520receptor%2520interact%2520with%2520a%2520common%2520receptor%2520microdomain%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1491%26epage%3D1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub>i</sub>) and the concentration of inhibitor which causes 50 per cent inhibition (IC<sub>50</sub>) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28IC50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span> </span><span class="NLM_article-title">A high resolution animal PET scanner using compact PS-PMT detectors</span> <span class="citation_source-journal">IEEE Trans. Nucl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm100925m&amp;key=10.1109%2F23.597001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm100925m&amp;key=1%3ACAS%3A528%3ADyaK2sXksVGgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1997&pages=1277-1282&author=M.+Watanabeauthor=H.+Okadaauthor=K.+Shimizuauthor=T.+Omuraauthor=E.+Yoshikawaauthor=T.+Kosugiauthor=S.+Moriauthor=T.+Yamashita&title=A+high+resolution+animal+PET+scanner+using+compact+PS-PMT+detectors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A high resolution animal PET scanner using compact PS-PMT detectors</span></div><div class="casAuthors">Watanabe, M.; Okada, H.; Shimizu, K.; Omura, T.; Yoshikawa, E.; Kosugi, T.; Mori, S.; Yamashita, T.</div><div class="citationInfo"><span class="NLM_cas:title">IEEE Transactions on Nuclear Science</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3, Pt. 2</span>),
    <span class="NLM_cas:pages">1277-1282</span>CODEN:
                <span class="NLM_cas:coden">IETNAE</span>;
        ISSN:<span class="NLM_cas:issn">0018-9499</span>.
    
            (<span class="NLM_cas:orgname">Institute of Electrical and Electronics Engineers</span>)
        </div><div class="casAbstract">A new high resoln. PET scanner dedicated to animal studies has been designed, built and tested.  The system utilizes 240 block detectors, each of which consists of a new compact position-sensitive photomultiplier tube (PS-PMT) and an 8 × 4 BGO array.  A total no. of 7,680 crystals (480 per ring) are positioned to form a 508 mm diam. of 16 detector rings with 7.2 mm pitch and 114 mm axial field of view (FOV).  The system is designed to perform activation studies using a monkey in a sitting position.  The data can be acquired in either 2D or 3D mode, where the slice collimators are retracted in 3D mode.  The transaxial resoln. is 2.6 mm FWHM at the center of the FOV, and the av. axial resoln. on the axis of the ring is 3.3 mm FWHM in the direct slice and 3.2 mm FWHM in the cross slice.  The scatter fraction, sensitivity and count rate performance were evaluated for a 10 cm diam. cylindrical phantom.  The total system sensitivity is 2.3 kcps/kBq/mL in 2D mode and 22.8 kcps/kBq/mL in 3D mode.  The noise equiv. count rate with 3D mode is equiv. to that with 2D mode at five times higher radioactivity level.  The applicable imaging capabilities of the scanner was demonstrated by animal studies with a monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxacjiYl3SbVg90H21EOLACvtfcHk0lgU3giIFOmeHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksVGgsrw%253D&md5=b05b207b02cc08181901d2712b31952b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1109%2F23.597001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1109%252F23.597001%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DH.%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DOmura%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DE.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DT.%26atitle%3DA%2520high%2520resolution%2520animal%2520PET%2520scanner%2520using%2520compact%2520PS-PMT%2520detectors%26jtitle%3DIEEE%2520Trans.%2520Nucl.%2520Sci.%26date%3D1997%26volume%3D44%26spage%3D1277%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hojo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span> </span><span class="NLM_article-title">Visualization of α5 subunit of GABA<sub>A</sub>/benzodiazepine receptor by [<sup>11</sup>C]Ro15-4513 using positron emission tomography</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2003&pages=200-208&author=J.+Maedaauthor=T.+Suharaauthor=K.+Kawabeauthor=T.+Okauchiauthor=S.+Obayashiauthor=J.+Hojoauthor=K.+Suzuki&title=Visualization+of+%CE%B15+subunit+of+GABAA%2Fbenzodiazepine+receptor+by+%5B11C%5DRo15-4513+using+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DKawabe%26aufirst%3DK.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DObayashi%26aufirst%3DS.%26aulast%3DHojo%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DK.%26atitle%3DVisualization%2520of%2520%25CE%25B15%2520subunit%2520of%2520GABAA%252Fbenzodiazepine%2520receptor%2520by%2520%255B11C%255DRo15-4513%2520using%2520positron%2520emission%2520tomography%26jtitle%3DSynapse%26date%3D2003%26volume%3D47%26spage%3D200%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a href="/doi/suppl/10.1021/jm100925m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80355"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data of target compounds and time−activity data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100925m/suppl_file/jm100925m_si_001.pdf">jm100925m_si_001.pdf (47.66 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100925m&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm100925m%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100925m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679920e838ea3c2e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
